• Abal'masov DV, Pozharitskaia MM, Starosel'tseva LK, Afanas'ev VV. Study of free-radical processes and antioxidant defense parameters during hirudotherapy of patients with diseases of salivary glands. Stomatologiia (Mosk.) 83: 27-29 (2004).

• Abe H, Tsuboi N, Yukawa S, Tsuji S, Hayashi H, Yukawa N, Takanashi H, Tahara K, Tonozuka N, Hayashi T. Thrombotic thrombocytopenic purpura complicating Sjogren's syndrome with crescentic glomerulonephritis and membranous nephritis. Mod. Rheumatol. 14: 174-178 (2004).

• Adams KM, Nelson JL. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 291: 1127-1131 (2004). *

• Adsay NV, Basturk O, Thirabanjasak D. Diagnostic features and differential diagnosis of autoimmune pancreatitis. Semin. Diagn. Pathol. 22: 309-317 (2005).

• Agoston-Coldea L, Fodor D, Pais R, Rusu ML, Georgiu C. Autoimmune cholangitis in patients with primary Sjogren's syndrome. A case report. Rom. J. Gastroenterol. 11: 321-324 (2002).

• Agrup C. Immune-mediated audiovestibular disorders in the paediatric population: a review. Int. J. Audiol. 47: 560-565 (2008).

• Aiello M, Chetta A, Marangio E, Zompatori M, Olivieri D. Pleural involvement in systemic disorders. Curr. Drug Targets Inflamm. Allergy 3: 441-447 (2004).

• Aittoniemi J, Pertovaara M, Hulkkonen J, Pasternack A, Hurme M, Laippala P, Antonen J. The significance of mannan-binding lectin gene alleles in patients with primary Sjogren's syndrome. Scand. J. Rheumatol. 31: 362-365 (2002). *

• Akimoto S, Ishikawa O, Muro Y, Takagi H, Tamura T, Miyachi Y. Clinical and immunological characterization of patients with systemic sclerosis overlapping primary biliary cirrhosis: a comparison with patients with systemic sclerosis alone. J. Dermatol. 26: 18-22 (1999).

• Akiyama Y, Suzuki T, Tanaka M, Fujimaki T, Asaoka T, Kobayashi K, Ohno S, Imai F, Matuo H. Primary biliary cirrhosis (PBC)-CREST overlap syndrome complicated with Sjogren's syndrome. Ryumachi 37: 42-47 (1997).

• Al-Awadhi AM, Olusi S, Hasan EA, Abdullah A. Serum concentrations of cardiac troponin-I in patients with rheumatoid arthritis, systemic lupus erythematosus, primary Sjogren's syndrome and Graves' disease. Singapore Med. J. 48: 847-849 (2007). *

• Al-Awadhi AM, Olusi S, Hasan EA, Abdullah A. Frequency of abnormal thyroid function tests in Kuwaiti arabs with autoimmune diseases. Med. Princ. Pract. 17: 61-65 (2008).

• Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA. Epidemiology of primary Sjogren's syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford) 45: 187-191 (2006). *

• Albrecht J, Atzeni F, Baldini C, Bombardieri S, Dalakas MC, Demirkesen C, Yazici H, Mat C, Werth VP, Sarzi-Puttini P. Skin involvement and outcome measures in systemic autoimmune diseases. Clin. Exp. Rheumatol. 24: S52-S59 (2006).

• Alcantara C, Gomes MJ, Ferreira C. Rituximab therapy in primary Sjogren's syndrome. Ann. N. Y. Acad. Sci. 1173: 701-705 (2009). *

• Allen M, Sandberg-Wollheim M, Sjogren K, Erlich HA, Petterson U, Gyllensten U. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum. Immunol. 39: 41-48 (1994).

• Alliende C, Kwon YJ, Brito M, Molina C, Aguilera S, Perez P, Leyton L, Quest AF, Mandel U, Veerman E, Espinosa M, Clausen H, Leyton C, Romo R, Gonzalez MJ. Reduced sulfation of MUC5B is linked to xerostomia in Sjogren's syndrome patients. Ann. Rheum. Dis. 67: 1480-1487 (2008).

• Almeras L, Lefranc D, Drobecq H, De Seze J, Dubucquoi S, Vermersch P, Prin L. New antigenic candidates in multiple sclerosis: identification by serological proteome analysis. Proteomics 4: 2184-2194 (2004). *

• Alpoz E, Guneri P, Onder G, Cankaya H, Kabasakal Y, Kose T. The efficacy of Xialine((R)) in patients with Sjogren's syndrome: a single-blind, cross-over study. Clin. Oral Investig. 12: 165-172 (2008). *

• Altschuler EL. Antiquity of Epstein-Barr virus, Sjogren's syndrome, and Hodgkin's disease - historical concordance and discordance. J. Natl. Cancer Inst. 91: 1512-1513 (1999). *

• Alver A, Mentese A, Karahan SC, Erem C, Keha EE, Arikan MK, Eminagaoglu MS, Deger O. Increased serum anti-carbonic anhydrase II antibodies in patients with Graves' disease. Exp. Clin. Endocrinol. Diabetes 115: 287-291 (2007).

• Alves MB, Motta AC, Messina WC, Migliari DA. Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial. Quintessence Int. 35: 392-396 (2004).

• Ambinder EP, Cohen LB, Wolke AM, Field SP, Adelsberg B, Schaffner F, Zaroulis CG. The clinical effectiveness and safety of chronic plasmapheresis in patients with primary biliary cirrhosis. J. Clin. Apheresis 2: 219-223 (1985).

• Anantharaju A, Baluch M, Van Thiel DH. Transverse myelitis occurring in association with primary biliary cirrhosis and Sjogren's syndrome. Dig. Dis. Sci. 48: 830-833 (2003). *

• Anaya JM, Correa PA, Herrera M, Eskdale J, Gallagher G. Interleukin 10 (IL-10) influences autoimmune response in primary Sjogren's syndrome and is linked to IL-10 gene polymorphism. J. Rheumatol. 29: 1874-1876 (2002). *

• Anaya JM, Correa PA, Mantilla RD, Arcos-Burgos M. TAP, HLA-DQB1, and HLA-DRB1 polymorphism in Colombian patients with primary Sjogren's syndrome. Semin. Arthritis Rheum. 31: 396-405 (2002). *

• Anaya JM, Delgado-Vega AM, Castiblanco J. Genetic basis of Sjogren's syndrome. How strong is the evidence? Clin. Dev. Immunol. 13: 209-222 (2006). *

• Anaya JM, Gomez L, Castiblanco J. Is there a common genetic basis for autoimmune diseases? Clin. Dev. Immunol. 13: 185-195 (2006). *

• Anaya JM, Mantilla RD, Correa PA. Immunogenetics of primary Sjogren's syndrome in Colombians. Semin. Arthritis Rheum. 34: 735-743 (2005). *

• Anaya JM, Rivera D, Palacio LG, Arcos-Burgos M, Correa PA. D6S439 microsatellite identifies a new susceptibility region for primary Sjogren's syndrome. J. Rheumatol. 30: 2152-2156 (2003).

• Anaya JM, Tobon GJ, Vega P, Castiblanco J. Autoimmune disease aggregation in families with primary Sjogren's syndrome. J. Rheumatol. 33: 2227-2234 (2006).

• Andersson A. Genetic control of disease in an experimental model for Sjogren's syndrome. Arthritis Res. Ther. 11: 102 (2009). *

• Andonopoulos AP, Skopouli FN, Dimou GS, Drosos AA, Moutsopoulos HM. Sjogren's syndrome in systemic lupus erythematosus. J. Rheumatol. 17: 201-204 (1990).

• Annesi G, Aguglia U, Tarantino P, Annesi F, De Marco E, Civitelli D, Torroni A, Quattrone A. SIL1 and SARA2 mutations in Marinesco-Sjogren and chylomicron retention diseases. Clin. Genet. 71: 288-289 (2007). *

• Antoniazzi RP, Miranda LA, Zanatta FB, Islabao AG, Gustafsson A, Chiapinotto GA, Oppermann RV. Periodontal conditions of individuals with Sjogren's syndrome. J. Periodontol. 80: 429-435 (2009).

• Aoki A, Kenmochi H, Hagiwara E, Ohno S, Ueda A, Tsuji T, Ideguchi H, Misumi M, Minamizawa K, Okudera K, Inoue Y, Ishigatsubo Y. Pulmonary hypertension in a patient with primary Sjogren's syndrome, Hashimoto's disease, and primary biliary cirrhosis. Nihon Rinsho Meneki Gakkai Kaishi 23: 462-469 (2000).

• Aoki A, Kirino Y, Ishigatsubo Y, Senuma A, Nagaoka S. Liver involvement in primary Sjogren's syndrome. Nihon Rinsho Meneki Gakkai Kaishi 27: 397-401 (2004).

• Aparisi L, Farre A, Gomez-Cambronero L, Martinez J, De Las Heras G, Corts J, Navarro S, Mora J, Lopez-Hoyos M, Sabater L, Ferrandez A, Bautista D, Perez-Mateo M, Mery S, Sastre J. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut 54: 703-709 (2005). *

• Aragona P, Stilo A, Ferreri F, Mobrici M. Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjogren's syndrome patients. Eye 19: 535-539 (2005).

• Archimandritis A, Tjivras M, Tsirantonaki M, Hatzis G, Delladetsima I. Sjogren's syndrome with antimitochondrial antibody-negative primary biliary cirrhosis: a case of autoimmune cholangitis. J. Clin. Gastroenterol. 20: 268-270 (1995).

• Ardesjo B, Hansson CM, Bruder CE, Rorsman F, Betterle C, Dumanski JP, Kampe O, Ekwall O. Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases. J. Autoimmun. 30: 273-282 (2008).

• Argueso P, Balaram M, Spurr-Michaud S, Keutmann HT, Dana MR, Gipson IK. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjogren syndrome. Invest. Ophthalmol. Vis. Sci. 43: 1004-1011 (2002). *

• Aries PM, Witte T, Lamprecht P. Report on the 34th Meeting of the German Clinical Immunology Workgroup, Frankfurt, 03.-04.11.2006. Z. Rheumatol. 66: 63-64 (2007).

• Arnett FC, Bias WB, Reveille JD. Genetic studies in Sjogren's syndrome and systemic lupus erythematosus. J. Autoimmun. 2: 403-413 (1989).

• Arnett FC, Hamilton RG, Reveille JD, Bias WB, Harley JB, Reichlin M. Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjogren's syndrome. Arthritis Rheum. 32: 413-419 (1989).

• Asashima N, Fujimoto M, Watanabe R, Nakashima H, Yazawa N, Okochi H, Tamaki K. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris. Br. J. Dermatol. 155: 330-336 (2006). *

• Asherson RA, Giampaolo D, Strimling M. A case of adult-onset Satoyoshi syndrome with gastric ulceration and eosinophilic enteritis. Nat. Clin. Pract. Rheumatol. 4: 439-444 (2008).

• Aslaksen HK, Nossent HC. Fatal pulmonary hypertension in primary Sjogren's syndrome. Clin. Exp. Rheumatol. 22: 507 (2004).

• Aslan E, Tarim E, Kilicdag E, Simsek E. Sjogren's syndrome diagnosed in pregnancy: a case report. J. Reprod. Med. 50: 67-70 (2005).

• Assimakopoulos SF, Michalopoulou S, Melachrinou M, Giannakoulas N, Papakonstantinou C, Lekkou A, Gogos C. Primary Sjogren syndrome complicated by autoimmune hemolytic anemia and pure red cell aplasia. Am. J. Med. Sci. 334: 493-496 (2007).

• Ates A, Kinikli G, Turgay M, Akay G, Tokgoz G. Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative study. Clin. Rheumatol. 26: 538-545 (2007). *

• Atsumi T, Amengual O, Yasuda S, Koike T. Antiprothrombin antibodies-are they worth assaying? Thromb. Res. 114: 533-538 (2004). *

• Atzeni F, Sarzi-Puttini P, Doria A, Iaccarino L, Capsoni F. Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review. Autoimmun. Rev. 4: 144-152 (2005).

• Auada MP, Puzzi MB, Cintra ML, Steiner CE, Alexandrino F, Sartorato EL, Aguiar TS, Azulay RD, Carney G, Rizzo WB. Sjogren-Larsson syndrome in Brazil is caused by a common c.1108-1G-->C splice-site mutation in the ALDH3A2 gene. Br. J. Dermatol. 154: 770-773 (2006). *

• Auada MP, Taube MB, Collares EF, Tanaka AM, Cintra ML. Sjogren-Larsson syndrome: biochemical defects and follow up in three cases. Eur. J. Dermatol. 12: 263-266 (2002).

• Avaniss-Aghajani E, Berzon S, Sarkissian A. Clinical value of multiplexed bead based immunoassays for detection of autoantibodies to nuclear antigens. Clin. Vaccine Immunol. 14: 505-509 (2007). *

• Aydogan K, Karadogan S, Balaban Adim S, Tunali S. Lupus erythematosus associated with erythema multiforme: report of two cases and review of the literature. J. Eur. Acad. Dermatol. Venereol. 19: 621-627 (2005).

• Ayed K, Gorgi Y, Sfar I, Khrouf M. Congenital heart block associated with maternal anti SSA/SSB antibodies: a report of four cases. Pathol. Biol. (Paris) 52: 138-147 (2004).

• Azeroual A, Benomar A, Harmouche H, Daoudi N, Ait Benhaddou EH, Yahyaoui M, Maaouni A. Primary Gougerot-Sjogren's syndrome presenting as a cerebellar syndrome. Rev. Neurol. (Paris) 163: 1242-1245 (2007).

• Baba A, Hara S, Sato Y, Yamada K, Fujimoto S, Eto T. Three patients with nephrotic syndrome due to membranous nephropathy complicated by Sjogren's syndrome. Nippon Jinzo Gakkai Shi 47: 882-886 (2005).

• Badn W, Kalliomaki S, Widegren B, Sjogren HO. Low-dose combretastatin a4 phosphate enhances the immune response of tumor hosts to experimental colon carcinoma. Clin. Cancer Res. 12: 4714-4719 (2006). *

• Baechler EC, Batliwalla FM, Reed AM, Peterson EJ, Gaffney PM, Moser KL, Gregersen PK, Behrens TW. Gene expression profiling in human autoimmunity. Immunol. Rev. 210: 120-137 (2006). *

• Baker OJ, Camden JM, Redman RS, Jones JE, Seye CI, Erb L, Weisman GA. The pro-inflammatory cytokines tumor necrosis factor-alpha and interferon-gamma alter tight junction structure and function in the rat parotid gland Par-C10 cell line. Am. J. Physiol. Cell Physiol. 295: C1191-C1201 (2008). *

• Baldini C, Giusti L, Bazzichi L, Lucacchini A, Bombardieri S. Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjogren's syndrome? Autoimmun. Rev. 7: 185-191 (2008).

• Banica L, Besliu A, Pistol G, Stavaru C, Ionescu R, Forsea AM, Tanaseanu C, Dumitrache S, Otelea D, Tamsulea I, Tanaseanu S, Chitonu C, Paraschiv S, Balteanu M, Stefanescu M, Matache C. Quantification and molecular characterization of regulatory T cells in connective tissue diseases. Autoimmunity 42: 41-49 (2009).

• Barone F, Bombardieri M, Manzo A, Blades MC, Morgan PR, Challacombe SJ, Valesini G, Pitzalis C. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome. Arthritis Rheum. 52: 1773-1784 (2005). *

• Barreda F, Contardo C, Leon A, Navarrete J, Figueroa R, Attanasio F. Primary sclerosing cholangitis associated with Sjogren's syndrome, retroperitoneal fibrosis and chronic pancreatitis. Report of a case. Rev. Gastroenterol. Peru 9: 106-114 (1989).

• Barta Z, Mekkel G, Csipo I, Toth L, Szakall S, Szabo GG, Bako G, Szegedi G, Zeher M. Microscopic colitis: a retrospective study of clinical presentation in 53 patients. World J. Gastroenterol. 11: 1351-1355 (2005). *

• Batbayar B, Nagy G, Kovesi G, Zelles T, Feher E. Morphological basis of sensory neuropathy and neuroimmunomodulation in minor salivary glands of patients with Sjogren's syndrome. Arch. Oral Biol. 49: 529-538 (2004).

• Baturone R, Soto M, Marquez M, Macias I, Montes de Oca M, Medina F, Chozas N, Garcia-Perez S, Giron-Gonzalez J. Health-related quality of life in patients with primary Sjogren's syndrome: relationship with serum levels of proinflammatory cytokines. Scand. J. Rheumatol. Jul 2 [Epub ahead of print] (2009). *

• Baudouin C, Pisella PJ, Brignole F. Current treatments of xerophthalmia in Sjogren's syndrome. Rev. Med. Interne. 25: 376-382 (2004).

• Baurmash HD. Diagnosing primary and secondary Sjogren's syndrome. J. Oral Maxillofac. Surg. 62: 764-765 (2004).

• Bave U, Nordmark G, Lovgren T, Ronnelid J, Cajander S, Eloranta ML, Alm GV, Ronnblom L. Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum. 52: 1185-1195 (2005). *

• Becker H, Pavenstaedt H, Willeke P. Emerging treatment strategies and potential therapeutic targets in primary Sjogren's syndrome. Inflamm. Allergy Drug Targets Sep 1 [Epub ahead of print] (2009).

• Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis. Arthritis Res. Ther. 8: R162 (2006). *

• Bejot Y, Osseby GV, Ben Salem D, Beynat J, Muller G, Moreau T, Giroud M. Bilateral optic neuropathy revealing Sjogren's syndrome. Rev. Neurol. (Paris) 164: 1044-1047 (2008).

• Belguith-Maalej S, Hadj-Kacem H, Kaddour N, Bahloul Z, Ayadi H. DNase1 exon2 analysis in Tunisian patients with rheumatoid arthritis, systemic lupus erythematosus and Sjogren syndrome and healthy subjects. Rheumatol. Int. Apr 10 [Epub ahead of print] (2009). *

• Beltran E, Toll A, Pros A, Carbonell J, Pujol RM. Assessment of nailfold capillaroscopy by x 30 digital epiluminescence (dermoscopy) in patients with Raynaud phenomenon. Br. J. Dermatol. 156: 892-898 (2007). *

• Bernacchi E, Amato L, Parodi A, Cottoni F, Rubegni P, De Pita O, Papini M, Rebora A, Bombardieri S, Fabbri P. Sjogren's syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology. Clin. Exp. Rheumatol. 22: 55-62 (2004).

• Bernard F, Romano A, Granel B. Regulatory T cells and systemic autoimmune diseases: systemic lupus erythematosus, rheumatoid arthritis, primary Sjogren's syndrome. Rev. Med. Interne. Dec 2 [Epub ahead of print] (2009).

• Bernatsky S, Ramsey-Goldman R, Clarke A. Malignancy and autoimmunity. Curr. Opin. Rheumatol. 18: 129-134 (2006).

• Bertolo F, De Vita S, Dolcetti R, Carbone A, Ferraccioli GF, Bartoli E, Boiocchi M. Lack of Fas and Fas-L mutations in patients with lymphoproliferative disorders associated with Sjogren's syndrome and type II mixed cryoglobulinemia. Clin. Exp. Rheumatol. 17: 339-342 (1999).

• Bertoni M, Niccoli L, Porciello G, Storri L, Nannini C, Manes A, Palazzini M, Galie N, Cantini F. Pulmonary hypertension in primary Sjogren's syndrome: report of a case and review of the literature. Clin. Rheumatol. 24: 431-434 (2005). *

• Bhat A, Naguwa S, Cheema G, Gershwin ME. The epidemiology of transverse myelitis. Autoimmun. Rev. Dec 22 [Epub ahead of print] (2009).

• Biasi D, Caramasch P, Carletto A, Casaril M, Colombari R, Zeminian S, Bambara LM. Sjogren's syndrome associated with autoimmune hepatitis. A case report. Clin. Rheumatol. 16: 409-412 (1997).

• Bikker A, van Woerkom J, Kruize A, Wenting-van Wijk M, de Jager W, Bijlsma J, Lafeber F, van Roon J. Increased expression of Interleukin-7 in labial salivary glands of patients with primary Sjogren's syndrome correlates with increased inflammation. Arthritis Rheum. Jan 13 [Epub ahead of print] (2010). *

• Biro E, Szekanecz Z, Czirjak L, Danko K, Kiss E, Szabo NA, Szucs G, Zeher M, Bodolay E, Szegedi G, Bako G. Association of systemic and thyroid autoimmune diseases. Clin. Rheumatol. 25: 240-245 (2006). *

• Biro T, Griger Z, Kiss E, Papp H, Aleksza M, Kovacs I, Zeher M, Bodolay E, Csepany T, Szucs K, Gergely P, Kovacs L, Szegedi G, Sipka S. Abnormal cell-specific expressions of certain protein kinase C isoenzymes in peripheral mononuclear cells of patients with systemic lupus erythematosus: effect of corticosteroid application. Scand. J. Immunol. 60: 421-428 (2004). *

• Bodil Roth E, Theander E, Londos E, Sandberg-Wollheim M, Larsson A, Sjoberg K, Stenberg P. Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sjogren's syndrome, multiple sclerosis and Alzheimer's disease. Scand. J. Immunol. 67: 626-631 (2008). *

• Boki KA, Drosos AA, Tzioufas AG, Lanchbury JS, Panayi GS, Moutsopoulos HM. Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients. Ann. Rheum. Dis. 52: 517-519 (1993). *

• Bolstad AI, Jonsson R. Genetic aspects of Sjogren's syndrome. Arthritis Res. 4: 353-359 (2002). *

• Bolstad AI, Jonsson R. Gene therapeutics in Sjogren's syndrome. Expert Opin. Biol. Ther. 5: 763-772 (2005).

• Bolstad AI, Wargelius A, Nakken B, Haga HJ, Jonsson R. Fas and Fas ligand gene polymorphisms in primary Sjogren's syndrome. J. Rheumatol. 27: 2397-2405 (2000).

• Bolstad AI, Wassmuth R, Haga HJ, Jonsson R. HLA markers and clinical characteristics in Caucasians with primary Sjogren's syndrome. J. Rheumatol. 28: 1554-1562 (2001).

• Bombardieri M, Barone F, Pittoni V, Alessandri C, Conigliaro P, Blades MC, Priori R, McInnes IB, Valesini G, Pitzalis C. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjogren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res. Ther. 6: R447-R456 (2004). *

• Bonaci-Nikolic B, Andrejevic S, Bukilica M, Urosevic I, Nikolic M. Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance. J. Clin. Immunol. 26: 438-446 (2006). *

• Borchers AT, Naguwa SM, Keen CL, Gershwin ME. Immunopathogenesis of Sjogren's syndrome. Clin. Rev. Allergy Immunol. 25: 89-104 (2003).

• Borda F, Vidan JR, Tunon T, Fortun MT. Primary biliary cirrhosis, CRST syndrome and Sjogren's syndrome. An uncommon association. Rev. Esp. Enferm. Apar. Dig. 71: 177-178 (1987).

• Borradori L, Hohl D, Rochat P, Frenk E. Annular bullous eruption in a patient with the CREST syndrome, primary biliary cirrhosis, and Sjogren's syndrome. J. Am. Acad. Dermatol. 29: 648-650 (1993).

• Bouali F, Berrah A, Si Ahmed-Bouali D, Harrieche F, Benhalima M, Hamladji RM, Arrada M. Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients). Rev. Med. Interne. 26: 777-783 (2005).

• Bourcier ME, Vinik AI. A 41-year-old man with polyarthritis and severe autonomic neuropathy. Ther. Clin. Risk Manag. 4: 837-842 (2008). *

• Bouros D, Pneumatikos I, Tzouvelekis A. Pleural involvement in systemic autoimmune disorders. Respiration 75: 361-371 (2008). *

• Bouysset M, Noel E, Tebib JG. Rheumatoid arthritis: a general disease and local diseases. Rev. Prat. 55: 2121-2133 (2005).

• Bowman SJ, Booth DA, Platts RG. Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool. Rheumatology (Oxford) 43: 758-764 (2004). *

• Bowman SJ, Ibrahim GH, Holmes G, Hamburger J, Ainsworth JR. Estimating the prevalence among Caucasian women of primary Sjogren's syndrome in two general practices in Birmingham, UK. Scand. J. Rheumatol. 33: 39-43 (2004).

• Bozinovic MT, Katic V, Krasic D, Veselinovic D, Jovanovic P, Krstic M. Clinical, histopathological and immunohistological study of lymphoid disorders in the parotid gland of patients with Sjogren's syndrome. Vojnosanit. Pregl. 66: 955-960 (2009).

• Brand A, Griffiths DJ, Herve C, Mallon E, Venables PJ. Human retrovirus-5 in rheumatic disease. J. Autoimmun. 13: 149-154 (1999).

• Brennan MT, Sankar V, Leakan RA, Grisius MM, Collins MT, Fox PC, Baum BJ, Pillemer SR. Sex steroid hormones in primary Sjogren's syndrome. J. Rheumatol. 30: 1267-1271 (2003).

• Briani C, Doria A, Ruggero S, Toffanin E, Luca M, Albergoni MP, D'Odorico A, Grassivaro F, Lucchetta M, De Lazzari F, Balzani I, Battistin L, Vernino S. Antibodies to muscle and ganglionic acetylcholine receptors (AchR) in celiac disease. Autoimmunity 41: 100-104 (2008).

• Brickman CM, Tsokos GC, Balow JE, Lawley TJ, Santaella M, Hammer CH, Frank MM. Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease. J. Allergy Clin. Immunol. 77: 749-757 (1986).

• Bridoux F, Kyndt X, Abou-Ayache R, Mougenot B, Baillet S, Bauwens M, Lemaitre V, Goujon JM, Touchard G, Vanhille P. Proximal tubular dysfunction in primary Sjogren's syndrome: a clinicopathological study of 2 cases. Clin. Nephrol. 61: 434-439 (2004).

• Brinton LA, Buckley LM, Dvorkina O, Lubin JH, Colton T, Murray MC, Hoover R. Risk of connective tissue disorders among breast implant patients. Am. J. Epidemiol. 160: 619-627 (2004). *

• Brito-Zeron P, Ramos-Casals M, Bove A, Sentis J, Font J. Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors. Rheumatology (Oxford) 46: 1359-1362 (2007). *

• Brito-Zeron P, Soria N, Munoz S, Bove A, Akasbi M, Belenguer R, Siso A, Ramos-Casals M. Prevalence and clinical relevance of autoimmune neutropenia in patients with primary Sjogren's syndrome. Semin. Arthritis Rheum. 38: 389-395 (2009). *

• Brookes SM, Pandolfino YA, Mitchell TJ, Venables PJ, Shattles WG, Clark DA, Entwistle A, Maini RN. The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br. J. Rheumatol. 31: 735-742 (1992).

• Brucato A, Brambilla G, Moreo A, Alberti A, Munforti C, Ghirardello A, Doria A, Shinar Y, Livneh A, Adler Y, Shoenfeld Y, Mauri F, Palmieri G, Spodick DH. Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. Am. J. Cardiol. 98: 267-271 (2006). *

• Brucato A, Shinar Y, Brambilla G, Robbiolo L, Ferrioli G, Patrosso MC, Zanni D, Penco S, Boiani E, Ghirardello A, Caforio AL, Bergantin A, Tombini V, Moreo A, Ashtamkar L, Doria A, Shoenfeld Y, Livneh A. Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients. Lupus 14: 670-674 (2005).

• Bryce AH, Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Inwards DJ, Yasenchak CA, Kumar SK, Gertz MA. Response to rituximab in patients with type II cryoglobulinemia. Clin. Lymphoma Myeloma 7: 140-144 (2006).

• Buchanan WW, Cox AG, Harden RM, Glen AI, Anderson JR, Gray KG. Gastric studies in Sjogren's syndrome. Gut 7: 351-354 (1966). *

• Burbelo PD, Ching KH, Issa AT, Loftus CM, Li Y, Satoh M, Reeves WH, Iadarola MJ. Rapid serological detection of autoantibodies associated with Sjogren's syndrome. J. Transl. Med. 7: 83 (2009). *

• Burnevich EZ, Lopatkina TN. System manifestations of primary biliary cirrhosis. Klin. Med. (Mosk.) 84: 42-46 (2006).

• Buskila D, Berezin M, Gur H, Lin HC, Alosachie I, Terryberry JW, Barka N, Shen B, Peter JB, Shoenfeld Y. Autoantibody profile in the sera of women with hyperprolactinemia. J. Autoimmun. 8: 415-424 (1995).

• Cabrera Pivaral CE, Gutierrez Gonzalez TY, Gamez Nava JI, Nava A, Villa Manzano AI, Luce Gonzalez E. Clinical competence for autoimmune and non-autoimmune rheumatic disorders in primary care. Rev. Alerg. Mex. 56: 18-22 (2009).

• Caccavo D, Afeltra A, Rigon A, Vadacca M, Zobel BB, Zennaro D, Arcarese L, Buzzulini F, Pellegrino NM, Amoroso A. Antibodies to carbonic anhydrase in patients with connective tissue diseases: relationship with lung involvement. Int. J. Immunopathol. Pharmacol. 21: 659-668 (2008).

• Calafat M, Larocca L, Roca V, Perez Leiros C. NOD mice exocrinopathy: towards a neuroimmune link. Neuroimmunomodulation 14: 175-181 (2007).

• Camargo JF, Correa PA, Castiblanco J, Anaya JM. Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun. 5: 609-614 (2004). *

• Canonica GW, Croci R, Bagnasco M, Ferrini S, Cosulich ME, Ferrini O, Giordano G. Deficiency of the autologous mixed lymphocyte reaction in patients with autoimmune thyroid disease. Int. Arch. Allergy Appl. Immunol. 73: 137-140 (1984).

• Caramaschi P, Biasi D, Volpe A, Carletto A, Cecchetto M, Bambara LM. Coexistence of systemic sclerosis with other autoimmune diseases. Rheumatol. Int. 27: 407-410 (2007). *

• Caramella C, Avouac J, Sogni P, Puechal X, Kahan A, Allanore Y. Association between rheumatoid arthritis and primary biliary cirrhosis. Joint Bone Spine 74: 279-281 (2007). *

• Carbone J, Perez-Fernandez R, Munoz A, Sabin P, Carreno L, Fernandez-Cruz E. Combined therapy with rituximab plus cyclophosphamide/vincristine/prednisone for Sjogren's syndrome-associated B-cell non-Hodgkin's lymphoma. Clin. Rev. Allergy Immunol. 34: 80-84 (2008). *

• Carbone J, Sarmiento E, Micheloud D, Rodriguez-Mahou M, Rodriguez-Molina JJ, Cobo R, Fernandez-Cruz E. Systemic autoimmune disease in patients with uveitis. Arch. Soc. Esp. Oftalmol. 81: 193-198 (2006).

• Carmassi F, Giannarelli C, DE Giorgi A, DE Negri F. Combined factor VIII and IX inhibitors in a non-haemophilic patient: successful treatment with immunosuppressive drugs. Haemophilia 13: 106-107 (2007). *

• Carney G, Wei S, Rizzo WB. Sjogren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2. Hum. Mutat. 24: 186 (2004). *

• Carpenter GH, Proctor GB, Pankhurst CL, O'Donohue J, Scott D, Hunnable MP. Sialochemical markers of salivary gland involvement with Sjogren's syndrome secondary to rheumatoid arthritis and primary biliary cirrhosis. J. Oral. Pathol. Med. 29: 452-459 (2000).

• Carpo M, Scarlato M, Bardella M, Terrani C, Peracchi M, Allaria S, Nobile-Orazio E, Bresolin N. Painful sensory neuropathy and dysimmunity: is there a relation? J. Peripher. Nerv. Syst. 9: 121 (2004).

• Caserta TM, Knisley AA, Tan FK, Arnett FC, Brown TL. Genotypic analysis of the TGF beta-509 allele in patients with systemic lupus erythematosus and Sjogren's syndrome. Ann. Genet. 47: 359-363 (2004).

• Castiblanco J, Anaya JM. The IkappaBL gene polymorphism influences risk of acquiring systemic lupus erythematosus and Sjogren's syndrome. Hum. Immunol. 69: 45-51 (2008).

• Caulfield VL, Balmer C, Dawson LJ, Smith PM. A role for nitric oxide-mediated glandular hypofunction in a non-apoptotic model for Sjogren's syndrome. Rheumatology (Oxford) 48: 727-733 (2009).

• Cavazzana I, Ceribelli A, Franceschini F, Cattaneo R. Unusual association between pure red cell aplasia and primary Sjogren's syndrome: a case report. Clin. Exp. Rheumatol. 25: 309-311 (2007).

• Cavazzana I, Ceribelli A, Quinzanini M, Scarsi M, Airo P, Cattaneo R, Franceschini F. Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. Lupus 17: 727-732 (2008). *

• Cavill D, Waterman SA, Gordon TP. Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjogren's syndrome. Scand. J. Immunol. 59: 261-266 (2004). *

• Cejkova J, Ardan T, Cejka C, Malec J, Jirsova K, Filipec M, Ruzickova E, Dotrelova D, Brunova B. Ocular surface injuries in autoimmune dry eye. The severity of microscopical disturbances goes parallel with the severity of symptoms of dryness. Histol. Histopathol. 24: 1357-1365 (2009). *

• Cejkova J, Ardan T, Jirsova K, Jechova G, Malec J, Simonova Z, Cejka C, Filipec M, Dotrelova D, Brunova B. The role of conjunctival epithelial cell xanthine oxidoreductase/xanthine oxidase in oxidative reactions on the ocular surface of dry eye patients with Sjogren's syndrome. Histol. Histopathol. 22: 997-1003 (2007).

• Cejkova J, Ardan T, Simonova Z, Cejka C, Malec J, Dotrelova D, Brunova B. Decreased expression of antioxidant enzymes in the conjunctival epithelium of dry eye (Sjogren's syndrome) and its possible contribution to the development of ocular surface oxidative injuries. Histol. Histopathol. 23: 1477-1483 (2008). *

• Cejkova J, Ardan T, Simonova Z, Cejka C, Malec J, Jirsova K, Filipec M, Dotrelova D, Brunova B. Nitric oxide synthase induction and cytotoxic nitrogen-related oxidant formation in conjunctival epithelium of dry eye (Sjogren's syndrome). Nitric Oxide 17: 10-17 (2007).

• Cellini M, Versura P, Leonetti P, Frigato M, Manfredini E, Malavolta N, Campos EC. Ocular surface and intraocular inflammation are related in SS-I and rheumatoid arthritis patients. Rheumatol. Int. 27: 853-857 (2007). *

• Cha S, Brayer J, Gao J, Brown V, Killedar S, Yasunari U, Peck AB. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand. J. Immunol. 60: 552-565 (2004). *

• Cha S, Singson E, Cornelius J, Yagna JP, Knot HJ, Peck AB. Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjogren's syndrome-associated autoantibodies. J. Rheumatol. 33: 296-306 (2006).

• Cha SI, Fessler MB, Cool CD, Schwarz MI, Brown KK. Lymphoid interstitial pneumonia: clinical features, associations, and prognosis. Eur. Respir. J. 28: 364-369 (2006).

• Chaby G, Viseux V, Poulain JF, De Cagny B, Denoeux JP, Lok C. Topical silver sulfadiazine-induced acute renal failure. Ann. Dermatol. Venereol. 132: 891-893 (2005).

• Chambers MS. Sjogren's syndrome. ORL Head Neck Nurs. 22: 22-30 (2004).

• Chan HL, Lee YS, Hong HS, Kuo TT. Anticentromere antibodies (ACA): clinical distribution and disease specificity. Clin. Exp. Dermatol. 19: 298-302 (1994).

• Chang HK, Bang KT, Lee BH, Kim JH, Bae KW, Kim MJ, Kim SK. Concurrence of Sjogren's syndrome in a patient with Chlamydia-induced reactive arthritis; an unusual finding. Korean J. Intern. Med. 21: 116-119 (2006).

• Chao YC, Cheng TS, Chou CT. Panniculitis: an unusual cutaneous manifestation of rheumatoid arthritis. J. Clin. Rheumatol. 12: 190-193 (2006).

• Charalabopoulos K, Mittari E, Peschos D, Golias C, Charalabopoulos A, Tsanou E, Batistatou A. Rare association of chronic lymphocytic thyroiditis with dermatomyositis. Arch. Med. Res. 37: 563-565 (2006).

• Chatte G, Streichenberger N, Boillot O, Gille D, Loire R, Cordier JF. Lymphocytic bronchitis/bronchiolitis in a patient with primary biliary cirrhosis. Eur. Respir. J. 8: 176-179 (1995).

• Chen CH, Chen HA, Wang HP, Liao HT, Chou CT, Huang de F. Pulmonary arterial hypertension in autoimmune diseases: an analysis of 19 cases from a medical center in northern Taiwan. J. Microbiol. Immunol. Infect. 39: 162-168 (2006). *

• Chen HA, Chen CH, Cheng HH. Hemolytic uremic syndrome and pericarditis as early manifestations of primary Sjogren's syndrome. Clin. Rheumatol. 28 Suppl. 1: S43-S46 (2009).

• Chen Q, Li X, He W, Zhang H, Gao A, Cheng Y, Lei J, Li S, Zeng L. The epitope study of alpha-fodrin autoantibody in primary Sjogren's syndrome. Clin. Exp. Immunol. 149: 497-503 (2007). *

• Chen WS, Lin KC, Chen CH, Liao HT, Wang HP, Li WY, Lee HT, Tsai CY, Chou CT. Autoantibody and biopsy grading are associated with expression of ICAM-1, MMP-3, and TRAIL in salivary gland mononuclear cells of Chinese patients with Sjogren's syndrome. J. Rheumatol. 36: 989-996 (2009).

• Chen X, Wolin SL. The Ro 60 kDa autoantigen: insights into cellular function and role in autoimmunity. J. Mol. Med. 82: 232-239 (2004).

• Chen Y, Zhao X, Tang D, Xu C, Sun L, Sun L, Wu J, Mei C. IgA nephropathy in two patients with Sjogren's syndrome: one with concomitant autoimmune hepatitis. Intern. Med. 49: 37-43 (2010). *

• Chiorini JA, Cihakova D, Ouellette CE, Caturegli P. Sjogren syndrome: advances in the pathogenesis from animal models. J. Autoimmun. 33: 190-196 (2009).

• Choudhuri G, Somani SK, Baba CS, Alexander G. Autoimmune hepatitis in India: profile of an uncommon disease. BMC Gastroenterol. 5: 27 (2005). *

• Christensen T, Moller-Larsen A. Human endogenous retroviruses and disease? Ugeskr. Laeger. 165: 556-561 (2003).

• Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM. Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome. J. Autoimmun. Nov 2 [Epub ahead of print] (2009).

• Christodoulou MI, Kapsogeorgou EK, Moutsopoulos NM, Moutsopoulos HM. Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors. Am. J. Pathol. 173: 1389-1396 (2008). *

• Cihakova D, Talor MV, Barin JG, Baldeviano GC, Fairweather D, Rose NR, Burek CL. Sex differences in a murine model of Sjogren's syndrome. Ann. N. Y. Acad. Sci. 1173: 378-383 (2009). *

• Civilibal M, Canpolat N, Yurt A, Kurugoglu S, Erdamar S, Bagci O, Sever L, Kasapcopur O, Caliskan S, Arisoy N. A child with primary Sjogren syndrome and a review of the literature. Clin. Pediatr. (Phila.) 46: 738-742 (2007).

• Claeys V, Wackens G. Sjogren syndrome: a review of the literature and a case report. Rev. Belge. Med. Dent. 61: 161-172 (2006).

• Coaccioli S, Giuliani M, Puxeddu A. The therapy of Sjogren's syndrome: a review. Clin. Ter. 158: 453-456 (2007).

• Cobb BL, Lessard CJ, Harley JB, Moser KL. Genes and Sjogren's syndrome. Rheum. Dis. Clin. North Am. 34: 847-868 (2008).

• Cojocaru VM, Ciurtin C, Puchianu E, Anothe F. Electroforetic analysis of lacrimal proteins - diagnostic method in secondary Sjogren syndrome. Oftalmologia 50: 3-5 (2006).

• Cojocaru VM, Ciurtin C, Puchianu E, Antohe F. Lacrimal proteins electrophoretic analysis - diagnostic method in secondary Sjogren syndrome. Oftalmologia 50: 60-63 (2006).

• Coll J, Palazon J, Yazbeck H, Gutierrez J, Aubo C, Benito P, Jagiello P, Maldyk H, Marrugat J, Anglada J, et al. Antibodies to human immunodeficiency virus (HIV-1) in autoimmune diseases: primary Sjogren's syndrome, systemic lupus erythematosus, rheumatoid arthritis and autoimmune thyroid diseases. Clin. Rheumatol. 14: 451-457 (1995).

• Coll J, Rives A, Grino MC, Setoain J, Vivancos J, Balcells A. Prevalence of Sjogren's syndrome in autoimmune diseases. Ann. Rheum. Dis. 46: 286-289 (1987). *

• Connolly MK. Sjogren's syndrome. Semin. Cutan. Med. Surg. 20: 46-52 (2001).

• Cooke SP, Rigby SP, Griffiths DJ, Venables PJ. Viral studies in rheumatic disease. Ann. Med. Interne. (Paris) 149: 30-33 (1998).

• Cooper RM, Butler DF, Ghali F, Grimwood RE. Periorbital cutaneous neonatal lupus. Skinmed. 6: 145-146 (2007).

• Correa PA, Gomez LM, Anaya JM. Polymorphism of TNF-alpha in autoimmunity and tuberculosis. Biomedica 24 Supp. 1: 43-51 (2004).

• Correa PA, Gomez LM, Cadena J, Anaya JM. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J. Rheumatol. 32: 219-224 (2005).

• Correa PA, Tobon GJ, Citera G, Cadena J, Schneeberger E, Camargo JF, Maldonado-Cocco JA, Anaya JM. Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1. Biomedica 24: 140-152 (2004).

• Costa C, Sambataro A, Baldi S, Modena V, Todros L, Libertucci D, Coni F, Fusaro E, Revello F, Murgia A, et al. Primary biliary cirrhosis: lung involvement. Liver 15: 196-201 (1995).

• Couderc AL, Costello R, Bagneres D, Rossi P, Vitton V, Demoux AL, Bonin-Guillaume S, Frances Y, Granel B. Is pure red cell aplasia a new extra digestive manifestation of celiac disease? Rev. Med. Interne. 27: 336-339 (2006).

• Coudevylle N, Rokas D, Sakarellos-Daitsiotis M, Krikorian D, Panou-Pomonis E, Sakarellos C, Boussard G, Cung MT. Phosphorylated and non-phosphorylated epitopes of the La/SSB autoantigen: comparison of their antigenic and conformational characteristics. Biopolymers 84: 368-382 (2006).

• Cox SW, Ebersole LE, Carpenter GH, Proctor GB. Effects of autonomic agonists and immunomodulatory cytokines on polymeric immunoglobulin receptor expression by cultured rat and human salivary and colonic cell lines. Arch. Oral Biol. 52: 411-416 (2007).

• Cozar-Castellano I, Del Valle Machargo M, Trujillo E, Arteaga MF, Gonzalez T, Martin-Vasallo P, Avila J. hIscA: a protein implicated in the biogenesis of iron-sulfur clusters. Biochim. Biophys. Acta 1700: 179-188 (2004). *

• Creange A. The diagnosis of acquired sensory neuropathies. Rev. Neurol. (Paris) 160: 363-370 (2004).

• Crestani B. The respiratory system in connective tissue disorders. Allergy 60: 715-734 (2005). *

• Creuzot-Garcher C, Lafontaine PO, Brignole F, Pisella PJ, d'Athis P, Bron A, Lapierre V, Baudouin C. Treating severe dry eye syndromes with autologous serum. J. Fr. Ophtalmol. 27: 346-351 (2004).

• Crispin-Acuna JC, Remes-Troche JM, Uribe M. Abnormal hepatic biochemistries and clinical liver disease in patients with primary Sjogren's syndrome. Ann. Hepatol. 6: 150-155 (2007). *

• Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M, Moser KL, Begovich AB, Carlton VE, Li W, Lee AT, Ortmann W, Behrens TW, Gregersen PK. Analysis of families in the Multiple Autoimmune Disease Genetics Consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am. J. Hum. Genet. 76: 561-571 (2005). *

• Crowson AN, Mihm MC Jr, Magro CM. Cutaneous vasculitis: a review. J. Cutan. Pathol. 30: 161-173 (2003). *

• Cruz AA, Akaishi PM, Vargas MA, de Paula SA. Association between thyroid autoimmune dysfunction and non-thyroid autoimmune diseases. Ophthal. Plast. Reconstr. Surg. 23: 104-108 (2007).

• Csepregi A, Szodoray P, Zeher M. Do autoantibodies predict autoimmune liver disease in primary Sjogren's syndrome? Data of 180 patients upon a 5 year follow-up. Scand. J. Immunol. 56: 623-629 (2002). *

• Cutolo M, Sulli A, Secchi ME, Paolino S, Pizzorni C. Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatology (Oxford) 45 Suppl. 4: iv43-iv46 (2006). *

• Czaja AJ. Extrahepatic immunologic features of chronic viral hepatitis. Dig. Dis. 15: 125-144 (1997).

• Czaja AJ. The autoimmune hepatitis/hepatitis C overlap syndrome: does it exist? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 42-43. October 15-16 (2003). *

• Czaja AJ. Autoimmune liver disease and rheumatic manifestations. Curr. Opin. Rheumatol. 19: 74-80 (2007).

• Czirjak L, Zeher M, Nagy Z, Szegedi G. Sjogren's syndrome, primary biliary cirrhosis and overlap with scleroderma symptoms. J. Intern. Med. 233: 427-428 (1993).

• d'Elia HF, Rehnberg E, Kvist G, Ericsson A, Konttinen YT, Mannerkorpi K. Fatigue and blood pressure in primary Sjogren's syndrome. Scand. J. Rheumatol. 37: 284-292 (2008). *

• D'Onofrio F, Miele L, Diaco M, Santoro L, De Socio G, Montalto M, Grieco A, Gasbarrini G, Manna R. Sjogrens syndrome in a celiac patient: searching for environmental triggers. Int. J. Immunopathol. Pharmacol. 19: 445-448 (2006).

• Dai Y, Liang YH, Xie PY, Chen BW, Liu XG. Clinical analysis of primary biliary cirrhosis: a report of 42 cases. Beijing Da Xue Xue Bao 37: 410-414 (2005).

• Dalvi V, Gonzalez EB, Lovett L. Lymphocytic interstitial pneumonitis (LIP) in Sjogren's syndrome: a case report and a review of the literature. Clin. Rheumatol. 26: 1339-1343 (2007).

• Dankof A, Morawietz L, Feist E. Labial salivary gland biopsy in Sjogren's syndrome. Pathologe 27: 416-421 (2006).

• Daridon C, Guerrier T, Devauchelle V, Saraux A, Pers JO, Youinou P. Polarization of B effector cells in Sjogren's syndrome. Autoimmun. Rev. 6: 427-431 (2007).

• Dartt DA. Dysfunctional neural regulation of lacrimal gland secretion and its role in the pathogenesis of dry eye syndromes. Ocul. Surf. 2: 76-91 (2004).

• Dawson L, Tobin A, Smith P, Gordon T. Antimuscarinic antibodies in Sjogren's syndrome: where are we, and where are we going? Arthritis Rheum. 52: 2984-2995 (2005). *

• Dawson LJ, Allison HE, Stanbury J, Fitzgerald D, Smith PM. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches. Rheumatology (Oxford) 43: 1488-1495 (2004). *

• De Paiva CS, Hwang CS, Pitcher JD 3rd, Pangelinan SB, Rahimy E, Chen W, Yoon KC, Farley WJ, Niederkorn JY, Stern ME, Li DQ, Pflugfelder SC. Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice. Rheumatology (Oxford) 49: 246-258 (2010).

• De Seze J, Dubucquoi S, Fauchais AL, Hachulla E, Matthias T, Lefranc D, Hatron PY, Vermersch P, Witte T. Autoantibodies against alpha-fodrin in Sjogren's syndrome with neurological manifestations. J. Rheumatol. 31: 500-503 (2004).

• De Vita S, Boiocchi M, Sorrentino D, Carbone A, Avellini C, Dolcetti R, Marzotto A, Gloghini A, Bartoli E, Beltrami CA, Ferraccioli G. Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren's syndrome. Arthritis Rheum. 40: 318-331 (1997).

• De Vita S, Ferraccioli GF, Dolcetti R, Marzotto A, Pivetta B, Pomponi F, Boiocchi M. The role of molecular analyses of B-cell and T-cell clonality in the study of B-cell lymphomagenesis. Clin. Exp. Rheumatol. 14 Suppl. 14: S21-S29 (1996).

• Deas JE, Liu LG, Thompson JJ, Sander DM, Soble SS, Garry RF, Gallaher WR. Reactivity of sera from systemic lupus erythematosus and Sjogren's syndrome patients with peptides derived from human immunodeficiency virus p24 capsid antigen. Clin. Diagn. Lab. Immunol. 5: 181-185 (1998). *

• Decuzzi M, Tatulli F, Giampaolo M, Tesse R, Gasparre M, Pepe G, Decuzzi P, Asteriadis I. Sialocintigraphy versus ultrasonography of the salivary glands in patients first diagnosed with Sjogren's syndrome. Hell. J. Nucl. Med. 9: 103-105 (2006).

• Delaleu N, Immervoll H, Cornelius J, Jonsson R. Biomarker profiles in serum and saliva of experimental Sjogren's syndrome - associations with specific autoimmune manifestations. Arthritis Res. Ther. 10: R22 (2008). *

• Delaleu N, Jonsson MV, Appel S, Jonsson R. New concepts in the pathogenesis of Sjogren's syndrome. Rheum. Dis. Clin. North Am. 34: 833-845 (2008).

• Delaleu N, Jonsson R, Koller MM. Sjogren's syndrome. Eur. J. Oral Sci. 113: 101-113 (2005). *

• Demenais F, Kanninen T, Lindgren CM, Wiltshire S, Gaget S, Dandrieux C, Almgren P, Sjogren M, Hattersley A, Dina C, Tuomi T, McCarthy MI, Froguel P, Groop LC. A meta-analysis of four European genome screens (GIFT Consortium) shows evidence for a novel region on chromosome 17p11.2-q22 linked to type 2 diabetes. Hum. Mol. Genet. 12: 1865-1873 (2003). *

• Derk CT, Vivino FB. A primary care approach to Sjogren's syndrome. Helping patients cope with sicca symptoms, extraglandular manifestations. Postgrad. Med. 116: 49-54, 59, 65 (2004).

• Deshmukh US, Lewis JE, Gaskin F, Kannapell CC, Waters ST, Lou YH, Tung KS, Fu SM. Immune responses to Ro60 and its peptides in mice. I. The nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantibodies. J. Exp. Med. 189: 531-540 (1999). *

• Deshmukh US, Ohyama Y, Bagavant H, Guo X, Gaskin F, Fu SM. Inflammatory stimuli accelerate Sjogren's syndrome-like disease in (NZB x NZW)F(1) mice. Arthritis Rheum. 58: 1318-1323 (2008). *

• Diamond B. Systemic lupus erythematosus and Sjogren syndrome. Curr. Opin. Rheumatol. 18: 449-450 (2006).

• Dias Gonzalez F, Pedreira Magalhaes F, Pontes Vilas Boas Freitas A, Castro Lima Filho H, Santiago MB. Lipodermatosclerosis in patients with diffuse connective tissue diseases. Eur. J. Intern. Med. 17: 288-289 (2006).

• Diaz Rodriguez C, Gonzalez Rivero C, Trinidad San Jose JC, Del Rio Romero D, Moreno Fernandez A, Granja Romero E. Osteal complications as first manifestation in a patient with primary Sjogren's syndrome and with associated distal tubular acidosis (type 1) and chronic renal insufficiency. Therap. Apher. Dial. 8: 160-163 (2004).

• Diaz-Lopez C, Geli C, Corominas H, Malat N, Diaz-Torner C, Llobet JM, De La Serna AR, Laiz A, Moreno M, Vazquez G. Are there clinical or serological differences between male and female patients with primary Sjogren's syndrome? J. Rheumatol. 31: 1352-1355 (2004). *

• Diep JT, Gorevic PD. Geriatric autoimmune diseases: systemic lupus erythematosus, Sjogren's syndrome, and myositis. Geriatrics 60: 32-38 (2005).

• DiGiovanna JJ, Robinson-Bostom L. Ichthyosis: etiology, diagnosis, and management. Am. J. Clin. Dermatol. 4: 81-95 (2003).

• Dogru M, Tsubota K. New insights into the diagnosis and treatment of dry eye. Ocul. Surf. 2: 59-75 (2004).

• Dominguez-Gonzalez C, Martinez-Salio A, Gordo-Manas R, Ballesteros-Plaza L, Hernandez-Lain A, Hernandez-Gallego J. Sensory ganglionopathy as a manifestation of celiac disease. Rev. Neurol. 45: 91-94 (2007).

• Dorner T, Feist E, Wagenmann A, Kato T, Yamamoto K, Nishioka K, Burmester GR, Hiepe F. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen. J. Rheumatol. 23: 462-468 (1996).

• Dorner T, Held C, Trebeljahr G, Lukowsky A, Yamamoto K, Hiepe F. Serologic characteristics in primary biliary cirrhosis associated with sicca syndrome. Scand. J. Gastroenterol. 29: 655-660 (1994).

• Downie-Doyle S, Bayat N, Rischmueller M, Lester S. Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjogren's syndrome. Arthritis Rheum. 54: 2434-2440 (2006). *

• Downie-Doyle S, Lester S, Bardy P, Gordon T, Rischmueller M, Pile K. Immunoglobulin kappa light chain gene alleles are not associated with primary Sjogren's syndrome. Genes Immun. 3 Suppl. 1: S63-S65 (2002). *

• Drosos AA, Georgiadis AN, Metafratzi ZM, Voulgari PV, Efremidis SC, Bai M. Sinus histocytosis with massive lymphadenopathy (Rosai-Dorfman disease) in a patient with primary Sjogren's syndrome. Scand. J. Rheumatol. 33: 119-122 (2004). *

• Drosos AA, Moutsopoulos HM. Rheumatoid arthritis in Greece: clinical, serological and genetic considerations. Clin. Exp. Rheumatol. 13 Suppl. 12: S7-S12 (1995).

• Dunn P, Kuo TT, Shih LY, Lin TL, Wang PN, Kuo MC, Tang CC. Primary salivary gland lymphoma: a clinicopathologic study of 23 cases in Taiwan. Acta Haematol. 112: 203-208 (2004).

• Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, Mortensen PB. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am. J. Psychiatry 163: 521-528 (2006). *

• Ectors N, Maillet B, Aerts R, Geboes K, Donner A, Borchard F, Lankisch P, Stolte M, Luttges J, Kremer B, Kloppel G. Non-alcoholic duct destructive chronic pancreatitis. Gut 41: 263-268 (1997). *

• Efthimiou P, Markenson JA. Role of biological agents in immune-mediated inflammatory diseases. South. Med. J. 98: 192-204 (2005).

• Ekroos M, Sjogren T. Structural basis for ligand promiscuity in cytochrome P450 3A4. Proc. Natl. Acad. Sci. U.S.A. 103: 13682-13687 (2006). *

• El Miedany YM, Ahmed I, Mourad HG, Mehanna AN, Aty SA, Gamal HM, El Baddini M, Smith P, El Gafaary M. Quantitative ultrasonography and magnetic resonance imaging of the parotid gland: can they replace the histopathologic studies in patients with Sjogren's syndrome? Joint Bone Spine 71: 29-38 (2004).

• El Miedany YM, Ahmed I, Moustafa H, El Baddini M. Hyperprolactinemia in Sjogren's syndrome: a patient subset or a disease manifestation? Joint Bone Spine 71: 203-208 (2004).

• El Miedany YM, Baddour M, Ahmed I, Fahmy H. Sjogren's syndrome: concomitant H. pylori infection and possible correlation with clinical parameters. Joint Bone Spine 72: 135-141 (2005).

• Elias E. Hepatology highlights. Hepatology 42: 1241-1242 (2005). *

• Elkayam O, Oumanski M, Yaron M, Caspi D. Watermelon stomach following and preceding systemic sclerosis. Semin. Arthritis Rheum. 30: 127-131 (2000). *

• Elzbieta R, Elzbieta W, Dariusz G, Langfort R, Ptak J. Lymphocytic interstitial pneumonia in primary Sjogren syndrome. Pneumonol. Alergol. Pol. 73: 277-280 (2005).

• Emamian ES, Leon JM, Lessard CJ, Grandits M, Baechler EC, Gaffney PM, Segal B, Rhodus NL, Moser KL. Peripheral blood gene expression profiling in Sjogren's syndrome. Genes Immun. 10: 285-296 (2009). *

• Endo Y, Negishi I, Ishikawa O. Possible contribution of microchimerism to the pathogenesis of Sjogren's syndrome. Rheumatology (Oxford) 41: 490-495 (2002). *

• Engels EA, Cerhan JR, Linet MS, Cozen W, Colt JS, Davis S, Gridley G, Severson RK, Hartge P. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study. Am. J. Epidemiol. 162: 1153-1161 (2005). *

• Enzenauer RJ, West SG. Sarcoidosis in autoimmune disease. Semin. Arthritis Rheum. 22: 1-17 (1992).

• Epstein O, Chapman RW, Lake-Bakaar G, Foo AY, Rosalki SB, Sherlock S. The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology 83: 1177-1182 (1982).

• Erbay SK, Stewart C, Hassanein A, Fletcher A, Bhattacharyya I, Cohen D, Wesson SK, Weinstein J, Lyons R, Reeves WH. Cutaneous mastocytosis in a patient with primary Sjogren's syndrome. J. Rheumatol. 33: 1697-1700 (2006).

• Eriksson P, Andersson C, Ekerfelt C, Ernerudh J, Skogh T. Sjogren's syndrome with myalgia is associated with subnormal secretion of cytokines by peripheral blood mononuclear cells. J. Rheumatol. 31: 729-735 (2004).

• Eriksson P, Andersson C, Ekerfelt C, Ernerudh J, Skogh T. Relationship between serum levels of IL-18 and IgG1 in patients with primary Sjogren's syndrome, rheumatoid arthritis and healthy controls. Clin. Exp. Immunol. 137: 617-620 (2004). *

• Ernstgard L, Iregren A, Sjogren B, Johanson G. Acute effects of exposure to vapours of dioxane in humans. Hum. Exp. Toxicol. 25: 723-729 (2006).

• Ersvaer E, Bertelsen LT, Espenes LC, Bredholt T, Boe SO, Iversen BM, Bruserud O, Ulvestad E, Gjertsen BT. Characterization of ribosomal P autoantibodies in relation to cell destruction and autoimmune disease. Scand. J. Immunol. 60: 189-198 (2004). *

• Espinosa A, Zhou W, Ek M, Hedlund M, Brauner S, Popovic K, Horvath L, Wallerskog T, Oukka M, Nyberg F, Kuchroo VK, Wahren-Herlenius M. The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death. J. Immunol. 176: 6277-6285 (2006). *

• Etienne M, Weimer LH. Immune-mediated autonomic neuropathies. Curr. Neurol. Neurosci. Rep. 6: 57-64 (2006).

• Euthymiopoulou K, Aletras AJ, Ravazoula P, Niarakis A, Daoussis D, Antonopoulos I, Liossis SN, Andonopoulos AP. Antiovarian antibodies in primary Sjogren's syndrome. Rheumatol. Int. 27: 1149-1155 (2007). *

• Evans CH, Ghivizzani SC, Gouze E, Rediske JJ, Schwarz EM, Robbins PD. The 3rd International Meeting on Gene Therapy in Rheumatology and Orthopaedics. Arthritis Res. Ther. 7: 273-278 (2005). *

• Fasolino M, Sabatini P, Cuomo T, Liguori G. Paraneoplastic subacute sensory neuronopathy associated with anti-ri antibodies. J. Peripher. Nerv. Syst. 9: 109 (2004).

• Fauchais AL, Boumediene A, Lalloue F, Gondran G, Loustaud-Ratti V, Vidal E, Jauberteau MO. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome. Scand. J. Rheumatol. 38: 50-57 (2009).

• Fauchais AL, Lambert M, Launay D, Michon-Pasturel U, Queyrel V, Nguyen N, Hebbar M, Hachulla E, Devulder B, Hatron PY. Antiphospholipid antibodies in primary Sjogren's syndrome: prevalence and clinical significance in a series of 74 patients. Lupus 13: 245-248 (2004).

• Fei H, Scharf S, Erlich H, Peebles C, Tan E, Fox R. Relationship between HLA D region gene and primary Sjogren's syndrome. Zhonghua Yi Xue Za Zhi 71: 555-559 (1991).

• Fei HM, Kang H, Scharf S, Erlich H, Peebles C, Fox R. Specific HLA-DQA and HLA-DRB1 alleles confer susceptibility to Sjogren's syndrome and autoantibody production. J. Clin. Lab. Anal. 5: 382-391 (1991).

• Feist E, Dorner T, Hansen A. Indications and options of new immune modulatory therapies for Sjogren's syndrome. Z. Rheumatol. 66: 679-685 (2007).

• Feist E, Hansen A. Critical overview of outcome parameters for patients with primary Sjogren's syndrome. Z. Rheumatol. 69: 25-31 (2010).

• Feist E, Hermann KG, Dankof A. Vasculopathy in Sjogren's syndrome. Z. Rheumatol. 68: 305-311 (2009).

• Felberg S, Dantas PE. Sjogren's syndrome: diagnosis and treatment. Arq. Bras. Oftalmol. 69: 959-963 (2006).

• Feltkamp TE, van Rossum AL. Antibodies to salivary duct cells, and other autoantibodies, in patients with Sjogren's syndrome and other idiopathic autoimmune diseases. Clin. Exp. Immunol. 3: 1-16 (1968). *

• Feng XG, Ye S, Lu Y, Xu XJ, Gu YY, Shen N, Ye P, Cheng FP, Wang AM, Chen SL. Antikinectin autoantibody in Behcet's disease and several other autoimmune connective tissue diseases. Clin. Exp. Rheumatol. 25: S80-S85 (2007).

• Ferec C, Youinou P, Le Goff P, Miossec P, Morin JF, Pennec Y, Morin PP, Le Menn G. Significance of antinuclear anti-histone antibodies. Ann. Med. Interne. (Paris) 135: 427-430 (1984).

• Fermin CD, Garry RF. Possible involvement of a recently discovered human retrovirus in idiopathic immunologic disorders, including Sjogren syndrome (autoimmune exocrinopathy). HNO 41: 239-249 (1993).

• Fernandez-Vozmediano JM, Armario-Hita JC, Gonzalez-Cabrerizo A. Sjogren-Larsson syndrome: treatment with topical calcipotriol. Pediatr. Dermatol. 20: 179-180 (2003). *

• Ferraccioli G, Tolusso B. Infections, B cell receptor activation and autoimmunity: different check-point impairments lead to autoimmunity, clonal B cell expansion and fibrosis in different immunological settings. Autoimmun. Rev. 7: 109-113 (2007).

• Ferri C. Mixed cryoglobulinemia. Orphanet J. Rare Dis. 3: 25 (2008). *

• Fischer A, Swigris JJ, du Bois RM, Groshong SD, Cool CD, Sahin H, Lynch DA, Gillis JZ, Cohen MD, Meehan RT, Brown KK. Minor salivary gland biopsy to detect primary Sjogren syndrome in patients with interstitial lung disease. Chest 136: 1072-1078 (2009). *

• Fishback N, Koss M. Update on lymphoid interstitial pneumonitis. Curr. Opin. Pulm. Med. 2: 429-433 (1996).

• Fletcher CA, Sutherland AP, Groom JR, Batten ML, Ng LG, Gommerman J, Mackay F. Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells. Eur. J. Immunol. 36: 2504-2514 (2006). *

• Florez JC, Sjogren M, Agapakis CM, Burtt NP, Almgren P, Lindblad U, Berglund G, Tuomi T, Gaudet D, Daly MJ, Ardlie KG, Hirschhorn JN, Altshuler D, Groop L. Association testing of common variants in the insulin receptor substrate-1 gene (IRS1) with type 2 diabetes. Diabetologia 50: 1209-1217 (2007). *

• Fonseca JE, Reis P, Saraiva F, Crujo C, Baptista A, da Silva JA, Viana Queiroz M. A complex case of hepatitis in a patient with systemic lupus erythematosus. Clin. Rheumatol. 18: 414-416 (1999).

• Font J, Garcia-Carrasco M, Ramos-Casals M, Aldea AI, Cervera R, Ingelmo M, Vives J, Yague J. The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjogren's syndrome. Rheumatology (Oxford) 41: 1025-1030 (2002). *

• Foster EN, Nguyen KK, Sheikh RA, Prindiville TP. Crohn's disease associated with Sweet's syndrome and Sjogren's syndrome treated with infliximab. Clin. Dev. Immunol. 12: 145-149 (2005). *

• Fox PC. Autoimmune diseases and Sjogren's syndrome, an autoimmune exocrinopathy. Ann. N. Y. Acad. Sci. 1098: 15-21 (2007). *

• Fox PC. Salivary enhancement therapies. Caries Res. 38: 241-246 (2004).

• Fox RI. Sjogren's syndrome. Curr. Opin. Rheumatol. 7: 409-416 (1995).

• Fox RI. Epidemiology, pathogenesis, animal models, and treatment of Sjogren's syndrome. Curr. Opin. Rheumatol. 6: 501-508 (1994).

• Fox RI. Sjogren's syndrome. Lancet 366: 321-331 (2005). *

• Fox RI. Sjogren's syndrome. Controversies and progress. Clin. Lab. Med. 17: 431-444 (1997).

• Fox RI, Liu AY. Sjogren's syndrome in dermatology. Clin. Dermatol. 24: 393-413 (2006).

• Fox RI, Luppi M, Kang HI, Pisa P. Reactivation of Epstein-Barr virus in Sjogren's syndrome. Springer Semin. Immunopathol. 13: 217-231 (1991).

• Fox RI, Saito I, Chan EK, Josephs S, Salahuddin SZ, Ahlashi DV, Staal FW, Gallo R, Pei-Ping H, Le CS. Viral genomes in lymphomas of patients with Sjogren's syndrome. J. Autoimmun. 2: 449-455 (1989).

• Fracchia M, Galatola G, Corradi F, Dall'Omo AM, Rovera L, Pera A, Vitale C, Bertero MT. Coeliac disease associated with Sjogren's syndrome, renal tubular acidosis, primary biliary cirrhosis and autoimmune hyperthyroidism. Dig. Liver Dis. 36: 489-491 (2004).

• Frallonardo P, Ramonda R, Salaffi F, Carotti M, Andretta M, Zucchetta P, Dorigo A, Campana C, Contessa C, Iagnocco A, Valesini G, Gerli R, Grassi W, Punzi L. Sjogren's syndrome: comparison among the main imaging techniques in the study of major salivary glands. Reumatismo 60: 141-149 (2008).

• Fredriksson J, Anevski D, Almgren P, Sjogren M, Lyssenko V, Carlson J, Isomaa B, Taskinen MR, Groop L, Orho-Melander M. Variation in GYS1 interacts with exercise and gender to predict cardiovascular mortality. PLoS ONE 2: e285 (2007). *

• Friedman J, Schattner A, Shvidel L, Berrebi A. Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren's syndrome - an important but underrecognized association. Semin. Arthritis Rheum. 35: 306-311 (2006). *

• Frieri M. Identification of masqueraders of autoimmune disease in the office. Allergy Asthma Proc. 24: 421-429 (2003).

• Frossard JL, Dumonceau JM, Spahr L, Giostra E, Hadengue A. Coincidental CFTR mutation and Sjogren syndrome revealing a pancreatic disease. Pancreas 35: 94-95 (2007).

• Fu Y, Nathan DM, Li F, Li X, Faustman DL. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity. J. Clin. Invest. 91: 2301-2307 (1993). *

• Fuertes I, Espinosa G, Ramos-Casals M, Cervera R. Association of Sjogren syndrome, autoimmune thyroiditis, sarcoidosis, primary biliary cirrhosis and primary amyloidosis in a single patient. Rev. Clin. Esp. 207: 376 (2007).

• Fugger L, Morling N, Ryder LP, Georgsen J, Jakobsen BK, Svejgaard A, Andersen V, Oxholm P, Karup Pedersen F, Friis J, et al. NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases. Tissue Antigens 34: 17-22 (1989).

• Fugger L, Morling N, Ryder LP, Jakobsen BK, Andersen V, Oxholm P, Dalhoff K, Heilmann C, Karup Pedersen F, Friis J, et al. Restriction fragment length polymorphism of two HLA-B-associated transcripts genes in five autoimmune diseases. Hum. Immunol. 30: 27-31 (1991).

• Fujikura S, Davis PA, Prindiville T, Leung P, Fox RI, Gershwin ME. Sjogren's syndrome and primary biliary cirrhosis: presence of autoantibodies to purified mitochondrial 2-oxo acid dehydrogenases. J. Rheumatol. 17: 1453-1457 (1990).

• Fujita J, Ohtsuki Y, Yoshinouchi T, Yamadori I, Bandoh S, Tokuda M, Miyawaki H, Kishimoto N, Ishida T. Idiopathic non-specific interstitial pneumonia: as an "autoimmune interstitial pneumonia". Respir. Med. 99: 234-240 (2005).

• Fujita Y, Fujii T, Takeda N, Tanaka M, Mimori T. Successful treatment of primary Sjogren's syndrome with chronic natural killer lymphocytosis by high-dose prednisolone and indomethacin farnesil. Intern. Med. 46: 251-254 (2007). *

• Fujiu K, Kanno R, Shio Y, Ohsugi J, Nozawa Y, Gotoh M. Triad of thymoma, myasthenia gravis and pure red cell aplasia combined with Sjogren's syndrome. Jpn. J. Thorac. Cardiovasc. Surg. 52: 345-348 (2004).

• Fukaya E, Watanabe H, Kobayashi H, Yokota T, Yamaguchi O, Kasukawa R, Sato Y. A case of interstitial cystitis accompanying Sjogren's syndrome. Mod. Rheumatol. 15: 73-76 (2005).

• Fukui T, Okazaki K, Yoshizawa H, Ohashi S, Tamaki H, Kawasaki K, Matsuura M, Asada M, Nakase H, Nakashima Y, Nishio A, Chiba T. A case of autoimmune pancreatitis associated with sclerosing cholangitis, retroperitoneal fibrosis and Sjogren's syndrome. Pancreatology 5: 86-91 (2005).

• Fulop M, Mackay M. Renal tubular acidosis, Sjogren syndrome, and bone disease. Arch. Intern. Med. 164: 905-909 (2004). *

• Furukawa M, Sakamoto A, Kita Y, Ohishi Y, Matsumura R, Tsubata R, Tsubata T, Iwamoto I, Saito Y, Sumida T. T-cell receptor repertoire of infiltrating T cells in lachrymal glands, salivary glands and kidneys from alymphoplasia (aly) mutant mice: a new model for Sjogren's syndrome. Br. J. Rheumatol. 35: 1223-1230 (1996). *

• Furuya T, Tateishi M, Nishinarita M, Kashiwazaki S. Primary biliary cirrhosis in patients with Sjogren's syndrome. Nippon Rinsho 53: 2536-2539 (1995).

• Gadalla SM, Amr S, Langenberg P, Baumgarten M, Davidson WF, Schairer C, Engels EA, Pfeiffer RM, Goedert JJ. Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case-control study. Br. J. Cancer 100: 817-821 (2009). *

• Galesic K, Morovic-Vergles J, Vergles D, Racic I, Horvatic I. Primary Sjogren's syndrome and hypokalaemic paralysis - case report. Reumatizam 51: 19-22 (2004).

• Gannot G, Tangrea MA, Gillespie JW, Erickson HS, Wallis BS, Leakan RA, Knezevic V, Hartmann DP, Chuaqui RF, Emmert-Buck MR. Layered peptide arrays: high-throughput antibody screening of clinical samples. J. Mol. Diagn. 7: 427-436 (2005). *

• Gao J, Cha S, Jonsson R, Opalko J, Peck AB. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjogren's syndrome patients by use of a transfected cell line assay. Arthritis Rheum. 50: 2615-2621 (2004). *

• Gao J, Killedar S, Cornelius JG, Nguyen C, Cha S, Peck AB. Sjogren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease. J. Autoimmun. 26: 90-103 (2006).

• Garberg H, Jonsson R, Brokstad KA. The serological pattern of autoantibodies to the Ro52, Ro60, and La48 autoantigens in primary Sjogren's syndrome patients and healthy controls. Scand. J. Rheumatol. 34: 49-55 (2005). *

• Gatumu MK, Jonsson MV, Oijordsbakken G, Skarstein K. Nuclear BCL10 in primary Sjogren's syndrome. J. Oral Pathol. Med. 38: 501-507 (2009).

• Gatumu MK, Skarstein K, Papandile A, Browning JL, Fava RA, Bolstad AI. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjogren's syndrome in salivary glands of non-obese diabetic mice. Arthritis Res. Ther. 11: R24 (2009). *

• Gaubitz M. Epidemiology of connective tissue disorders. Rheumatology (Oxford) 45 Suppl. 3: iii3-iii4 (2006). *

• Gelber AC, Pillemer SR, Baum BJ, Wigley FM, Hummers LK, Morris S, Rosen A, Casciola-Rosen LA. Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma. Ann. Rheum. Dis. 65: 1028-1032 (2006). *

• Gensch K, Gudowius S, Niehues T, Kuhn A. Connective tissue diseases in childhood. Hautarzt. 56: 925-936 (2005).

• Gescuk B, Wu AJ, Whitcher JP, Daniels TE, Lund S, Fye K, Davis Jr JC. Lamivudine is not effective in primary Sjogren's syndrome. Ann. Rheum. Dis. 64: 1326-1330 (2005). *

• Geyer JT, Ferry JA, Harris NL, Stone JH, Zukerberg LR, Lauwers GY, Pilch BZ, Deshpande V. Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease. Am. J. Surg. Pathol. Jan 7 [Epub ahead of print] (2010).

• Ghirardello A, Doria A, Zampieri S, Tarricone E, Tozzoli R, Villalta D, Bizzaro N, Piccoli A, Gambari PF. Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. J. Autoimmun. 22: 235-240 (2004).

• Gilburd B, Abu-Shakra M, Shoenfeld Y, Giordano A, Bocci EB, delle Monache F, Gerli R. Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluation - a homogeneous, multiplexed system. Clin. Dev. Immunol. 11: 53-56 (2004). *

• Gillespie K, Kodani I, Dickinson DP, Ogbureke KU, Camba AM, Wu M, Looney S, Chu TC, Qin H, Bisch F, Sharawy M, Schuster GS, Hsu SD. Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease. Life Sci. 83: 581-588 (2008). *

• Gipson IK, Hori Y, Argueso P. Character of ocular surface mucins and their alteration in dry eye disease. Ocul. Surf. 2: 131-148 (2004).

• Giroux Leprieur E, Antoine M, Gounant V, Copie-Bergman C, Lavole A, Milleron B. Association between thymic MALT lymphoma and Sjogren's syndrome. Rev. Pneumol. Clin. 65: 108-112 (2009).

• Gloerich J, Ijlst L, Wanders RJ, Ferdinandusse S. Bezafibrate induces FALDH in human fibroblasts; implications for Sjogren-Larsson syndrome. Mol. Genet. Metab. 89: 111-115 (2006). *

• Glynn F, O'Sullivan P. Vocal fold deposits in macrophagic myofasciitis. Ear Nose Throat J. 86: 238-239 (2007).

• Godeau P, Bletry O, Zafrani ES, Brion N, Chauveinc L, Galian A. Chronic hepatopathy and progressive systemic sclerosis. Frequency of association with Gougerot-Sjogren's disease. A report on six new cases. Sem. Hop. 56: 1895-1900 (1980).

• Goel A, Christian CL. Gastric antral vascular ectasia (watermelon stomach) in a patient with Sjogren's syndrome. J. Rheumatol. 30: 1090-1092 (2003).

• Goicovich E, Molina C, Perez P, Aguilera S, Fernandez J, Olea N, Alliende C, Leyton C, Romo R, Leyton L, Gonzalez MJ. Enhanced degradation of proteins of the basal lamina and stroma by matrix metalloproteinases from the salivary glands of Sjogren's syndrome patients: correlation with reduced structural integrity of acini and ducts. Arthritis Rheum. 48: 2573-2584 (2003). *

• Goldenberg DM. Epratuzumab in the therapy of oncological and immunological diseases. Expert Rev. Anticancer Ther. 6: 1341-1353 (2006).

• Gomez FE, Cassis-Nosthas L, Morales-De-Leon JC, Bourges H. Detection and recognition thresholds to the 4 basic tastes in Mexican patients with primary Sjogren's syndrome. Eur. J. Clin. Nutr. 58: 629-636 (2004). *

• Gomez LM, Anaya JM, Gonzalez CI, Pineda-Tamayo R, Otero W, Arango A, Martin J. PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases. Genes Immun. 6: 628-631 (2005). *

• Gonzalez M, Ribalta J, Reyes H, Klinger J, Maggiolo P, Varleta P, Hernandez I, Delgado M, Donoso S. Primary biliary cirrhosis. The clinical experience in 31 patients. Rev. Med. Chil. 118: 1350-1354 (1990).

• Gonzalez-Buitrago JM, Gonzalez C, Hernando M, Carrasco R, Sanchez A, Navajo JA, Papisch W. Antibodies to centromere antigens measured by an automated enzyme immunoassay. Clin. Chim. Acta 328: 135-138 (2003). *

• Goransson LG, Brun JG, Harboe E, Mellgren SI, Omdal R. Intraepidermal nerve fiber densities in chronic inflammatory autoimmune diseases. Arch. Neurol. 63: 1410-1413 (2006). *

• Goransson LG, Herigstad A, Tjensvoll AB, Harboe E, Mellgren SI, Omdal R. Peripheral neuropathy in primary Sjogren syndrome: a population-based study. Arch. Neurol. 63: 1612-1615 (2006). *

• Gordon TP, Cavill D, Neufing P, Zhang YJ, Pietropaolo M. ICA69 autoantibodies in primary Sjogren's syndrome. Lupus 13: 483-484 (2004).

• Gorriz L, Molino R, Arjona D, Estripeaut D. Sjogren syndrome associated with renal tubular acidosis type I. Rev. Med. Panama 25: 30-33 (2000).

• Goto E, Matsumoto Y, Kamoi M, Endo K, Ishida R, Dogru M, Kaido M, Kojima T, Tsubota K. Tear evaporation rates in Sjogren syndrome and non-Sjogren dry eye patients. Am. J. Ophthalmol. 144: 81-85 (2007). *

• Gottenberg JE. Primary Sjogren's syndrome: pathophysiological, clinical and therapeutic advances. Joint Bone Spine 76: 591-594 (2009). *

• Gottenberg JE, Aucouturier F, Goetz J, Sordet C, Jahn I, Busson M, Cayuela JM, Sibilia J, Mariette X. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome. Ann. Rheum. Dis. 66: 23-27 (2007). *

• Gottenberg JE, Busson M, Loiseau P, Cohen-Solal J, Lepage V, Charron D, Sibilia J, Mariette X. In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum. 48: 2240-2245 (2003). *

• Gottenberg JE, Busson M, Loiseau P, Dourche M, Cohen-Solal J, Lepage V, Charron D, Miceli C, Sibilia J, Mariette X. Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjogren's syndrome. Arthritis Rheum. 50: 570-580 (2004). *

• Gottenberg JE, Cagnard N, Lucchesi C, Letourneur F, Mistou S, Lazure T, Jacques S, Ba N, Ittah M, Lepajolec C, Labetoulle M, Ardizzone M, Sibilia J, Fournier C, Chiocchia G, Mariette X. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc. Natl. Acad. Sci. U.S.A. 103: 2770-2775 (2006). *

• Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Anaya JM, Sibilia J, Mariette X. Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann. Rheum. Dis. 64: 913-920 (2005). *

• Gottenberg JE, Lavie F, Abbed K, Gasnault J, Le Nevot E, Delfraissy JF, Taoufik Y, Mariette X. CD4 CD25(high) regulatory T cells are not impaired in patients with primary Sjogren's syndrome. J. Autoimmun. 24: 235-242 (2005).

• Gottenberg JE, Loiseau PP, Azarian MM, Chen CC, Cagnard NN, Hachulla EE, Puechal XX, Sibilia JJ, Charron DD, Mariette XX, Miceli-Richard CC. CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjogren syndrome. Arthritis Res. Ther. 9: R24 (2007). *

• Gottenberg JE, Mignot S, Nicaise-Rolland P, Cohen-Solal J, Aucouturier F, Goetz J, Labarre C, Meyer O, Sibilia J, Mariette X. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjogren's syndrome. Ann. Rheum. Dis. 64: 114-117 (2005). *

• Gottenberg JE, Sellam J, Ittah M, Lavie F, Proust A, Zouali H, Sordet C, Sibilia J, Kimberly RP, Mariette X, Miceli-Richard C. No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjogren's syndrome. Arthritis Res. Ther. 8: R30 (2006). *

• Goules A, Tzioufas AG, Manousakis MN, Kirou KA, Crow MK, Routsias JG. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. J. Autoimmun. 26: 165-171 (2006).

• Granel B, Ravix V, Pedeillier K, Serratrice J, Disdier P, Voelckel MA, Mattei JF, Weiller PJ. A first molecular approach towards CGG repeat expansion in FMR1 gene in systemic lupus erythematosus and in Sjogren's syndrome: a preliminary report. Clin. Rheumatol. 19: 262-264 (2000).

• Gregorio GV, Davies ET, Mieli-Vergani G, Vergani D. Significance of extractable nuclear antigens in childhood autoimmune liver disease. Clin. Exp. Immunol. 102: 308-313 (1995). *

• Grennan DM, Ferguson M, Williamson J, Mavrikakis M, Dick WC, Buchanan WW. Sjogren's syndrome in SLE: part I. The frequency of the clinical and subclinical features of Sjogren's syndrome in patients with SLE. N. Z. Med. J. 86: 374-376 (1977).

• Griffiths DJ, Venables PJ, Weiss RA, Boyd MT. A novel exogenous retrovirus sequence identified in humans. J. Virol. 71: 2866-2872 (1997). *

• Grover S, Tandon S, Misra R, Aggarwal A. Interleukin-1 receptor antagonist gene polymorphism in patients with rheumatoid arthritis in India. Indian J. Med. Res. 123: 815-820 (2006).

• Grulich AE, Vajdic CM. The epidemiology of non-Hodgkin lymphoma. Pathology 37: 409-419 (2005).

• Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev. 16: 405-408 (2007). *

• Grundy HO, Peltz G, Moore KW, Golbus MS, Jackson LG, Lebo RV. The polymorphic Fc gamma receptor II gene maps to human chromosome 1q. Immunogenetics 29: 331-339 (1989).

• Gu EL, Yao GB. The clinical characteristics of primary biliary cirrhosis in China: a systimatic review. Zhonghua Gan Zang Bing Za Zhi 17: 861-866 (2009).

• Guarneri F, Guarneri C, Benvenga S. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? J. Cell. Mol. Med. 9: 741-744 (2005). *

• Guennoc AM, Corcia P, Maisonobe T, Lefrancq T, De Toffol B, Autret A. Demyelinating neuropathy and Sjogren's syndrome: a diagnostic pitfall. Rev. Neurol. (Paris) 160: 717-720 (2004).

• Guerrero P, Martin M, Conde JM, Castro M, Rodriguez MC, Castilla L, Guillen P. Primary segmental sclerosing cholangitis associated with Sjogren's syndrome. Rev. Esp. Enferm. Dig. 79: 363-366 (1991).

• Guggenbuhl P, Jean S, Jego P, Grosbois B, Chales G, Semana G, Lancien G, Veillard E, Pawlotsky Y, Perdriger A. Primary Sjogren's syndrome: role of the HLA-DRB1*0301-*1501 heterozygotes. J. Rheumatol. 25: 900-905 (1998).

• Gunnare S, Vidali M, Lillienberg L, Ernstgard L, Sjogren B, Hagberg M, Albano E, Johanson G. Non-positive autoimmune responses against CYP2E1 in refrigeration mechanics exposed to halogenated hydrocarbons. Sci. Total Environ. 383: 90-97 (2007).

• Guo K, Major G, Foster H, Bassendine M, Collier J, Ross D, Griffiths I. Defective repair of O6-methylguanine-DNA in primary Sjogren's syndrome patients predisposed to lymphoma. Ann. Rheum. Dis. 54: 229-232 (1995). *

• Gupta RC, Dickson ER, McDuffie FC, Baggenstoss AH. Immune complexes in primary biliary cirrhosis. Higher prevalence of circulating immune complexes in patients with associated autoimmune features. Am. J. Med. 73: 192-198 (1982).

• Gurcan HM, Keskin DB, Stern JN, Nitzberg MA, Shekhani H, Ahmed AR. A review of the current use of rituximab in autoimmune diseases. Int. Immunopharmacol. 9: 10-25 (2009).

• Gwosdz M, Korber A, Hillen U, Dissemond J. Vasculitic leg ulcers in primary Sjogren syndrome. Hautarzt. 59: 404-408 (2008).

• Habib GS, Nashashibi M. Hypergammaglobulinemic purpura in two sisters with Sjogren's syndrome responding to colchicine treatment. Clin. Rheumatol. 23: 170-171 (2004).

• Hadj Kacem H, Kaddour N, Adyel FZ, Bahloul Z, Ayadi H. HLA-DQB1 CAR1/CAR2, TNFa IR2/IR4 and CTLA-4 polymorphisms in Tunisian patients with rheumatoid arthritis and Sjogren's syndrome. Rheumatology (Oxford) 40: 1370-1374 (2001). *

• Haga HJ, Gjesdal CG, Irgens LM, Ostensen M. Reproduction and gynaecological manifestations in women with primary Sjogren's syndrome: a case-control study. Scand. J. Rheumatol. 34: 45-48 (2005).

• Haga HJ, Gjesdal CG, Koksvik HS, Skomsvoll JF, Irgens LM, Ostensen M. Pregnancy outcome in patients with primary Sjogren's syndrome. A case-control study. J. Rheumatol. 32: 1734-1736 (2005).

• Haga HJ, Peen E. A study of the arthritis pattern in primary Sjogren's syndrome. Clin. Exp. Rheumatol. 25: 88-91 (2007).

• Hagiwara K, Murai H, Ochi H, Osoegawa M, Shigeto H, Ohyagi Y, Kira JI. Upper motor neuron syndrome associated with subclinical Sjogren's syndrome. Intern. Med. 47: 1047-1051 (2008). *

• Hahn JS, Kim C, Min YH, Ko YW, Suh CO, Park YY. Non-Hodgkin's lymphoma and primary biliary cirrhosis with Sjogren's syndrome. Yonsei. Med. J. 42: 258-263 (2001). *

• Hama K, Miwa H, Nishino I, Nonaka I, Kondo T. Inclusion body myositis associated with chronic thyroiditis, Sjogren's syndrome and autoimmune cholangitis. No To Shinkei 56: 503-507 (2004).

• Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, Fukushima M, Nikaido T, Nakayama K, Usuda N, Kiyosawa K. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N. Engl. J. Med. 344: 732-738 (2001). *

• Hamburger J. Guidelines for the management of Sjogren's syndrome in secondary care. Dent. Update 31: 178 (2004).

• Hansen A, Gosemann M, Pruss A, Reiter K, Ruzickova S, Lipsky PE, Dorner T. Abnormalities in peripheral B cell memory of patients with primary Sjogren's syndrome. Arthritis Rheum. 50: 1897-1908 (2004). *

• Hansen A, Lipsky PE, Dorner T. New concepts in the pathogenesis of Sjogren syndrome: many questions, fewer answers. Curr. Opin. Rheumatol. 15: 563-570 (2003).

• Hansen A, Lipsky PE, Dorner T. B cells in Sjogren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res. Ther. 9: 218 (2007). *

• Hansen A, Reiter K, Ziprian T, Jacobi A, Hoffmann A, Gosemann M, Scholze J, Lipsky PE, Dorner T. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjogren's syndrome. Arthritis Rheum. 52: 2109-2119 (2005). *

• Hansen BU, Lindgren S, Eriksson S, Henricsson V, Larsson A, Manthorpe R, Warfvinge G. Clinical and immunological features of Sjogren's syndrome in patients with primary biliary cirrhosis with emphasis on focal sialadenitis. Acta Med. Scand. 224: 611-619 (1988).

• Harangi M, Kaminski WE, Fleck M, Orso E, Zeher M, Kiss E, Szekanecz Z, Zilahi E, Marienhagen J, Aslanidis C, Paragh G, Bolstad AI, Jonsson R, Schmitz G. Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjogren's syndrome. Eur. J. Immunol. 35: 305-317 (2005). *

• Harboe E, Beyer MK, Greve OJ, Goransson LG, Tjensvoll AB, Kvaloy JT, Omdal R. Cerebral white matter hyperintensities are not increased in patients with primary Sjogren's syndrome. Eur. J. Neurol. 16: 576-581 (2009).

• Harboe E, Tjensvoll AB, Vefring HK, Goransson LG, Kvaloy JT, Omdal R. Fatigue in primary Sjogren's syndrome - a link to sickness behaviour in animals? Brain Behav. Immun. 23: 1104-1108 (2009).

• Harner KC, Jackson LW, Drabick JJ. Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren's syndrome. Rheumatology (Oxford) 43: 1309-1310 (2004). *

• Harscher S, Rummler S, Oelzner P, Mentzel HJ, Brodhun M, Witte OW, Terborg C, Isenmann S. Selective immunoadsorption in neurologic complications of systemic lupus erythematosus. Nervenarzt. 78: 441-444 (2007).

• Hartkamp A, Geenen R, Bijl M, Kruize AA, Godaert GL, Derksen RH. Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjogren's syndrome. Ann. Rheum. Dis. 63: 1335-1337 (2004). *

• Hartkamp A, Geenen R, Godaert GL, Bootsma H, Kruize AA, Bijlsma JW, Derksen RH. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjogren's syndrome: a randomized controlled trial. Ann. Rheum. Dis. 67: 91-97 (2008).

• Hartung K, Seelig HP. Laboratory diagnostics of systemic autoimmune diseases. Part 1. Collagenoses. Z. Rheumatol. 65: 709-724 (2006).

• Hatano T, Fukuda M, Shiotsuki H, Miwa H, Urabe T, Mizuno Y. Chronic inflammatory demyelinating polyneuropathy followed by systemic lupus erythematosus and Sjogren syndrome: a case report. Rinsho Shinkeigaku 46: 203-209 (2006).

• Hattori N, Nakashima H, Usui T, Maeda T, Yanagisawa K, Nakamaki T, Tomoyasu S. Successful treatment with prednisolone for autoimmune myelofibrosis accompanied with Sjogren syndrome. Rinsho Ketsueki 48: 1539-1543 (2007).

• Hatzis GS, Fragoulis GE, Karatzaferis A, Delladetsima I, Barbatis C, Moutsopoulos HM. Prevalence and longterm course of primary biliary cirrhosis in primary Sjogren's syndrome. J. Rheumatol. 35: 2012-2016 (2008). *

• Haug S, Braun-Falco M. Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome. Arch. Dermatol. Res. 296: 568-572 (2005). *

• Haug S, Braun-Falco M. Restoration of fatty aldehyde dehydrogenase deficiency in Sjogren-Larsson syndrome. Gene Ther. 13: 1021-1026 (2006). *

• Hayakawa I, Tedder TF, Zhuang Y. B-lymphocyte depletion ameliorates Sjogren's syndrome in Id3 knockout mice. Immunology 122: 73-79 (2007). *

• Hayashi Y, Hamano H, Haneji N, Ishimaru N, Yanagi K. Biased T cell receptor V beta gene usage during specific stages of the development of autoimmune sialadenitis in the MRL/lpr mouse model of Sjogren's syndrome. Arthritis Rheum. 38: 1077-1084 (1995).

• Hayashi Y, Haneji N, Hamano H. Pathogenesis of Sjogren's syndrome-like autoimmune lesions in MRL/lpr mice. Pathol. Int. 44: 559-568 (1994).

• Hayashi Y, Haneji N, Hamano H, Yanagi K. Transfer of Sjogren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment. Eur. J. Immunol. 24: 2826-2831 (1994).

• Hayashi Y, Ishimaru N, Arakaki R, Tsukumo S, Fukui H, Kishihara K, Shiota H, Yasutomo K, Hayashi Y. Effective treatment of a mouse model of Sjogren's syndrome with eyedrop administration of anti-CD4 monoclonal antibody. Arthritis Rheum. 50: 2903-2910 (2004). *

• Hazi-Mihailovic M, Jankovic L, Cakic S. Circulating immune complexes, immunoglobulin G, salivary proteins and salivary immunoglobulin A in patients with Sjogren's syndrome. Srp. Arh. Celok. Lek. 137: 134-139 (2009).

• Hebbar M, Jeannin P, Magistrelli G, Hatron PY, Hachulla E, Devulder B, Bonnefoy JY, Delneste Y. Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjogren's syndrome and systemic sclerosis. Clin. Exp. Immunol. 136: 388-392 (2004). *

• Helenius LM, Meurman JH, Helenius I, Kari K, Hietanen J, Suuronen R, Hallikainen D, Kautiainen H, Leirisalo-Repo M, Lindqvist C. Oral and salivary parameters in patients with rheumatic diseases. Acta Odontol. Scand. 63: 284-293 (2005).

• Hendrickson RG, Morocco AP, Greenberg MI. Pilocarpine toxicity and the treatment of xerostomia. J. Emerg. Med. 26: 429-432 (2004).

• Hennig J, Bresell A, Sandberg M, Hennig KD, Wahren-Herlenius M, Persson B, Sunnerhagen M. The fellowship of the RING: the RING-B-box linker region interacts with the RING in TRIM21/Ro52, contains a native autoantigenic epitope in Sjogren syndrome, and is an integral and conserved region in TRIM proteins. J. Mol. Biol. 377: 431-449 (2008). *

• Hennig J, Ottosson L, Andresen C, Horvath L, Kuchroo VK, Broo K, Wahren-Herlenius M, Sunnerhagen M. Structural organization and Zn2+ dependent subdomain interactions involving autoantigenic epitopes in the Ring-B-box-Coiled-Coil (RBCC) region of Ro52. J. Biol. Chem. 280: 33250-33261 (2005). *

• Henriksson G, Sallmyr A, Du L, Larsson A, Manthorpe R, Bredberg A. Enhanced DNA-dependent protein kinase activity in Sjogren's syndrome B cells. Rheumatology (Oxford) 43: 1109-1115 (2004). *

• Hilditch CJ, McEvoy RD, George KE, Thompson CC, Ryan MK, Rischmueller M, Catcheside PG. Upper airway surface tension but not upper airway collapsibility is elevated in primary Sjogren's syndrome. Sleep 31: 367-374 (2008). *

• Hincapie-Zapata ME, Suarez-Escudero JC, Pineda-Tamayo R, Anaya JM. Quality of life in multiple sclerosis and other chronic autoimmune and non-autoimmune diseases. Rev. Neurol. 48: 225-230 (2009).

• Hiraide A, Imazeki F, Yokosuka O, Kanda T, Kojima, H, Fukai K, Suzuki Y, Hata A, Saisho H. Fas polymorphisms influence susceptibility to autoimmune hepatitis. Am. J. Gastroenterol. 100: 1322-1329 (2005). *

• Hiraoka A, Kojima N, Yamauchi Y, Ninomiya T, Masumoto T, Michitaka K, Horiike N, Onji M. An autopsy case of primary biliary cirrhosis with severe interstitial pneumonia. Intern. Med. 40: 1104-1108 (2001). *

• Hjelmervik TO, Petersen K, Jonassen I, Jonsson R, Bolstad AI. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects. Arthritis Rheum. 52: 1534-1544 (2005). *

• Hobson-Webb LD, Donofrio PD. Inflammatory neuropathies: an update on evaluation and treatment. Curr. Rheumatol. Rep. 7: 348-355 (2005).

• Hoppenreijs EP, van Dijken PJ, Kabel PJ, Th Draaisma JM. Hereditary C1q deficiency and secondary Sjogren's syndrome. Ann. Rheum. Dis. 63: 1524-1525 (2004). *

• Horita M, Takahashi N, Seike M, Nasu S, Takaki R. A case of primary biliary cirrhosis associated with Hashimoto's thyroiditis, scleroderma and Sjogren's syndrome. Intern. Med. 31: 418-421 (1992). *

• Horvath IF, Szodoray P, Zeher M. Primary Sjogren's syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients. Clin. Rheumatol. 27: 1479-1483 (2008). *

• Hoshina T, Yamaguchi Y, Ohga S, Kira R, Ishimura M, Takada H, Tanaka T, Hara T. Sjogren's syndrome-associated meningoencephalomyelitis: cerebrospinal fluid cytokine levels and therapeutic utility of tacrolimus. J. Neurol. Sci. 267: 182-186 (2008).

• Hosokawa A, Takahashi H, Akaike J, Okuda H, Murakami R, Kawahito Y, Tokuno T, Makiguchi Y, Sakamoto H, Hinoda Y, Imai K. A case of Sjogren's syndrome associated with inflammatory pseudotumor of the liver. Nihon Rinsho Meneki Gakkai Kaishi 21: 226-233 (1998).

• Houghton KM, Cabral DA, Petty RE, Tucker LB. Primary Sjogren's syndrome in dizygotic adolescent twins: one case with lymphocytic interstitial pneumonia. J. Rheumatol. 32: 1603-1606 (2005).

• Hsu S, Dickinson D. A new approach to managing oral manifestations of Sjogren's syndrome and skin manifestations of lupus. J. Biochem. Mol. Biol. 39: 229-239 (2006). *

• Hsu TC, Chang CH, Lin MC, Liu ST, Yen TJ, Tsay GJ. Anti-CENP-H antibodies in patients with Sjogren's syndrome. Rheumatol. Int. 26: 298-303 (2006). *

• Hu DC, Cathro HP, Okusa MD. Polymorphoneutrophilic infiltration in acute interstitial nephritis of Sjogren syndrome. Am. J. Med. Sci. 327: 278-280 (2004).

• Hu S, Wang J, Meijer J, Ieong S, Xie Y, Yu T, Zhou H, Henry S, Vissink A, Pijpe J, Kallenberg C, Elashoff D, Loo JA, Wong DT. Salivary proteomic and genomic biomarkers for primary Sjogren's syndrome. Arthritis Rheum. 56: 3588-3600 (2007). *

• Huang CM, Yang YH, Chiang BL. Different familial association patterns of autoimmune diseases between juvenile-onset systemic lupus erythematosus and juvenile rheumatoid arthritis. J. Microbiol. Immunol. Infect. 37: 88-94 (2004). *

• Hulkkonen J, Pertovaara M, Antonen J, Lahdenpohja N, Pasternack A, Hurme M. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjogren's syndrome. Arthritis Rheum. 44: 176-179 (2001). *

• Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxford) 40: 656-661 (2001). *

• Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M, Pollanen P, Lehtimaki T. Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome. Rheumatology (Oxford) 43: 1476-1479 (2004). *

• Hultin-Rosenberg L, Jagannathan S, Nilsson KC, Matis SA, Sjogren N, Huby RD, Salter AH, Tugwood JD. Predictive models of hepatotoxicity using gene expression data from primary rat hepatocytes. Xenobiotica 36: 1122-1139 (2006). *

• Humbert P, Dupond JL. Multiple autoimmune syndromes. Ann. Med. Interne. (Paris) 139: 159-168 (1988).

• Hyphantis TN, Tsifetaki N, Siafaka V, Voulgari PV, Pappa C, Bai M, Palieraki K, Venetsanopoulou A, Mavreas V, Drosos AA. The impact of psychological functioning upon systemic sclerosis patients' quality of life. Semin. Arthritis Rheum. 37: 81-92 (2007). *

• Iannello S, Cavaleri A, Milazzo P, Cantarella S, Belfiore F. Low fasting serum triglyceride level as a precocious marker of autoimmune disorders. MedGenMed. 5: 20 (2003). *

• Ichimura T, Kondo S, Ambo Y, Hirano S, Ohmi M, Okushiba S, Morikawa T, Shimizu M, Katoh H. Primary sclerosing cholangitis associated with autoimmune pancreatitis. Hepatogastroenterology 49: 1221-1224 (2002).

• Iggman D, Arnlov J, Vessby B, Cederholm T, Sjogren P, Riserus U. Adipose tissue fatty acids and insulin sensitivity in elderly men. Diabetologia Feb 3 [Epub ahead of print] (2010). *

• Ijichi S, Iwata S, Une F, Tara M, Igata A. B cell malignancy associated with Sjogren syndrome and primary biliary cirrhosis: a case report and review. Rinsho Ketsueki 28: 911-916 (1987).

• Ikuno N, Mackay IR, Jois J, Omagari K, Rowley MJ. Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 16: 1390-1394 (2001). *

• Illei GG. The clinical impact of neuropsychiatric manifestations in early systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 3: 428-429 (2007). *

• Imanishi T, Morinobu A, Hayashi N, Kanagawa S, Koshiba M, Kondo S, Kumagai S. A novel polymorphism of the SSA1 gene is associated with anti-SS-A/Ro52 autoantibody in Japanese patients with primary Sjogren's syndrome. Clin. Exp. Rheumatol. 23: 521-524 (2005).

• Imbert Y, Foulks GN, Brennan MD, Jumblatt MM, John G, Shah HA, Newton C, Pouranfar F, Young WW Jr. MUC1 and estrogen receptor alpha gene polymorphisms in dry eye patients. Exp. Eye Res. 88: 334-338 (2009). *

• Inoue K, Hirohara J, Nakano T, Seki T, Sasaki H, Higuchi K, Ohta Y, Onji M, Muto Y, Moriwaki H. Prediction of prognosis of primary biliary cirrhosis in Japan. Liver 15: 70-77 (1995).

• Invernizzi P, Battezzati PM, Crosignani A, Zermiani P, Bignotto M, Del Papa N, Zuin M, Podda M. Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status. Clin. Exp. Immunol. 114: 448-454 (1998). *

• Iolascon A, Volinia S, Borriello A, Giordani L, Moretti A, Servedio V, Maiorano N, Cucciolla V, Criniti V, Gasparini P, Indaco S, Della Ragione F. Genes transcriptionally modulated by interferon alpha2a correlate with the cytokine activity. Haematologica 89: 1046-1053 (2004). *

• Isenberg DA. Systemic lupus erythematosus and Sjogren's syndrome: historical perspective and ongoing concerns. Arthritis Rheum. 50: 681-683 (2004). *

• Ishimaru N, Arakaki R, Yoshida S, Yamada A, Noji S, Hayashi Y. Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjogren's syndrome-like autoimmune exocrinopathy. J. Exp. Med. 205: 2915-2927 (2008). *

• Ishimaru N, Nitta T, Arakaki R, Yamada A, Lipp M, Takahama Y, Hayashi Y. In situ patrolling of regulatory T cells is essential for protecting autoimmune exocrinopathy. PLoS One 5: e8588 (2010). *

• Ishimaru N, Takagi A, Kohashi M, Yamada A, Arakaki R, Kanno J, Hayashi Y. Neonatal exposure to low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin causes autoimmunity due to the disruption of T cell tolerance. J. Immunol. 182: 6576-6586 (2009).

• Isobe Z, Suga T, Hamaguchi S, Yamaguchi S, Hara K, Aoki F, Aoki N, Aoyagi K, Ueno M, Maeno T, Kurabayashi M. A case of HLA-DR8 positive sarcoidosis following polymyositis and Sjogren's syndrome. Nihon Kokyuki Gakkai Zasshi 46: 96-100 (2008).

• Isshiki I, Okamoto S, Kakimoto T, Chen CK, Mori T, Yokoyama K, Hattori Y, Ikeda Y. Recurrence of autoimmune disease after autologous peripheral blood stem cell transplantation for multiple myeloma. Int. J. Hematol. 84: 354-358 (2006).

• Ito M, Kojima T, Miyata M, Saka M, Kokubun M, Ohira H, Ishikawa H, Kuroda M, Sato Y, Takagi T, et al. Primary biliary cirrhosis (PBC)-CREST (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly and telangiectasia) overlap syndrome complicated by Sjogren's syndrome and arthritis. Intern. Med. 34: 451-454 (1995). *

• Ittah M, Gottenberg JE, Proust A, Hachulla E, Puechal X, Loiseau P, Mariette X, Miceli-Richard C. No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjogren's syndrome. Genes Immun. 6: 457-458 (2005). *

• Ittah M, Miceli-Richard C, Eric Gottenberg J, Lavie F, Lazure T, Ba N, Sellam J, Lepajolec C, Mariette X. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome. Arthritis Res. Ther. 8: R51 (2006). *

• Iwasaki K, Okawa-Takatsuji M, Aotsuka S, Ono T. Detection of anti-SS-A/Ro and anti-SS-B/La antibodies of IgA and IgG isotypes in saliva and sera of patients with Sjogren's syndrome. Nihon Rinsho Meneki Gakkai Kaishi 26: 346-354 (2003).

• Iwata N, Mori M, Miyamae T, Ito S, Imagawa T, Yokota S. Sjogren's syndrome associated with childhood-onset systemic lupus erythematosus. Nihon Rinsho Meneki Gakkai Kaishi 31: 166-171 (2008).

• Izumi H, Nobukawa B, Takahashi K, Kumasaka T, Miyamoto H, Yamazaki A, Sonobe S, Uekusa T, Suda K. Multilocular thymic cyst associated with follicular hyperplasia: clinicopathologic study of 4 resected cases. Hum. Pathol. 36: 841-844 (2005).

• Izzotti A, Sacca SC, Bagnis A, Recupero SM. Glaucoma and Helicobacter pylori infection: correlations and controversies. Br. J. Ophthalmol. 93: 1420-1427 (2009).

• Jabs DA, Gerard HC, Wei Y, Campbell AL, Hudson AP, Akpek EK, Lee B, Prendergast RA, Whittum-Hudson JA. Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice. Invest. Ophthalmol. Vis. Sci. 45: 2293-2298 (2004). *

• Jara LJ, Navarro C, Brito-Zeron MD, García-Carrasco M, Escarcega RO, Ramos-Casals M. Thyroid disease in Sjogren's syndrome. Clin. Rheumatol. 26: 1601-1606 (2007). *

• Jaraquemada D, Ollier W, Awad J, Young A, Festenstein H. HLA and rheumatoid arthritis: susceptibility or severity? Dis. Markers 4: 43-53 (1986).

• Jaster R, Emmrich J. Molecular characteristics of autoimmune pancreatitis. Curr. Pharm. Des. 12: 3781-3786 (2006).

• Jean S, Quelvennec E, Alizadeh M, Guggenbuhl P, Birebent B, Perdriger A, Grosbois B, Pawlotsky PY, Semana G. DRB1*15 and DRB1*03 extended haplotype interaction in primary Sjogren's syndrome genetic susceptibility. Clin. Exp. Rheumatol. 16: 725-728 (1998).

• Ji JD, Lee WJ, Kong KA, Woo JH, Choi SJ, Lee YH, Song GG. Association of STAT4 polymorphism with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol. Biol. Rep. May 29 [Epub ahead of print] (2009). *

• Johanneson B, Lima G, von Salome J, Alarcon-Segovia D, Alarcon-Riquelme ME; Collaborative Group on the Genetics of SLE, The BIOMED II Collaboration on the Genetics of SLE and Sjogrens syndrome. A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31. Am. J. Hum. Genet. 71: 1060-1071 (2002). *

• Johnson S, Hulton SA, Brundler MA, Moss C, Huissoon A, Taylor CM. End-stage renal failure in adolescence with Sjogren's syndrome autoantibodies SSA and SSB. Pediatr. Nephrol. 22: 1793-1797 (2007).

• Johnston SL, Dudley CR, Unsworth DJ, Lock RJ. Life-threatening acute pulmonary haemorrhage in primary Sjogren's syndrome with cryoglobulinaemia. Scand. J. Rheumatol. 34: 404-407 (2005). *

• Jonsson MV, Delaleu N, Jonsson R. Animal models of Sjogren's syndrome. Clin. Rev. Allergy Immunol. 32: 215-224 (2007). *

• Jonsson MV, Skarstein K. Follicular dendritic cells confirm lymphoid organization in the minor salivary glands of primary Sjogren's syndrome. J. Oral Pathol. Med. 37: 515-521 (2008).

• Jonsson R, Bolstad AI, Brokstad KA, Brun JG. Sjogren's syndrome - a plethora of clinical and immunological phenotypes with a complex genetic background. Ann. N. Y. Acad .Sci. 1108: 433-447 (2007). *

• Jonsson R, Gordon TP, Konttinen YT. Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjogren's syndrome. Curr. Rheumatol. Rep. 5: 311-316 (2003).

• Jonsson R, Nginamau E, Szyszko E, Brokstad KA. Role of B cells in Sjogrens syndrome - from benign lymphoproliferation to overt malignancy. Front. Biosci. 12: 2159-2170 (2007).

• Joplin R. Infectious etiology of primary biliary cirrhosis? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 19-20. October 15-16 (2003). *

• Jorge A, Findor J, Esley C, Bruch E. Primary sclerosing cholangitis. Z. Gastroenterol. 26: 322-330 (1988).

• Josephs KA, Rubino FA, Dickson DW. Nonvasculitic autoimmune inflammatory meningoencephalitis. Neuropathology 24: 149-152 (2004).

• Jouen F, Vittecoq O, Leguillou F, Tabti-Titon I, Menard JF, Mejjad O, Pouplin S, Boumier P, Fardellone P, Gayet A, Gilbert D, Tron F, Le Loet X. Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis. Clin. Exp. Immunol. 137: 606-611 (2004). *

• Kageyama G, Kawano S, Kanagawa S, Kondo S, Sugita M, Nakanishi T, Shimizu A, Kumagai S. Effect of mutated transporters associated with antigen-processing 2 on characteristic major histocompatibility complex binding peptides: analysis using electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 18: 995-1000 (2004). *

• Kahaly GJ, Bang H, Berg W, Dittmar M. Alpha-fodrin as a putative autoantigen in Graves' ophthalmopathy. Clin. Exp. Immunol. 140: 166-172 (2005). *

• Kahlmann D, Davalos-Misslitz AC, Ohl L, Stanke F, Witte T, Forster R. Genetic variants of chemokine receptor CCR7 in patients with systemic lupus erythematosus, Sjogren's syndrome and systemic sclerosis. BMC Genet. 8: 33 (2007). *

• Kaido M, Dogru M, Yamada M, Sotozono C, Kinoshita S, Shimazaki J, Tsubota K. Functional visual acuity in Stevens-Johnson syndrome. Am. J. Ophthalmol. 142: 917-922.e1 (2006). *

• Kalden JR, Herrmann M. Autoimmune diseases in humans, e.g. autoimmune rheumatic diseases. Intervirology 35: 176-185 (1993).

• Kamali S, Polat NG, Kasapoglu E, Gul A, Ocal L, Aral O, Konice M, Badur S, Inanc M. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjogren's syndrome, and Wegener's granulomatosis. Clin. Rheumatol. 24: 673-676 (2005).

• Kamao T, Miyazaki T, Soga Y, Komori H, Terada M, Ohashi Y, Nose M. Genetic dissociation of dacryoadenitis and sialadenitis in a Sjogren's syndrome mouse model with common and different susceptibility gene loci. Invest. Ophthalmol. Vis. Sci. 50: 3257-3265 (2009). *

• Kamisawa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 6: 132-137 (2005).

• Kanagawa S, Morinobu A, Koshiba M, Kageyama G, Hayashi N, Yoshino S, Tokano Y, Hashimoto H, Kumagai S. Association of the TAP2*Bky2 allele with presence of SS-A/Ro and other autoantibodies in Japanese patients with systemic lupus erythematosus. Lupus 12: 258-265 (2003).

• Kane D, Grassi W, Sturrock R, Balint PV. Musculoskeletal ultrasound - a state of the art review in rheumatology. Part 2: Clinical indications for musculoskeletal ultrasound in rheumatology. Rheumatology (Oxford) 43: 829-838 (2004). *

• Kaneda Y, Yamaai T, Mizukawa N, Nagatsuka H, Yamachika E, Gunduz M, Sawaki K, Yamanishi Y, Matsubara M, Katase N, Takagi S. Localization of antimicrobial peptides human beta-defensins in minor salivary glands with Sjogren's syndrome. Eur. J. Oral Sci. 117: 506-510 (2009).

• Kaneoka H, Naito S. Superantigens and autoimmune diseases. Nippon Rinsho 55: 1363-1369 (1997).

• Kang SY, Lee WI. Clinical significance of dense fine speckled pattern in anti-nuclear antibody test using indirect immunofluorescence method. Korean J. Lab. Med. 29: 145-151 (2009).

• Karim S, Majithia V. Devic's Syndrome as Initial Presentation of Systemic Lupus Erythematosus. Am. J. Med. Sci. 338: 245-247 (2009).

• Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch. Intern. Med. 164: 1275-1284 (2004). *

• Katayama Y, Kohriyama K, Kirizuka K, Nishizaki H, Fujii H, Tanji Y. Sjogren's syndrome complicated with autoimmune hepatitis and antiphospholipid antibody syndrome. Intern. Med. 39: 73-76 (2000). *

• Kato H, Ichikawa H, Hayashi D, Yamazaki T, Ohnaka Y, Kawamura M. A 25-year-old woman with primary Sjogren syndrome who developed optic neuritis and encephalomyelitis associated with an anti-aquaporin 4 antibody. Rinsho Shinkeigaku 49: 576-581 (2009).

• Katsanos KH, Saougos V, Kosmidou M, Doukas M, Kamina S, Asproudis I, Tsianos EV. Sjogren's syndrome in a patient with ulcerative colitis and primary sclerosing cholangitis: case report and review of the literature. Journal of Crohn's and Colitis 3: 200-203 (2009).

• Katsifis GE, Moutsopoulos NM, Wahl SM. T lymphocytes in Sjogren's syndrome: contributors to and regulators of pathophysiology. Clin. Rev. Allergy Immunol. 32: 252-264 (2007). *

• Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM. Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis. Am. J. Pathol. 175: 1167-1177 (2009). *

• Katsikas GA, Maragou M, Rontogianni D, Gouma P, Koutsouvelis I, Kappou-Rigatou I. Secondary cutaneous nodular AA amyloidosis in a patient with primary Sjogren syndrome and celiac disease. J. Clin. Rheumatol. 14: 27-29 (2008).

• Katz J, Stavropoulos F, Bhattacharyya I, Stewart C, Perez FM, Caudle RM. Receptor of advanced glycation end product (RAGE) expression in the minor salivary glands of patients with Sjogren's syndrome: a preliminary study. Scand. J. Rheumatol. 33: 174-178 (2004).

• Kau CK, Hu JC, Lu LY, Tseng JC, Wang JS, Cheng HH. Primary Sjogren's syndrome complicated with cryoglobulinemic glomerulonephritis, myocarditis, and multi-organ involvement. J. Formos. Med. Assoc. 103: 707-710 (2004).

• Kauppi M, Kankaanpaa E, Kautiainen H. Exocrine dysfunction of the pancreas in patients with chronic polyarthritis. J. Clin. Rheumatol. 7: 166-169 (2001).

• Kawakami A, Nakashima K, Tamai M, Nakamura H, Iwanaga N, Fujikawa K, Aramaki T, Arima K, Iwamoto N, Ichinose K, Kamachi M, Ida H, Origuchi T, Eguchi K. Toll-like receptor in salivary glands from patients with Sjogren's syndrome: functional analysis by human salivary gland cell line. J. Rheumatol. 34: 1019-1026 (2007).

• Kersemans R, Van Ongeval C, Van Steen A, Drijkoningen M. Amyloid deposition of the breast in primary Sjogren syndrome. JBR-BTR 89: 313-314 (2006).

• Kessel A, Toubi E, Rozenbaum M, Zisman D, Sabo E, Rosner I. Sjogren's syndrome in the community: can serology replace salivary gland biopsy? Rheumatol. Int. 26: 337-339 (2006). *

• Keystone EC. The utility of tumour necrosis factor blockade in orphan diseases. Ann. Rheum. Dis. 63 Suppl. 2: ii79-ii83 (2004). *

• Kikawada M, Watanabe D, Kimura A, Hanyu H, Serizawa H, Iwamoto T. Autoimmune hemolytic anemia in an elderly patient with primary Sjogren's syndrome. Intern. Med. 44: 1312-1315 (2005). *

• Killedar SY, Eckenrode SE, McIndoe RA, She JX, Nguyen CQ, Peck AB, Cha S. Early pathogenic events associated with Sjogren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis. Lab. Invest. 86: 1243-1260 (2006). *

• Kim KP, Kim MH, Lee YJ, Song MH, Park do H, Lee SS, Seo DW, Lee SK, Min YI, Song DE, Yu ES. Clinical characteristics of 17 cases of autoimmune chronic pancreatitis. Korean J. Gastroenterol. 43: 112-119 (2004).

• Kimura T, Suzuki K, Inada S, Hayashi A, Saito H, Miyai T, Ohsugi Y, Matsuzaki Y, Tanaka N, Osuga T, et al. Induction of autoimmune disease by graft-versus-host reaction across MHC class II difference: modification of the lesions in IL-6 transgenic mice. Clin. Exp. Immunol. 95: 525-529 (1994). *

• Kino-Ohsaki J, Nishimori I, Morita M, Okazaki K, Yamamoto Y, Onishi S, Hollingsworth MA. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjogren's syndrome. Gastroenterology 110: 1579-1586 (1996). *

• Kiriyama K, Yabu M, Taniguti M, Kato T, Takeda A, Matsusima N, Himeno S. A case of primary sclerosing cholangitis associated with chronic pancreatitis and Sjogren's syndrome. Nippon Shokakibyo Gakkai Zasshi 99: 967-973 (2002).

• Kiss E, Danko K, Suto G, Zeher M. Shared and distinctive characteristics of systemic autoimmune disorders. Orv. Hetil. 148: S44-S51 (2007).

• Kitada J, Yamad G, Ochi T, Tanaka S, Itoh T, Watanabe A, Satoh M, Takahashi H. Primary Sjogren's syndrome with lymphocytic interstitial pneumonia, autoimmune hemolytic anemia and an endobronchial amyloid nodule. Nihon Kokyuki Gakkai Zasshi 46: 960-965 (2008).

• Kitagawa S, Zen Y, Harada K, Sasaki M, Sato Y, Minato H, Watanabe K, Kurumaya H, Katayanagi K, Masuda S, Niwa H, Tsuneyama K, Saito K, Haratake J, Takagawa K, Nakanuma Y. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Kuttner's tumor). Am. J. Surg. Pathol. 29: 783-791 (2005).

• Kleeff J, Welsch T, Esposito I, Lohr M, Singer R, Buchler MW, Friess H. Autoimmune pancreatitis - a surgical disease? Chirurg. 77: 154-165 (2006).

• Kobayashi M, Kawano S, Hatachi S, Kurimoto C, Okazaki T, Iwai Y, Honjo T, Tanaka Y, Minato N, Komori T, Maeda S, Kumagai S. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjogren's syndrome. J. Rheumatol. 32: 2156-2163 (2005).

• Kocaman O, Aygun C, Gurbuz Y, Cefle A, Konduk T, Senturk O, Celebi A, Hulagu S. Burst of autoimmunity with the emergence of primary Sjogren syndrome, cholestatic autoimmune hepatitis and latent autoimmune diabetes of adults (LADA). South. Med. J. 99: 1014-1015 (2006).

• Kocijancic K, Kocijancic I. Primary Sjogren's syndrome associated with non-Hodgkin's lymphoma of salivary gland and cystic lung disease. Coll. Antropol. 30: 925-927 (2006).

• Koga H, Shimizu K, Tarumi K, Sadahira Y, Matsumoto T, Iida M, Haruma K. Rectal mucosal prolapse syndrome as an unusual gastrointestinal manifestation of Sjogren's syndrome: a case report. J. Med. Case Reports 3: 85 (2009). *

• Kogawa H, Migita K, Ito M, Takii Y, Daikoku M, Nakao M, Miyashita T, Kimura H, Ezaki H, Nakamura M, Yatsuhashi H, Eguchi K, Ishibashi H. Idiopathic portal hypertension associated with systemic sclerosis and Sjogren's syndrome. Clin. Rheumatol. 24: 544-547 (2005). *

• Kohashi M, Ishimaru N, Arakaki R, Hayashi Y. Effective treatment with oral administration of rebamipide in a mouse model of Sjogren's syndrome. Arthritis Rheum. 58: 389-400 (2008). *

• Koike K. Hepatitis C as a metabolic disease: implication for the pathogenesis of NASH. Hepatol. Res. 33: 145-150 (2005).

• Koike K, Utsunomiya Y, Ito Y, Tokudome S, Miyazaki Y, Suzuki T, Okonogi H, Kawamura T, Yamada A, Hosoya T, Joh K. A case of glomerulopathy showing podocytic infolding in association with Sjogren's syndrome and primary biliary cirrhosis. Clin. Exp. Nephrol. 12: 489-493 (2008).

• Komai K, Shiozawa K, Tanaka Y, Yoshihara R, Tanaka C, Sakai H, Yamane T, Murata M, Tsumiyama K, Hashiramoto A, Shiozawa S. Sjogren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment. Mod. Rheumatol. 19: 416-419 (2009). *

• Komaki S, Kohno M, Matsuura N, Shimadzu M, Adachi N, Hoshide R, Nishiyama S, Matsuda I. The polymorphic 43Thr bcl-2 protein confers relative resistance to autoimmunity: an analytical evaluation. Hum. Genet. 103: 435-440 (1998). *

• Kondo T, Inoue H, Usui T, Mimori T, Tomimoto H, Vernino S, Takahashi R. Autoimmune autonomic ganglionopathy with Sjogren's syndrome: significance of ganglionic acetylcholine receptor antibody and therapeutic approach. Auton. Neurosci. 146: 33-35 (2009).

• Kong HJ, Anderson DE, Lee CH, Jang MK, Tamura T, Tailor P, Cho HK, Cheong J, Xiong H, Morse HC, Ozato K. Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J. Immunol. 179: 26-30 (2007). *

• Konno A, Takiguchi M, Takada K, Usami T, Azumi K, Kubota H, Inaba M, Saegusa J, Kon Y. Identification of a quantitative trait locus regulating B cell-dominant infiltration into autoimmune sialitis lesions of the IQI mouse model of primary Sjogren's syndrome. Immunogenetics 59: 853-859 (2007). *

• Konstantinidis I, Paschaloudi S, Triaridis S, Fyrmpas G, Sechlidis S, Constantinidis J. Bilateral multiple sialolithiasis of the parotid gland in a patient with Sjogren's syndrome. Acta Otorhinolaryngol. Ital. 27: 41-44 (2007).

• Konttinen YT, Azuma M. Matrix metalloproteinase 9 in the saliva of patients with Sjogren's syndrome: comment on the article by Goicovich et al. Arthritis Rheum. 50: 2374 (2004). *

• Konttinen YT, Kasna-Ronkainen L. Sjogren's syndrome: viewpoint on pathogenesis. One of the reasons I was never asked to write a textbook chapter on it. Scand. J. Rheumatol. Suppl. 116: 15-22 (2002).

• Korman BD, Alba MI, Le JM, Alevizos I, Smith JA, Nikolov NP, Kastner DL, Remmers EF, Illei GG. Variant form of STAT4 is associated with primary Sjogren's syndrome. Genes Immun. 9: 267-270 (2008). *

• Koseki M, Maki Y, Matsukubo T, Ohashi Y, Tsubota K. Salivary flow and its relationship to oral signs and symptoms in patients with dry eyes. Oral. Dis. 10: 75-80 (2004). *

• Kosmopoulou A, Vlassi M, Stavrakoudis A, Sakarellos C, Sakarellos-Daitsiotis M. T-cell epitopes of the La/SSB autoantigen: prediction based on the homology modeling of HLA-DQ2/DQ7 with the insulin-B peptide/HLA-DQ8 complex. J. Comput. Chem. 27: 1033-1044 (2006). *

• Koss MN, Hochholzer L, Langloss JM, Wehunt WD, Lazarus AA. Lymphoid interstitial pneumonia: clinicopathological and immunopathological findings in 18 cases. Pathology 19: 178-185 (1987).

• Kountouras J, Zavos C, Chatzopoulos D. Induction of apoptosis as a proposed pathophysiological link between glaucoma and Helicobacter pylori infection. Med. Hypotheses 62: 378-381 (2004). *

• Kountouras J, Zavos C, Chatzopoulos D. A concept on the role of Helicobacter pylori infection in autoimmune pancreatitis. J. Cell. Mol. Med. 9: 196-207 (2005). *

• Kourbeti IS, Boumpas DT. Biological therapies of autoimmune diseases. Curr. Drug Targets Inflamm. Allergy 4: 41-46 (2005).

• Koutroubakis IE, Drygiannakis D, Karmiris K, Drygiannakis I, Makreas S, Kouroumalis EA. Pancreatic autoantibodies in Greek patients with inflammatory bowel disease. Dig. Dis. Sci. 50: 2330-2334 (2005). *

• Kovacs A, Endreffy E, Petri I, Kovacs L, Pokorny G. HLA class II allele polymorphism in Hungarian patients with primary Sjogren's syndrome. Scand. J. Rheumatol. 35: 75-76 (2006). *

• Kovacs L, Marczinovits I, Gyorgy A, Toth GK, Dorgai L, Pal J, Molnar J, Pokorny G. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3213-228 in primary Sjogren's syndrome. Rheumatology (Oxford) 44: 1021-1025 (2005). *

• Kovacs L, Papos M, Takacs R, Roka R, Csenke Z, Kovacs A, Varkonyi T, Pajor L, Pavics L, Pokorny G. Autonomic nervous system dysfunction involving the gastrointestinal and the urinary tracts in primary Sjogren's syndrome. Clin. Exp. Rheumatol. 21: 697-703 (2003).

• Krajewska M, Weyde W, Klinger M. The significance of regulatory CD4+CD25+ T cells in the pathogenesis and treatment of kidney disease. Postepy. Hig. Med. Dosw. (Online) 61: 178-184 (2007).

• Krause S, Kuckelkorn U, Dorner T, Burmester GR, Feist E, Kloetzel PM. Immunoproteasome subunit LMP2 expression is deregulated in Sjogren's syndrome but not in other autoimmune disorders. Ann. Rheum. Dis. 65: 1021-1027 (2006). *

• Krawiec P, Batko B, Skura A, Adamek-Guzik T, Czesnikiewicz-Guzik M, Krzanowski M, Rydz-Stryszowska I, Ryszawa N, Guzik TJ. Difficulties in differential diagnosis of Sjogren's syndrome and systemic lupus erythematosus. Przegl. Lek. 63: 278-283 (2006).

• Krenn V, Jakobs M, Kriegsmann J, Krukemeyer MG, Rieger A. Is bioptic assurance reasonable in patients with Sjogren's syndrome? From focus score to diagnosing vasculitides. Z. Rheumatol. 69: 11-18 (2010).

• Kristiansson E, Sjogren A, Rudemo M, Nerman O. Quality optimised analysis of general paired microarray experiments. Stat. Appl. Genet. Mol. Biol. 5: Article 10 (2006).

• Kristiansson E, Sjogren A, Rudemo M, Nerman O. Weighted analysis of paired microarray experiments. Stat. Appl. Genet. Mol. Biol. 4: Article 30 (2005).

• Kruszka P, O'Brian RJ. Diagnosis and management of Sjogren syndrome. Am. Fam. Physician 79: 465-470 (2009).

• Kubota T, Moritani S, Yoshino T, Nagai H, Terasaki H. Ocular adnexal mucosa-associated lymphoid tissue lymphoma with polyclonal hypergammaglobulinemia. Am. J. Ophthalmol. 145: 1002-1006 (2008).

• Kujawa A, Rozycki R. Immunological phenomenons in the pathology of the tear film. Is cyclosporine the turn point in the Sjogren's syndrome treatment? Preliminary report. Klin. Oczna. 106: 489-491 (2004).

• Kulkarni K, Selesniemi K, Brown TL. Interferon-gamma sensitizes the human salivary gland cell line, HSG, to tumor necrosis factor-alpha induced activation of dual apoptotic pathways. Apoptosis 11: 2205-2215 (2006). *

• Kulling D, Tresch S, Renner E. Triad of sclerosing cholangitis, chronic pancreatitis, and Sjogren's syndrome: case report and review. Gastrointest. Endosc. 57: 118-120 (2003).

• Kumagai S, Jikimoto T, Saegusa J. Pathological roles of oxidative stress in autoimmune diseases. Rinsho Byori 51: 126-132 (2003).

• Kumagai S, Kanagawa S, Morinobu A, Takada M, Nakamura K, Sugai S, Maruya E, Saji H. Association of a new allele of the TAP2 gene, TAP2*Bky2 (Val577), with susceptibility to Sjogren's syndrome. Arthritis Rheum. 40: 1685-1692 (1997).

• Kumagi T, Heathcote JE. Primary biliary cirrhosis. Orphanet J. Rare Dis. 3: 1 (2008). *

• Kurien BT, Asfa S, Li C, Dorri Y, Jonsson R, Scofield RH. Induction of oral tolerance in experimental Sjogren's syndrome autoimmunity. Scand. J. Immunol. 61: 418-425 (2005). *

• Kurien BT, Mathews SA, Scofield RH. Can low dose diagnostic dental radiation trigger Sjogren's syndrome? Med. Hypotheses 69: 995-1000 (2007).

• Kuroda N, Mitani T, Takeda N, Ishimaru N, Arakaki R, Hayashi Y, Bando Y, Izumi K, Takahashi T, Nomura T, Sakaguchi S, Ueno T, Takahama Y, Uchida D, Sun S, Kajiura F, Mouri Y, Han H, Matsushima A, Yamada G, Matsumoto M. Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice. J. Immunol. 174: 1862-1870 (2005). *

• Kuroda Y, Fukuoka M, Endo C, Matsui M, Kurohara K, Kakigi R, Tokunaga O. Occurrence of primary biliary cirrhosis, CREST syndrome and Sjogren's syndrome in a patient with HTLV-I-associated myelopathy. J. Neurol. Sci. 116: 47-51 (1993).

• Kuroiwa T, Iwasaki T, Imado T, Sekiguchi M, Fujimoto J, Sano H. Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease. Arthritis Res. Ther. 8: R123 (2006). *

• Kurtovic J, Riordan S. Clinical aspects of primary biliary cirrhosis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 31-32. October 15-16 (2003). *

• Kvien TK, Uhlig T. The population based studies in rheumatoid arthritis. A method of longterm followup studies. J. Rheumatol. Suppl. 69: 35-40 (2004).

• Kwon YD, Lee HS, Park CH, Jeen YT, Chun HJ, Lee SW, Choi JH, Kim CD, Ryu HS, Hyun JH. A case of auto-immune hepatitis associated with primary Sjogren's syndrome. Taehan Kan Hakhoe Chi 9: 25-30 (2003).

• Laine M, Porola P, Udby L, Kjeldsen L, Cowland JB, Borregaard N, Hietanen J, Stĺhle M, Pihakari A, Konttinen YT. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjogren's syndrome. Arthritis Rheum. 56: 2575-2584 (2007). *

• Lakatos PL, Bajnok E, Tornai I, Folhoffer A, Horvath A, Lakatos P, Habior A, Szalay F. Insulin-like growth factor I gene microsatellite repeat, collagen type Ialpha1 gene Sp1 polymorphism, and bone disease in primary biliary cirrhosis. Eur. J. Gastroenterol. Hepatol. 16: 753-759 (2004).

• Lambert NC, Stevens AM, Tylee TS, Erickson TD, Furst DE, Nelson JL. From the simple detection of microchimerism in patients with autoimmune diseases to its implication in pathogenesis. Ann. N. Y. Acad. Sci. 945: 164-171 (2001). *

• Lambova SN, Kuzmanova SI. Raynaud's phenomenon in common rheumatic diseases. Folia Med. (Plovdiv.) 48: 22-28 (2006).

• Lamey PJ, Lundy FT, Al-Hashimi I. Sjogren's syndrome: a condition with features of chronic graft-versus-host disease: does duct cell adhesion or permeability play a role in pathogenesis? Med. Hypotheses 62: 825-829 (2004).

• Lamprecht P. TNF-alpha inhibitors in systemic vasculitides and connective tissue diseases. Autoimmun. Rev. 4: 28-34 (2005). *

• Langerman AJ, Blair EA, Sweiss NJ, Taxy JB. Utility of lip biopsy in the diagnosis and treatment of Sjogren's syndrome. Laryngoscope 117: 1004-1008 (2007).

• Lapcevic M. Autoimmune thyroid disease and associated diseases. Srp. Arh. Celok. Lek. 133 Suppl. 1: 84-87 (2005).

• Lappe MA. Silicone-reactive disorder: a new autoimmune disease caused by immunostimulation and superantigens. Med. Hypotheses 41: 348-352 (1993).

• Larche MJ. A short review of the pathogenesis of Sjogren's syndrome. Autoimmun. Rev. 5: 132-135 (2006).

• Larsson A, Bredberg A, Henriksson G, Manthorpe R, Sallmyr A. Immunohistochemistry of the B-cell component in lower lip salivary glands of Sjogren's syndrome and healthy subjects. Scand. J. Immunol. 61: 98-107 (2005). *

• Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M. Pulmonary arterial hypertension: a rare complication of primary Sjogren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore) 86: 299-315 (2007).

• Launay D, Hebbar M, Janin A, Hachulla E, Hatron PY, Devulder B. Primary biliary cirrhosis and systemic scleroderma (Reynolds syndrome): apropos of 8 new cases. The contribution of accessory salivary gland biopsy. Rev. Med. Interne. 19: 393-398 (1998).

• Lavie F, Miceli-Richard C, Ittah M, Sellam J, Gottenberg JE, Mariette X. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjogren's syndrome. Scand. J. Immunol. 67: 185-192 (2008). *

• Lavie F, Miceli-Richard C, Quillard J, Roux S, Leclerc P, Mariette X. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjogren's syndrome. J. Pathol. 202: 496-502 (2004). *

• Lawind MF, Alyasky A, Elwan NM, Mourad H, Al-Bendary A. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome. Egypt. J. Immunol. 11: 75-81 (2004).

• Lawson CA, Donaldson IJ, Bowman SJ, Shefta J, Morgan AW, Gough A, Isaacs JD, Griffiths B, Emery P, Pease CT, Boylston AW. Analysis of the insertion/deletion related polymorphism within T cell antigen receptor beta variable genes in primary Sjogren's syndrome. Ann. Rheum. Dis. 64: 468-470 (2005). *

• Lazaridis KN, Lindor KD. Primary biliary cirrhosis. Curr. Treat. Options Gastroenterol. 2: 473-480 (1999).

• Lazarus MN, Isenberg DA. Development of additional autoimmune diseases in a population of patients with primary Sjogren's syndrome. Ann. Rheum. Dis. 64: 1062-1064 (2005). *

• Lazarus MN, Robinson D, Mak V, Moller H, Isenberg DA. Incidence of cancer in a cohort of patients with primary Sjogren's syndrome. Rheumatology (Oxford) 45: 1012-1015 (2006). *

• Lazzarini LC, de Fatima do Amparo Teixeira M, Souza Rodrigues R, Marcos Nunes Valiante P. Necrotizing sarcoid granulomatosis in a family of patients with sarcoidosis reinforces the association between both entities. Respiration 76: 356-360 (2007). *

• Le Pottier L, Devauchelle V, Fautrel A, Daridon C, Saraux A, Youinou P, Pers JO. Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells. J. Immunol. 182: 3540-3547 (2009).

• Le Pottier L, Devauchelle V, Pers JO, Jamin C, Youinou P. The mosaic of B-cell subsets (with special emphasis on primary Sjogren's syndrome). Autoimmun. Rev. 6: 149-154 (2007). *

• Lee BH, Tudares MA, Nguyen CQ. Sjogren's syndrome: an old tale with a new twist. Arch. Immunol. Ther. Exp. (Warsz.) 57: 57-66 (2009).

• Lee EY, Lee ZH, Song YW. CXCL10 and autoimmune diseases. Autoimmun. Rev. 8: 379-383 (2009).

• Lee J, Chang JE, Cho YJ, Han WS. A case of reactive plasmacytosis mimicking multiple myeloma in a patient with primary Sjogren's syndrome. J. Korean Med. Sci. 20: 506-508 (2005). *

• Lee J, Chang KH, Park CS, Lee CH, Song CH, Park YN, Park C, Lee SK. A case of autoimmune cholangitis associated with Sjogren's syndrome and arthropathy. J. Korean Med. Sci. 13: 85-88 (1998). *

• Lee KL, Chen MY, Yeh JH, Huang SW, Tai HC, Yu HJ. Lower urinary tract symptoms in female patients with rheumatoid arthritis. Scand. J. Rheumatol. 35: 96-101 (2006). *

• Lee LA. Transient autoimmunity related to maternal autoantibodies: neonatal lupus. Autoimmun. Rev. 4: 207-213 (2005).

• Lefevre C, Bouadjar B, Ferrand V, Tadini G, Megarbane A, Lathrop M, Prud'homme JF, Fischer J. Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3. Hum. Mol. Genet. 15: 767-776 (2006). *

• Leibovitch L, George J, Levi Y, Bakimer R, Shoenfeld Y. Anti-actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA. Immunol. Lett. 48: 129-132 (1995).

• Leng XM, Zhao Y, Zhou DB, Situ H, Li TS, Shen T, Zhao YQ, Zeng XF, Zhang FC, Dong Y, Tang FL. A pilot trial for severe, refractory systemic autoimmune disease with stem cell transplantation. Chin. Med. Sci. J. 20: 159-165 (2005).

• Leon-Monzon M, Soriano V, Escudero D, Gonzalez-Lahoz J. Serologic activity against retrovirus in patients with Sjogren syndrome. Med. Clin. (Barc.) 100: 121-124 (1993).

• Lester S, Danda D, Cavill D, Pile K, Downie-Doyle S, Rischmueller M. Humoral immunity to Ro52 is not associated with the Ro52 9571 C/T polymorphism in Australian patients with primary Sjogren's syndrome. Arthritis Rheum. 48: 3293-3294 (2003). *

• Lester S, Downie-Doyle S, Rischmueller M. CTLA4 polymorphism and primary Sjogren's syndrome. Arthritis Res. Ther. 9: 401 (2007). *

• Lester SE, McLure C, Williamson J, Bardy P, Rischmueller M, Dawkins RL. Epistasis between MHC and the RCA alpha block in primary Sjogren's syndrome. Ann. Rheum. Dis. 67: 849-854 (2008). *

• Leung KC, Brce J, Doyle N, Lee HJ, Leong GM, Sjogren K, Ho KK. Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases. Endocrinology 148: 2417-2423 (2007). *

• Leuschner U. Primary biliary cirrhosis - presentation and diagnosis. Clin. Liver Dis. 7: 741-758 (2003).

• Levy C, Lindor KD. Current management of primary biliary cirrhosis and primary sclerosing cholangitis. J. Hepatol. 38: S24-S37 (2003). *

• Li H, Dai M, Zhuang Y. A T cell intrinsic role of Id3 in a mouse model for primary Sjogren's syndrome. Immunity 21: 551-560 (2004). *

• Li J, Ha YM, Ku NY, Choi SY, Lee SJ, Oh SB, Kim JS, Lee JH, Lee EB, Song YW, Park K. Inhibitory effects of autoantibodies on the muscarinic receptors in Sjogren's syndrome. Lab. Invest. 84: 1430-1438 (2004). *

• Li N, Shigihara T, Tzioufas AG, Notkins AL, Yoon JW, Jun HS. Human chorionic gonadotropin prevents Sjogren's syndrome-like exocrinopathy in mice. Arthritis Rheum. 56: 2211-2215 (2007). *

• Li X. Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling. Cytokine 41: 105-113 (2008).

• Lian EC, Tzakis AG, Andrews D. Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis. Am. J. Hematol. 77: 363-365 (2004). *

• Liden M, Kristjansson G, Valtysdottir S, Hallgren R. Gluten sensitivity in patients with primary Sjogren's syndrome. Scand. J. Gastroenterol. 42: 962-967 (2007). *

• Liden M, Kristjansson G, Valtysdottir S, Venge P, Hallgren R. Cow's milk protein sensitivity assessed by the mucosal patch technique is related to irritable bowel syndrome in patients with primary Sjogren's syndrome. Clin. Exp. Allergy 38: 929-935 (2008). *

• Lienesch DW, Sherman KE, Metzger A, Shen GQ. Anti-Clq antibodies in patients with chronic hepatitis C infection. Clin. Exp. Rheumatol. 24: 183-185 (2006).

• Lima I, Carneiro AS, Amorim CA, Santiago MB. Hodgkin lymphoma as a complication of primary Sjogren's syndrome. Mod. Rheumatol. 18: 200-202 (2008). *

• Limaye V, Lester S, Downie-Doyle S, Pile K, Bardy P, Gordon TP, Rischmueller M. Polymorphisms of the interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjogren's syndrome. J. Rheumatol. 27: 2945-2946 (2000).

• Lin LH, Tsai CN, Liu MF, Wang CR. Common variable immunodeficiency mimicking rheumatoid arthritis with Sjogren's syndrome. J. Microbiol. Immunol. Infect. 38: 358-360 (2005). *

• Linardaki G, Skopouli FN, Koufos C, Moutsopoulos HM. Subclinical multisystemic autoimmunity presenting as a progressive myelopathy. Lupus 6: 675-677 (1997).

• Linden D, William-Olsson L, Ahnmark A, Ekroos K, Hallberg C, Sjogren HP, Becker B, Svensson L, Clapham JC, Oscarsson J, Schreyer S. Liver-directed overexpression of mitochondrial glycerol-3-phosphate acyltransferase results in hepatic steatosis, increased triacylglycerol secretion and reduced fatty acid oxidation. FASEB J. 20: 434-443 (2006). *

• Lindgren S, Hansen B, Sjoholm AG, Manthorpe R. Complement activation in patients with primary Sjogren's syndrome: an indicator of systemic disease. Autoimmunity 16: 297-300 (1993).

• Lindgren S, Manthorpe R, Eriksson S. Autoimmune liver disease in patients with primary Sjogren's syndrome. J. Hepatol. 20: 354-358 (1994).

• Lindholm E, Bakhtadze E, Sjogren M, Cilio CM, Agardh E, Groop L, Agardh CD. The -374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients. Diabetologia 49: 2745-2755 (2006). *

• Lindstom F. Gastrointestinal involvement in primary Sjorgen's syndrome. http://www.sjogrensyndrom.se/100-site/spdfs/S6.pdf (2004). *

• Lipworth L, Tarone RE, McLaughlin JK. Silicone breast implants and connective tissue disease: an updated review of the epidemiologic evidence. Ann. Plast. Surg. 52: 598-601 (2004).

• Liquidato BM, Bussoloti Filho I. Evaluation of sialometry and minor salivary gland biopsy in classification of Sjogren's syndrome patients. Rev. Bras. Otorrinolaringol. (Engl. Ed). 71: 346-354 (2005).

• Liu B, Zhang FC, Zhang ZL, Zhang W, Gao LX. Interstitial lung disease and Sjogren's syndrome in primary biliary cirrhosis: a causal or casual association? Clin. Rheumatol. 27: 1299-1306 (2008). *

• Liu MF, Lin LH, Weng CT, Weng MY. Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjogren's syndrome. Lupus 17: 34-39 (2008). *

• Liu Y, Fan R, Zhou S, Yu Z, Zhang Z. Potential contribution of VH gene replacement in immunity and disease. Ann. N. Y. Acad. Sci. 1062: 175-181 (2005). *

• Locht H, Pelck R, Manthorpe R. Clinical manifestations correlated to the prevalence of autoantibodies in a large (n=321) cohort of patients with primary Sjogren's syndrome. A comparison of patients initially diagnosed according to the Copenhagen classification criteria … Autoimmun. Rev. 4: 276-281 (2005).

• Lodde B, Mineshiba F, Kok M, Wang J, Zheng C, Schmidt M, Cotrim A, Kriete M, Tak P, Baum B. NOD mouse model for Sjogren's syndrome: lack of longitudinal stability. Oral Dis. 12: 566-572 (2006). *

• Lodde BM, Sankar V, Kok MR, Leakan RA, Tak PP, Pillemer SR. Adult heart block is associated with disease activity in primary Sjogren's syndrome. Scand. J. Rheumatol. 34: 383-386 (2005). *

• Lodde BM, Sankar V, Kok MR, Leakan RA, Tak PP, Pillemer SR. Serum lipid levels in Sjogren's syndrome. Rheumatology (Oxford) 45: 481-484 (2006). *

• Loiseau P, Lepage V, Djelal F, Busson M, Tamouza R, Raffoux C, Menkes CJ, Meyer O, Charron D, Goldberg D. HLA class I and class II are both associated with the genetic predisposition to primary Sjogren syndrome. Hum. Immunol. 62: 725-731 (2001).

• Lonyai A, Kodama S, Burger D, Davis M, Faustman DL. The promise of HOX11+ stem cells of the spleen for treating autoimmune diseases. Horm. Metab. Res. 40: 137-146 (2008).

• Lonyai A, Kodama S, Burger D, Faustman DL. Fetal Hox11 expression patterns predict defective target organs: a novel link between developmental biology and autoimmunity. Immunol. Cell Biol. 86: 301-309 (2008). *

• Lopate G, Pestronk A, Al-Lozi M, Lynch T, Florence J, Miller T, Levine T, Rampy T, Beson B, Ramneantu I. Peripheral neuropathy in an outpatient cohort of patients with Sjogren's syndrome. Muscle Nerve 33: 672-676 (2006).

• Lossos A, Khoury M, Rizzo WB, Gomori JM, Banin E, Zlotogorski A, Jaber S, Abramsky O, Argov Z, Rosenmann H. Phenotypic variability among adult siblings with Sjogren-Larsson syndrome. Arch. Neurol. 63: 278-280 (2006). *

• Lotti TM, Comacchi C, Ghersetich I. Cutaneous necrotizing vasculitis. Relation to systemic disease. Adv. Exp. Med. Biol. 455: 115-125 (1999).

• Lovgren T, Eloranta ML, Kastner B, Wahren-Herlenius M, Alm GV, Ronnblom L. Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjogren's syndrome autoantigen-associated RNA. Arthritis Rheum. 54: 1917-1927 (2006). *

• Lowe DP, Cook MA, Bowman SJ, Briggs DC; the UK Sjogren's Interest Group. Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. Rheumatology (Oxford) 48: 359-362 (2009). *

• Lu W, Sun G. Clinical characteristics of primary biliary cirrhosis with Sjogren's syndrome of 20 cases. Zhonghua Nei Ke Za Zhi 40: 747-749 (2001).

• Lu Y, Ye P, Chen SL, Tan EM, Chan EK. Identification of kinectin as a novel Behcet's disease autoantigen. Arthritis Res. Ther. 7: R1133-R1139 (2005). *

• Luft LM, Barr SG, Martin LO, Chan EK, Fritzler MJ. Autoantibodies to tissue transglutaminase in Sjogren's syndrome and related rheumatic diseases. J. Rheumatol. 30: 2613-2619 (2003).

• Lyons R, Narain S, Nichols C, Satoh M, Reeves WH. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease. Ann. N. Y. Acad. Sci. 1050: 217-228 (2005). *

• Lyssenko V, Almgren P, Anevski D, Orho-Melander M, Sjogren M, Saloranta C, Tuomi T, Groop L; Botnia Study Group. Genetic prediction of future type 2 diabetes. PLoS Med. 2: e345 (2005). *

• Macdonald P, Palmer J, Kirby JA, Jones DE. Apoptosis as a mechanism for cell surface expression of the autoantigen pyruvate dehydrogenase complex. Clin. Exp. Immunol. 136: 559-567 (2004). *

• Macejova Z, Benhatchi K, Lazurova I. Chronic autoimmune thyroiditis and connective tissue system diseases. Vnitr. Lek. 52: 801-804 (2006).

• Machida T, Takahashi T, Itoh T, Hirayama M, Morita T, Horita S. Reactive lymphoid hyperplasia of the liver: a case report and review of literature. World J. Gastroenterol. 13: 5403-5407 (2007). *

• Machin ND, Chard MD, Paice EW. Serum angiotensin converting enzyme in Sjogren's syndrome - a case report and study of 21 further cases. Postgrad. Med. J. 60: 270-271 (1984). *

• Mackay F, Sierro F, Grey ST, Gordon TP. The BAFF/APRIL system: an important player in systemic rheumatic diseases. Curr. Dir. Autoimmun. 8: 243-265 (2005).

• Mackay IR, Groom J, Mackay CR. Levels of BAFF in serum in primary biliary cirrhosis and autoimmune diabetes. Autoimmunity 35: 551-553 (2002).

• MacSween RN, Goudie RB, Anderson JR, Armstrong E, Murray MA, Mason DK, Jasani MK, Boyle JA, Buchanan WW, Williamson J. Occurrence of antibody to salivary duct epithelium in Sjogren's disease, rheumatoid arthritis, and other arthritides. A clinical and laboratory study. Ann. Rheum. Dis. 26: 402-411 (1967).

• Maeno N, Takei S, Fujikawa S, Yamada Y, Imanaka H, Hokonohara M, Kawano Y, Oda H. Antiagalactosyl IgG antibodies in juvenile idiopathic arthritis, juvenile onset Sjogren's syndrome, and healthy children. J. Rheumatol. 31: 1211-1217 (2004).

• Magnusson V, Nakken B, Bolstad AI, Alarcon-Riquelme ME. Cytokine polymorphisms in systemic lupus erythematosus and Sjogren's syndrome. Scand. J. Immunol. 54: 55-61 (2001). *

• Magro CM, Porcu P, Ahmad N, Klinger D, Crowson AN, Nuovo G. Cutaneous immunocytoma: a clinical, histologic, and phenotypic study of 11 cases. Appl. Immunohistochem. Mol. Morphol. 12: 216-224 (2004).

• Mahoney EJ, Spiegel JH. Sjogren's disease. Otolaryngol. Clin. North Am. 36: 733-745 (2003).

• Maiti AK, Kim-Howard X, Viswanathan P, Guillen L, Rojas-Villarraga A, Deshmukh H, Direskeneli H, Saruhan-Direskeneli G, Canas C, Tobon GJ, Sawalha AH, Chernavsky AC, Anaya JM, Nath SK. Confirmation of an association between rs6822844 at the IL2-IL21 region and multiple autoimmune diseases: evidence of a general susceptibility locus. Arthritis Rheum. 62: 323-329 (2010). *

• Makino M, Honda H, Miyoshi F, Ban Y, Katagiri T, Matsuyama TA, Ota H, Yoshitake O, Kusano M, Shibata T, Akizawa T. A fulminant case of renal vein thrombosis in a patient with autoimmune disorder and membranous nephropathy. Intern. Med. 47: 969-973 (2008). *

• Manavalan SJ, Valiando JR, Reeves WH, Arnett FC, Necker A, Simantov R, Lyons R, Satoh M, Posnett DN. Genomic absence of the gene encoding T cell receptor Vbeta7.2 is linked to the presence of autoantibodies in Sjogren's syndrome. Arthritis Rheum. 50: 187-198 (2004). *

• Mandel L, Dehlinger N. Primary biliary cirrhosis and Sjogren's syndrome: case report. J. Oral Maxillofac. Surg. 61: 1358-1361 (2003). *

• Mandel L, Sunwoo J. Primary Sjogren's syndrome. N.Y. State Dent. J. 69: 34-36 (2003).

• Mandl T, Bredberg A, Jacobsson LT, Manthorpe R, Henriksson G. CD4+ T-lymphocytopenia - a frequent finding in anti-SSA antibody seropositive patients with primary Sjogren's syndrome. J. Rheumatol. 31: 726-728 (2004).

• Manganelli P, Fietta P, Quaini F. Hematologic manifestations of primary Sjogren's syndrome. Clin. Exp. Rheumatol. 24: 438-448 (2006).

• Manna R, Verrecchia E, Fonnesu C, Giovinale M, De Socio G, Curigliano V, Cerquaglia C, Soriano A, Granata M, Migliore A, Massafra U, Gasbarrini G. Cyclosporine A: good response for patients affected by autoimmune disorders and HCV infection? Eur. Rev. Med. Pharmacol. Sci. 13 Suppl. 1: 63-69 (2009).

• Manolakis AC, Kapsoritakis AN, Ioannou M, Tsikouras AN, Koukoulis GK, Potamianos SP. Sickle cell trait-related ischemic colitis in a patient with Sjogren's syndrome. Am. J. Gastroenterol. 103: 2952-2954 (2008). *

• Manoussakis MN, Georgopoulou C, Zintzaras E, Spyropoulou M, Stavropoulou A, Skopouli FN, Moutsopoulos HM. Sjogren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjogren's syndrome. Arthritis Rheum. 50: 882-891 (2004). *

• Manoussakis MN, Kapsogeorgou EK. The role of epithelial cells in the pathogenesis of Sjogren's syndrome. Clin. Rev. Allergy Immunol. 32: 225-230 (2007). *

• Mansour MJ, Al-Hashimi I, Wright JM. Coexistence of Sjogren's syndrome and sarcoidosis: a report of five cases. J. Oral Pathol. Med. 36: 337-341 (2007). *

• Manthorpe R, Svensson A, Wirestrand LE. Late neonatal lupus erythematosus onset in a child born of a mother with primary Sjogren's syndrome. Ann. Rheum. Dis. 63: 1496-1497 (2004). *

• Manuel SL, Rahman S, Wigdahl B, Khan ZK, Jain P. Dendritic cells in autoimmune diseases and neuroinflammatory disorders. Front. Biosci. 10: 4315-4335 (2007).

• Marchini B, Dolcher MP, Sabbatini A, Klein G, Migliorini P. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases. J. Autoimmun. 7: 179-191 (1994).

• Marcos M, Alvarez F, Brito-Zeron P, Bove A, Perez-De-Lis M, Diaz C, Sanchez-Tapias JM, Ramos-Casals M. Chronic hepatitis B virus infection in Sjogren's syndrome: prevalence and clinical significance in 603 patients. Autoimmun. Rev. 8: 616-620 (2009).

• Marczinovits I, Kovacs L, Gyorgy A, Toth GK, Dorgai L, Molnar J, Pokorny G. A peptide of human muscarinic acetylcholine receptor 3 is antigenic in primary Sjogren's syndrome. J. Autoimmun. 24: 47-54 (2005).

• Margaix-Munoz M, Bagan JV, Poveda R, Jimenez Y, Sarrion G. Sjogren's syndrome of the oral cavity. Review and update. Med. Oral Patol. Oral Cir. Bucal. 14: E325-E330 (2009). *

• Mariette X. Treatment of oral dryness in Sjogren's syndrome. Rev. Med. Interne. 25: 287-293 (2004).

• Mariette X. Sjogren's syndrome and virus. Ann. Med. Interne. (Paris) 146: 243-246 (1995).

• Mariette X, Ravaud P, Steinfeld S, Baron G, Goetz J, Hachulla E, Combe B, Puechal X, Pennec Y, Sauvezie B, Perdriger A, Hayem G, Janin A, Sibilia J. Inefficacy of infliximab in primary Sjogren's syndrome: results of the randomized, controlled trial of remicade in primary Sjogren's syndrome (TRIPSS). Arthritis Rheum. 50: 1270-1276 (2004). *

• Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T, Kimberly R. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann. Rheum. Dis. 62: 168-171 (2003). *

• Marinho R, Graca H, Ramalho F, Costa A, Batista A, De Moura MC. Autoimmune cholangiopathy. Acta Med. Port. 14: 361-366 (2001).

• Marka M, Bessenyei B, Zeher M, Semsei I. IL-10 promoter -1082 polymorphism is associated with elevated IL-10 levels in control subjects but does not explain elevated plasma IL-10 observed in Sjogren's syndrome in a Hungarian cohort. Scand. J. Immunol. 62: 474-480 (2005). *

• Martin M. Primary sclerosing cholangitis. Annu. Rev. Med. 44: 221-227 (1993). *

• Maruyama T, Saito I, Hayashi Y, Kompfner E, Fox RI, Burton DR, Ditzel HJ. Molecular analysis of the human autoantibody response to alpha-fodrin in Sjogren's syndrome reveals novel apoptosis-induced specificity. Am. J. Pathol. 165: 53-61 (2004). *

• Masaki N, Hayashi S. Autoimmune liver disease complicating Sjogren's syndrome. Nippon Rinsho 53: 2530-2535 (1995).

• Masaki Y, Sugai S. Lymphoproliferative disorders in Sjogren's syndrome. Autoimmun. Rev. 3: 175-182 (2004).

• Masaki Y, Umehara H. IgG4-related disease-the diagnostic confusion and how to avoid it. Nihon Rinsho Meneki Gakkai Kaishi 32: 478-483 (2009).

• Masilamani M, Nowack R, Witte T, Schlesier M, Warnatz K, Glocker MO, Peter HH, Illges H. Reduction of soluble complement receptor 2/CD21 in systemic lupus erythomatosus and Sjogren's syndrome but not juvenile arthritis. Scand. J. Immunol. 60: 625-630 (2004). *

• Mason AL, Xu L, Guo L, Garry RF. Retroviruses in autoimmune liver disease: genetic or environmental agents? Arch. Immunol. Ther. Exp. (Warsz.) 47: 289-297 (1999).

• Massardo L, Aguirre V, Garcia ME, Cervila V, Nicovani S, Gonzalez A, Rivero S, Jacobelli S. Clinical expression of rheumatoid arthritis in Chilean patients. Semin. Arthritis Rheum. 25: 203-213 (1995).

• Mathews SA, Kurien BT, Scofield RH. Oral manifestations of Sjogren's syndrome. J. Dent. Res. 87: 308-318 (2008). *

• Mathsson L, Ahlin E, Sjowall C, Skogh T, Ronnelid J. Cytokine induction by circulating immune complexes and signs of in-vivo complement activation in systemic lupus erythematosus are associated with the occurrence of anti-Sjogren's syndrome A antibodies. Clin. Exp. Immunol. 147: 513-520 (2007). *

• Matorras R, Ocerin I, Unamuno M, Nieto A, Peiro E, Burgos J, Exposito A. Prevalence of endometriosis in women with systemic lupus erythematosus and Sjogren's syndrome. Lupus 16: 736-740 (2007). *

• Matsui T, Kurokawa M, Kobata T, Oki S, Azuma M, Tohma S, Inoue T, Yamamoto K, Nishioka K, Kato T. Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases. J. Immunol. 162: 4328-4335 (1999). *

• Matsumoto I, Tsubota K, Satake Y, Kita Y, Matsumura R, Murata H, Namekawa T, Nishioka K, Iwamoto I, Saitoh Y, Sumida T. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjogren's syndrome. J. Clin. Invest. 97: 1969-1977 (1996). *

• Matsumoto T, Morizane T, Aoki Y, Yamasaki S, Nakajima M, Enomoto N, Kobayashi S, Hashimoto H. Autoimmune hepatitis in primary Sjogren's syndrome: pathological study of the livers and labial salivary glands in 17 patients with primary Sjogren's syndrome. Pathol. Int. 55: 70-76 (2005). *

• Matsushita M, Takasaki Y, Takeuchi K, Yamada H, Matsudaira R, Hashimoto H. Autoimmune response to proteasome activator 28alpha in patients with connective tissue diseases. J. Rheumatol. 31: 252-259 (2004).

• Matsushita T, Sato S. The role of BAFF in autoimmune diseases. Nihon Rinsho Meneki Gakkai Kaishi 28: 333-342 (2005).

• Mattey DL, Gonzalez-Gay MA, Hajeer AH, Dababneh A, Thomson W, Garcia-Porrua C, Ollier WE. Association between HLA-DRB1*15 and secondary Sjogren's syndrome in patients with rheumatoid arthritis. J. Rheumatol. 27: 2611-2616 (2000).

• Mavragani CP, Moutsopoulos HM. Conventional therapy of Sjogren's syndrome. Clin. Rev. Allergy Immunol. 32: 284-291 (2007). *

• Mavragani CP, Moutsopoulos HM. The geoepidemiology of Sjogren's syndrome. Autoimmun. Rev. Nov 7 [Epub ahead of print] (2009).

• Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The management of Sjogren's syndrome. Nat. Clin. Pract. Rheumatol. 2: 252-261 (2006). *

• Mayo I, Arribas J, Villoslada P, Alvarez DoForno R, Rodriguez-Vilarino S, Montalban X, De Sagarra MR, Castano JG. The proteasome is a major autoantigen in multiple sclerosis. Brain 125: 2658-2667 (2002). *

• Mazur-Roszak M, Litwiniuk M, Lacka K. Lymphoma of the thyroid in a patient with autoimmune thyroiditis and Sjogren's syndrome - case report. Pol. Merkur. Lekarski. 25: 155-157 (2008).

• McDonagh JE, Isenberg DA. Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus. Ann. Rheum. Dis. 59: 230-232 (2000). *

• McGrath-Morrow S, Laube B, Tzou SC, Cho C, Cleary J, Kimura H, Rose NR, Caturegli P. IL-12 overexpression in mice as a model for Sjogren lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L837-L846 (2006). *

• McMurray RW. Adhesion molecules in autoimmune disease. Semin. Arthritis Rheum. 25: 215-233 (1996). *

• McQueen FM, Dalbeth N. Will Jill come tumbling after? The case for a JAK2-type mutation as a prequel to the connective tissue disorders. Med. Hypotheses 73: 651-654 (2009).

• Mecacci F, Pieralli A, Bianchi B, Paidas MJ. The impact of autoimmune disorders and adverse pregnancy outcome. Semin. Perinatol. 31: 223-226 (2007).

• Meijer JM, Pijpe J, Bootsma H, Vissink A, Kallenberg CG. The future of biologic agents in the treatment of Sjogren's syndrome. Clin. Rev. Allergy Immunol. 32: 292-297 (2007). *

• Melo FM, Cavalcanti MS, Santos SB, Lopes AK, Oliveira FA. Association between serum markers for celiac and thyroid autoimmune diseases. Arq. Bras. Endocrinol. Metabol. 49: 542-547 (2005).

• Meloni F, Transi MG, Nigro D, Belli S, Bernardi A, Bottazzi M, Valesini G. Biopsy of the minor salivary glands in Sjogren's syndrome. Clin. Ter. 135: 367-372 (1990).

• Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann. Intern. Med. 126: 866-873 (1997).

• Mertzanis P, Abetz L, Rajagopalan K, Espindle D, Chalmers R, Snyder C, Caffery B, Edrington T, Simpson T, Nelson JD, Begley C. The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample. Invest. Ophthalmol. Vis. Sci. 46: 46-50 (2005). *

• Metskula K, Salur L, Mandel M, Uibo R. Demonstration of high prevalence of SS-A antibodies in a general population: association with HLA-DR and enterovirus antibodies. Immunol. Lett. 106: 14-18 (2006).

• Meyer O. Superantigens and their implication in autoimmune diseases. Presse. Med. 24: 1171-1177 (1995).

• Meyer O. Evaluating inflammatory joint disease: how and when can autoantibodies help? Joint Bone Spine 70: 433-447 (2003).

• Miceli-Richard C, Comets E, Loiseau P, Puechal X, Hachulla E, Mariette X. Association of an IRF5 gene functional polymorphism with Sjogren's syndrome. Arthritis Rheum. 56: 3989-3994 (2007). *

• Miceli-Richard C, Gestermann N, Ittah M, Comets E, Loiseau P, Puechal X, Hachulla E, Gottenberg JE, Lebon P, Becquemont L, Mariette X. The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjogren's syndrome. Arthritis Rheum. 60: 1991-1997 (2009). *

• Miceli-Richard C, Gottenberg JE, Mariette X. CTLA-4 polymorphism and primary Sjogren's syndrome: authors' response. Arthritis Res. Ther. 9: 402 (2007).

• Mieliauskaite D, Venalis P, Dumalakiene I, Venalis A, Distler J. Relationship between serum levels of TGF-beta1 and clinical parameters in patients with rheumatoid arthritis and Sjogren's syndrome secondary to rheumatoid arthritis. Autoimmunity 42: 356-358 (2009).

• Migliore A, Bizzi E, Massafra U, Capuano A, Martin Martin LS. Multiple chemical sensitivity syndrome in Sjogren's syndrome patients: casual association or related diseases? Arch. Environ. Occup. Health 61: 285-287 (2006). *

• Mihailova D, Grigorova R, Vassileva B, Mladenova G, Ivanova N, Stephanov S, Lissitchky K, Dimova E. Autoimmune thyroid disorders in juvenile chronic arthritis and systemic lupus erythematosus. Adv. Exp. Med. Biol. 455: 55-60 (1999).

• Min JK, Han NI, Kim JA, Lee YS, Cho CS, Kim HY. A case of cholestatic autoimmune hepatitis and acute liver failure: an unusual hepatic manifestation of mixed connective tissue disease and Sjogren's syndrome. J. Korean Med. Sci. 16: 512-515 (2001). *

• Min JK, Park KS, Yu WJ, Lee YS, Park SM, Park SH, Cho CS, Kim HY. Systemic mononuclear inflammatory vasculopathy associated with Sjogren's syndrome in a patient with primary biliary cirrhosis. Korean J. Intern. Med. 15: 89-92 (2000).

• Minozzi F, Galli M, Gallottini L, Minozzi M, Unfer V. Stomatological approach to Sjogren's syndrome: diagnosis, management and therapeutical timing. Eur. Rev. Med. Pharmacol. Sci. 13: 201-216 (2009).

• Mircheff AK. Sjogrens syndrome as failed local immunohomeostasis: prospects for cell-based therapy. Ocul. Surf. 1: 160-179 (2003).

• Mitchell RJ, Fabb SA, Whittingham S. Serum protein polymorphisms in patients with primary Sjogren's syndrome. Hum. Hered. 35: 302-305 (1985).

• Mitoma H, Horiuchi T, Kimoto Y, Tsukamoto H, Uchino A, Tamimoto Y, Miyagi Y, Harada M. Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus. Int. J. Mol. Med. 16: 609-615 (2005).

• Mitsias DI, Kapsogeorgou EK, Moutsopoulos HM. The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: lessons from Sjogren's syndrome (autoimmune epithelitis). Lupus 15: 255-261 (2006).

• Mitsushima H, Kawazoe K, Takahashi A, Oishi K, Nagatake T. Secondary bronchiolitis obliterans organizing pneumonia with primary Sjogren's syndrome, resulting in acute respiratory distress syndrome: a case report. Nihon Kokyuki Gakkai Zasshi 42: 261-265 (2004).

• Miwa Y, Hosaka M, Wakabayashi K, Odai T, Isozaki T, Matsunawa M, Yajima N, Shiozawa F, Hanaoka R, Negishi M, Ide H, Kasama T, Adachi M. Rheumatoid arthritis patients with Sjogren's syndrome are more prone to depression than patients with rheumatoid arthritis or Sjogren's syndrome alone. Curr. Rheumatol. Rev. 4: 46-49 (2008).

• Miyachi K, Iwai M, Asada K, Saito I, Hankins R, Mikoshiba K. Inositol 1,4,5-trisphosphate receptors are autoantibody target antigens in patients with Sjogren's syndrome and other systemic rheumatic diseases. Mod. Rheumatol. 17: 137-143 (2007). *

• Miyachi K, Shibata M, Onozuka Y, Kikuchi F, Imai N, Horigome T. Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62 complex bearing N-acetylglucosamine residues from rat liver nuclear envelope. Anti-p62 complex antibody in PBC. Mol. Biol. Rep. 23: 227-234 (1996).

• Miyagawa S, Shinohara K, Nakajima M, Kidoguchi K, Fujita T, Fukumoto T, Yoshioka A, Dohi K, Shirai T. Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects. Arthritis Rheum. 41: 927-934 (1998). *

• Miyagawa S, Tanaka M, Okamoto S, Ishihara T, Nakajima M, Taira K, Yoshioka A, Asada H. Autoimmune thyroid disease in anti-Ro/SS-A-positive children with annular erythema: report of two cases. Br. J. Dermatol. 150: 1005-1008 (2004). *

• Miyagawa T, Mochizuki Y, Nakahara Y, Kawamura T, Sasaki S, Kobashi Y. A case of Sjogren syndrome with pulmonary nodular amyloidosis and pulmonary multiple cysts. Nihon Kokyuki Gakkai Zasshi 47: 737-741 (2009).

• Miyamoto H, Azuma A, Taniguchi Y, Takahashi T, Yoshimura A, Hemmi S, Fukuda Y, Kudoh S. Interstitial pneumonia complicated by Sjogren's syndrome, Hashimoto's disease, rheumatoid arthritis and primary biliary cirrhosis. Intern. Med. 39: 970-975 (2000). *

• Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, Nochy D, Debre P, Piette JC, Gorochov G. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol. 175: 8392-8400 (2005). *

• Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y. Clinical and serological heterogeneity in patients with anticentromere antibodies. J. Rheumatol. 32: 1488-1494 (2005).

• Miyazaki K, Takeda N, Ishimaru N, Omotehara F, Arakaki R, Hayashi Y. Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjogren's syndrome. Am. J. Pathol. 167: 1051-1059 (2005). *

• Miyazaki Y, Yamamoto K. Detection of antigen specific T cell clonality in autoimmune diseases and epitope analysis of autoantigen-reactive T cells. Nippon Rinsho 55: 1403-1409 (1997).

• Mohammed K, Pope J, le Riche N, Brintnell W, Cairns E, Coles R, Bell DA. Association of severe inflammatory polyarthritis in primary Sjogren's syndrome: clinical, serologic, and HLA analysis. J. Rheumatol. 36: 1937-1942 (2009).

• Molta CT, Khan MA, Aponte CJ, Reynolds TL, Macintyre SS. Familial occurrence of systemic sclerosis, rheumatoid arthritis and other immunological disorders: report of two kindreds with study of HLA antigens and review of the literature. Clin. Exp. Rheumatol. 7: 229-236 (1989).

• Mondini M, Vidali M, Andrea MD, Azzimonti B, Airo P, D'Ambrosio R, Riboldi P, Meroni PL, Albano E, Shoenfeld Y, Gariglio M, Landolfo S. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16. Arthritis Rheum. 54: 3939-3944 (2006). *

• Montefusco PP, Geiss AC, Bronzo RL, Randall S, Kahn E, McKinley MJ. Sclerosing cholangitis, chronic pancreatitis, and Sjogren's syndrome: a syndrome complex. Am. J. Surg. 147: 822-826 (1984).

• Monteiro P, Coutinho M, Salvador MJ, Malcata A. Primary Sjogren syndrome and inclusion body myositis. Acta Reumatol. Port. 34: 261-265 (2009).

• Moran S, Rodriguez-Leal G, Marin-Lopez E, Arista J, Poo JL, Vargas-Vorackova F, Kershenobich D, Uribe M. Primary biliary cirrhosis: clinical features and survival of a Mexican population. Rev. Gastroenterol. Mex. 61: 212-219 (1996).

• Morawietz L, Martinez-Gamboa L, Scheffler S, Hausdorf G, Dankof A, Kuckelkorn U, Doerner T, Egerer K, Burmester GR, Faustman DL, Feist E. Expression of proteasomal immunosubunit ss1i is dysregulated in inflammatory infiltrates of minor salivary glands in Sjogren's syndrome. J. Rheumatol. 36: 2694-2703 (2009).

• Morinobu A, Kanagawa S, Koshiba M, Sugai S, Kumagai S. Association of the glutathione S-transferase M1 homozygous null genotype with susceptibility to Sjogren's syndrome in Japanese individuals. Arthritis Rheum. 42: 2612-2615 (1999). *

• Moriuchi J, Ichikawa Y, Takaya M, Shimizu H, Uchiyama M, Inoko H, Tsuji K, Arimori S. Lack of deletion of complement C4 and steroid 21-hydroxylase genes in Japanese patients with primary Sjogren's syndrome. J. Rheumatol. 19: 700-703 (1992).

• Morling N, Andersen V, Fugger L, Georgsen J, Halberg P, Oxholm P, Odum N, Svejgaard A. Immunogenetics of rheumatoid arthritis and primary Sjogren's syndrome: DNA polymorphism of HLA class II genes. Dis. Markers 9: 289-296 (1991).

• Mosca M, Tani C, Neri C, Baldini C, Bombardieri S. Undifferentiated connective tissue diseases (UCTD). Autoimmun. Rev. 6: 1-4 (2006).

• Moser KL, Gaffney P, Peterson E, Behrens T. Keys to unlocking the mysteries of rheumatic autoimmune disease. Minn. Med. 87: 46-51 (2004).

• Moser KL, Gaffney PM, Grandits ME, Emamian ES, Machado DB, Baechler EC, Rhodus NL, Behrens TW. The use of microarrays to study autoimmunity. J. Investig. Dermatol. Symp. Proc. 9: 18-22 (2004). *

• Mostafavi B, Akyuz S, Jacobsson ME, Nilsen LV, Theander E, Jacobsson LH. Perinatal characteristics and risk of developing primary Sjogren's syndrome: a case-control study. J. Rheumatol. 32: 665-668 (2005).

• Moulin P, Lehucher-Michel MP. Wegener's disease and exposure to silica. Presse. Med. 33: 1349-1351 (2004).

• Mountz JD, Gause WC, Jonsson R. Murine models for systemic lupus erythematosus and Sjogren's syndrome. Curr. Opin. Rheumatol. 3: 738-756 (1991).

• Moutsopoulos HM. Sjogren's syndrome or autoimmune epithelitis? Clin. Rev. Allergy Immunol. 32: 199-200 (2007). *

• Moutsopoulos HM. Sjogren's syndrome: autoimmune epithelitis. Clin. Immunol. Immunopathol. 72: 162-165 (1994).

• Moutsopoulos HM, Papadopoulos GK. Possible viral implication in the pathogenesis of Sjogren's syndrome. Eur. J. Med. 1: 219-223 (1992).

• Moutsopoulos NM, Katsifis GE, Angelov N, Leakan RA, Sankar V, Pillemer S, Wahl SM. Lack of efficacy of etanercept in Sjogren's syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation. Ann. Rheum. Dis. 67: 1437-1443 (2008).

• Moyes DL, Martin A, Sawcer S, Temperton N, Worthington J, Griffiths DJ, Venables PJ. The distribution of the endogenous retroviruses HERV-K113 and HERV-K115 in health and disease. Genomics 86: 337-341 (2005). *

• Muller FB, Groth W, Mahrle G. Multiple autoimmune syndrome/Reynolds' syndrome (acral scleroderma, primary biliary cirrhosis, Sjogren syndrome) associated with the lupus erythematosus/lichen planus overlap syndrome. Hautarzt. 55: 465-470 (2004).

• Mullighan CG, Heatley S, Bardy PG, Lester S, Rischmueller M, Gordon TP. Lack of association between mannose-binding lectin gene polymorphisms and primary Sjogren's syndrome. Arthritis Rheum. 43: 2851-2852 (2000). *

• Mullighan CG, Heatley S, Lester S, Rischmueller M, Gordon TP, Bardy PG. Fas gene promoter polymorphisms in primary Sjogren's syndrome. Ann. Rheum. Dis. 63: 98-101 (2004). *

• Muraki Y, Tsutsumi A, Takahashi R, Suzuki E, Hayashi T, Chino Y, Goto D, Matsumoto I, Murata H, Noguchi E, Sumida T. Polymorphisms of IL-1beta gene in Japanese patients with Sjogren's syndrome and systemic lupus erythematosus. J. Rheumatol. 31: 720-725 (2004).

• Murata Y, Maeda K, Kawai H, Terashima T, Okabe H, Kashiwagi A, Yasuda H. Antiganglion neuron antibodies correlate with neuropathy in Sjogren's syndrome. Neuroreport 16: 677-681 (2005).

• Murphy JR, Sjogren MH, Kikendall JW, Peura DA, Goodman Z. Small bile duct abnormalities in sarcoidosis. J. Clin. Gastroenterol. 12: 555-561 (1990).

• Mutimer DJ, Fussey SP, Yeaman SJ, Kelly PJ, James OF, Bassendine MF. Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis. Hepatology 10: 403-407 (1989).

• Mzali S, Johanet C, Chretien P, Abuaf N. Antinuclear antibodies in primary biliary cirrhosis. Gastroenterol. Clin. Biol. 13: 690-695 (1989).

• Nacionales DC, Kelly KM, Lee PY, Zhuang H, Li Y, Weinstein JS, Sobel E, Kuroda Y, Akaogi J, Satoh M, Reeves WH. Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane). Am. J. Pathol. 168: 1227-1240 (2006). *

• Nadashkevich ON. Autoimmune theory of pathogenesis of systemic scleroderma. Lik. Sprava. 2001: 15-17 (2001).

• Nagata Y, Inoue H, Yamada K, Higashiyama H, Mishima K, Kizu Y, Takeda I, Mizuno F, Hayashi Y, Saito I. Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients. Immunology 111: 223-229 (2004). *

• Nagler RM, Nagler A. The molecular basis of salivary gland involvement in graft-vs.-host disease. J. Dent. Res. 83: 98-103 (2004). *

• Nagler RM, Nagler A. Salivary gland involvement in graft-versus-host disease: the underlying mechanism and implicated treatment. Isr. Med. Assoc. J. 6: 167-172 (2004). *

• Nahon Uzan K, Levy P, O'toole D, Belmatoug N, Pierre Vullierme M, Couvelard A, Ponsot P, Palazzo L, Abbas A, Hammel P, Ruszniewski P. Is idiopathic chronic pancreatitis an autoimmune disease? Clin. Gastroenterol. Hepatol. 3: 903-909 (2005).

• Naito Y, Matsumoto I, Wakamatsu E, Goto D, Sugiyama T, Matsumura R, Ito S, Tsutsumi A, Sumida T. Muscarinic acetylcholine receptor autoantibodies in patients with Sjogren's syndrome. Ann. Rheum. Dis. 64: 510-511 (2005). *

• Najjar S, Bernbaum M, Lai G, Devinsky O. Immunology and epilepsy. Rev. Neurol. Dis. 5: 109-116 (2008).

• Nakagawa N, Osanai S, Ide H, Nishigaki Y, Takahashi S, Nakano H, Ohsaki Y, Kikuchi K, Tokusashi Y, Obata H. Severe pulmonary hypertension associated with primary Sjogren's syndrome. Intern. Med. 42: 1248-1252 (2003). *

• Nakamura H, Eguchi K, Nakamura T, Mizokami A, Shirabe S, Kawakami A, Matsuoka N, Migita K, Kawabe Y, Nagataki S. High prevalence of Sjogren's syndrome in patients with HTLV-I associated myelopathy. Ann. Rheum. Dis. 56: 167-172 (1997). *

• Nakamura H, Kawakami A, Eguchi K. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjogren's syndrome. Transl. Res. 148: 281-288 (2006). *

• Nakamura H, Kawakami A, Ida H, Koji T, Eguchi K. EGF activates PI3K-Akt and NF-kappaB via distinct pathways in salivary epithelial cells in Sjogren's syndrome. Rheumatol. Int. 28: 127-136 (2007). *

• Nakamura S, Miyazaki Y, Mihar T, Seki M, Izumikawa K, Yanagihara K, Ohno H, Higashiyama Y, Hirakata Y, Soejima Y, Tashiro T, Kohno S. A case of multiple nodular pulmonary amyloidosis complicated with primary Sjogren syndrome. Nihon Kokyuki Gakkai Zasshi 45: 356-360 (2007).

• Nakamura T, Higashi SI, Tomoda K, Tsukano M, Sugi K. Primary biliary cirrhosis (PBC)-CREST overlap syndrome with coexistence of Sjogren's syndrome and thyroid dysfunction. Clin. Rheumatol. 26: 596-600 (2007). *

• Nakamura T, Matsui M, Uchida K, Futatsugi A, Kusakawa S, Matsumoto N, Nakamura K, Manabe T, Taketo MM, Mikoshiba K. M3 muscarinic acetylcholine receptor plays critical role in parasympathetic control of salivation in mice. J. Physiol. 558: 561-575 (2004). *

• Nakayama S, Mukae H, Sugiyama K, Kakugawa T, Yoshioka S, Sakamoto N, Hayashi T, Kohno S. A case of multiple pulmonary infarctions associated with Sjogren's syndrome and antipsychotic agent administration. Nihon Kokyuki Gakkai Zasshi 42: 975-980 (2004).

• Nakken B, Jonsson R, Bolstad AI. Polymorphisms of the Ro52 gene associated with anti-Ro 52-kd autoantibodies in patients with primary Sjogren's syndrome. Arthritis Rheum. 44: 638-646 (2001). *

• Nakken B, Jonsson R, Brokstad KA, Omholt K, Nerland AH, Haga HJ, Halse AK. Associations of MHC class II alleles in Norwegian primary Sjogren's syndrome patients: implications for development of autoantibodies to the Ro52 autoantigen. Scand. J. Immunol. 54: 428-433 (2001). *

• Nardi N, Brito-Zeron P, Ramos-Casals M, Aguilo S, Cervera R, Ingelmo M, Font J. Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjogren's syndrome. Prevalence and clinical significance in 335 patients. Clin. Rheumatol. 25: 341-346 (2006). *

• Nasu M, Matsubara O, Kamiyama R, Yamada T, Nishido T, Yamato H. Gastric plasmacytoma and multisystem autoimmune disease. Virchows Arch. A. Pathol. Anat. Histopathol. 404: 109-115 (1984).

• Natsuga K, Sawamura D, Homma E, Nomura T, Abe M, Muramatsu R, Mochizuki T, Koike T, Shimizu H. Amicrobial pustulosis associated with IgA nephropathy and Sjogren's syndrome. J. Am. Acad. Dermatol. 57: 523-526 (2007).

• Navone R, Lunardi C, Gerli R, Tinazzi E, Peterlana D, Bason C, Corrocher R, Puccetti A. Identification of tear lipocalin as a novel autoantigen target in Sjogren's syndrome. J. Autoimmun. 25: 229-234 (2005).

• Negoro A, Umemoto M, Fujii M, Kakibuchi M, Terada T, Hashimoto N, Sakagami M. Taste function in Sjogren's syndrome patients with special reference to clinical tests. Auris. Nasus. Larynx. 31: 141-147 (2004).

• Nelson JL. Microchimerism and human autoimmune diseases. Lupus 11: 651-654 (2002). *

• Nelson JL. HLA relationships of pregnancy, microchimerism and autoimmune disease. J. Reprod. Immunol. 52: 77-84 (2001).

• Nelson JL. Microchimerism: incidental byproduct of pregnancy or active participant in human health? Trends Mol. Med. 8: 109-113 (2002). *

• Ng KP, Isenberg DA. Sjogren's syndrome: diagnosis and therapeutic challenges in the elderly. Drugs Aging 25: 19-33 (2008).

• Nguyen C, Cornelius J, Singson E, Killedar S, Cha S, Peck AB. Role of complement and B lymphocytes in Sjogren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2(b) mice. Mol. Immunol. 43: 1332-1329 (2006). *

• Nguyen C, Singson E, Kim JY, Cornelius JG, Attia R, Doyle ME, Bulosan M, Cha S, Peck AB. Sjogren's syndrome-like disease of C57BL/6.NOD-Aec1 Aec2 mice: gender differences in keratoconjunctivitis sicca defined by a cross-over in the chromosome 3 Aec1 locus. Scand. J. Immunol. 64: 295-307 (2006). *

• Nguyen CQ, Cha SR, Peck AB. Sjogren's syndrome (SjS)-like disease of mice: the importance of B lymphocytes and autoantibodies. Front. Biosci. 12: 1767-1789 (2007).

• Nguyen CQ, Cornelius JG, Cooper L, Neff J, Tao J, Lee BH, Peck AB. Identification of possible candidate genes regulating Sjogren's syndrome-associated autoimmunity: a potential role for TNFSF4 in autoimmune exocrinopathy. Arthritis Res. Ther. 10: R137 (2008). *

• Nguyen CQ, Gao JH, Kim H, Saban DR, Cornelius JG, Peck AB. IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjogren's syndrome-like disease of the nonobese diabetic mouse. J. Immunol. 179: 382-390 (2007). *

• Nguyen CQ, Hu MH, Li Y, Stewart C, Peck AB. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren's syndrome: findings in humans and mice. Arthritis Rheum. 58: 734-743 (2008). *

• Nguyen CQ, Kim H, Cornelius JG, Peck AB. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3. J. Immunol. 179: 2318-2329 (2007). *

• Nguyen CQ, Peck AB. Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocul. Surf. 7: 11-27 (2009).

• Nguyen CQ, Sharma A, She JX, McIndoe RA, Peck AB. Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjogren's syndrome (SJS)-like disease of the C57BL/6.NOD-Aec1Aec2 mouse. Exp. Eye Res. 88: 398-409 (2009).

• Nicaise Roland P, Grootenboer Mignot S, Bruns A, Hurtado M, Palazzo E, Hayem G, Dieude P, Meyer O, Chollet Martin S. Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy. Arthritis Res. Ther. 10: R142 (2008). *

• Nicodeme F, Geffroy S, Conti M, Delobel B, Soenen V, Grardel N, Porte H, Copin MC, Lai JL, Andrieux J. Familial occurrence of thymoma and autoimmune diseases with the constitutional translocation t(14;20)(q24.1;p12.3). Genes Chromosomes Cancer 44: 154-160 (2005). *

• Niemela RK, Takalo R, Paakko E, Suramo I, Paivansalo M, Salo T, Hakala M. Ultrasonography of salivary glands in primary Sjogren's syndrome. A comparison with magnetic resonance imaging and magnetic resonance sialography of parotid glands. Rheumatology (Oxford) 43: 875-879 (2004). *

• Nieminen U, Koivisto T, Kahri A, Farkkila M. Sjogren's syndrome with chronic pancreatitis, sclerosing cholangitis, and pulmonary infiltrations. Am. J. Gastroenterol. 92: 139-142 (1997).

• Nikolov NP, Smith JA, Patronas NJ, Illei GG. Diagnosis and treatment of vasculitis of the central nervous system in a patient with systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 2: 627-633 (2006). *

• Nilsson E, Poulsen P, Sjogren M, Ling C, Ridderstrale M, Groop L, Vaag A. Regulation of skeletal muscle PPAR delta mRNA expression in twins. J. Physiol. 584: 1011-1017 (2007). *

• Nishimori I, Miyaji E, Morimoto K, Kohsaki T, Okamoto N, Onishi S. Diminished cellular immune response to carbonic anhydrase II in patients with Sjogren's syndrome and idiopathic chronic pancreatitis. JOP 5: 186-192 (2004). *

• Nishimori I, Miyaji E, Morimoto K, Nagao K, Kamada M, Onishi S. Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis. Gut 54: 274-281 (2005). *

• Nishimori I, Morita M, Kino J, Onodera M, Nakazawa Y, Okazaki K, Yamamoto Y, Yamamoto Y. Pancreatic involvement in patients with Sjogren's syndrome and primary biliary cirrhosis. Int. J. Pancreatol. 17: 47-54 (1995).

• Nishimori I, Okazaki K, Yamamoto Y, Morita M, Tamura S, Yamamoto Y. Specific cellular immune responses to pancreatic antigen in chronic pancreatitis and Sjogren's syndrome. J. Clin. Immunol. 13: 265-271 (1993).

• Nishinarita M, Hanzawa M, Iikuni N, Ota S. The effectiveness of cevimeline hydrochloride on dry cough in Sjogren's syndrome. Nihon Rinsho Meneki Gakkai Kaishi 27: 99-102 (2004).

• Nishio A, Keeffe EB, Ishibashi H, Gershwin EM. Diagnosis and treatment of primary biliary cirrhosis. Med. Sci. Monit. 6: 181-193 (2000). *

• Nishio A, Neuberger J, Gershwin ME. Management of patients with primary biliary cirrhosis: a practical guide. BioDrugs 12: 159-173 (1999).

• Nishiyama S, Miyawaki S. Splenic marginal zone B-cell lymphoma associated with primary Sjogren's syndrome. Clin. Rheumatol. 23: 242-245 (2004).

• Nishiyama T, Mishima K, Obara K, Inoue H, Doi T, Kondo S, Saka M, Tabunoki Y, Hattori Y, Kodama T, Tsubota K, Saito I. Amelioration of lacrimal gland inflammation by oral administration of K-13182 in Sjogren's syndrome model mice. Clin. Exp. Immunol. 149: 586-595 (2007). *

• Nissinen R, Paimela L, Julkunen H, Tienari PJ, Leirisalo-Repo M, Palosuo T, Vaarala O. Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sjogren syndrome. Scand. J. Rheumatol. 32: 337-342 (2003). *

• No authors listed. Sjogren's syndrome. When your tissues dry out. Mayo Clin. Health Lett. 24: 7 (2006).

• No authors listed. In this issue. Eur. J. Immunol. 38: 1773-1774 (2008). *

• Noble BA, Loh RS, MacLennan S, Pesudovs K, Reynolds A, Bridges LR, Burr J, Stewart O, Quereshi S. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br. J. Ophthalmol. 88: 647-652 (2004).

• Nordmark G, Alm GV, Ronnblom L. Mechanisms of disease: primary Sjogren's syndrome and the type I interferon system. Nat. Clin. Pract. Rheumatol. 2: 262-269 (2006). *

• Nordmark G, Kristjansdottir G, Theander E, Eriksson P, Brun JG, Wang C, Padyukov L, Truedsson L, Alm G, Eloranta ML, Jonsson R, Ronnblom L, Syvanen AC. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjogren's syndrome. Genes Immun. 10: 68-76 (2009). *

• Nossent JC, Lester S, Zahra D, Mackay CR, Rischmueller M. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome. Rheumatology (Oxford) 47: 1311-1316 (2008). *

• Novljan MP, Rozman B, Jerse M, Rotar Z, Vidmar G, Kveder T, Tomsic M. Comparison of the different classification criteria sets for primary Sjogren's syndrome. Scand. J. Rheumatol. 35: 463-467 (2006).

• Nozawa K, Fritzler MJ, Von Muhlen CA, Chan EK. Giantin is the major Golgi autoantigen in human anti-Golgi complex sera. Arthritis Res. Ther. 6: R95-R102 (2004). *

• Oak JS, Deane JA, Kharas MG, Luo J, Lane TE, Cantley LC, Fruman DA. Sjogren’s syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc. Natl. Acad. Sci. U.S.A. 103: 16882-16887 (2006). *

• Obermayer-Straub P, Manns MP. Hepatitis C and D, retroviruses and autoimmune manifestations. J. Autoimmun. 16: 275-285 (2001). *

• Ochoa ER, Harris NL, Pilch BZ. Marginal zone B-cell lymphoma of the salivary gland arising in chronic sclerosing sialadenitis (Kuttner tumor). Am. J. Surg. Pathol. 25: 1546-1550 (2001).

• Offerhaus GJ, Schipper ME, Lazenby AJ, Montgomery E, Morsink FH, Bende RJ, Musler AR, van Lier RA, van Noesel CJ. Graft-versus-host-like disease complicating thymoma: lack of AIRE expression as a cause of non-hereditary autoimmunity? Immunol. Lett. 114: 31-37 (2007).

• Ogata S, Bando Y, Saito N, Katsuoka K, Ishii M. Kikuchi-Fujimoto disease developed into autoimmune disease: a report of two cases. Mod. Rheumatol. Jan 15 [Epub ahead of print] (2010). *

• Ogawa N, Kawanami T, Shimoyama K, Ping L, Sugai S. Expression of interferon-inducible T cell alpha chemoattractant (CXCL11) in the salivary glands of patients with Sjogren's syndrome. Clin. Immunol. 112: 235-238 (2004). *

• Ogawa N, Shimoyama K, Kawanami T. Molecular mechanisms of salivary gland destruction in patients with Sjogren's syndrome. Nihon Rinsho Meneki Gakkai Kaishi 28: 10-20 (2005).

• Ohara H, Nakazawa T, Ando T, Joh T. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. J. Gastroenterol. 42 Suppl. 18: 15-21 (2007). *

• Ohara H, Nakazawa T, Sano H, Ando T, Okamoto T, Takada H, Hayashi K, Kitajima Y, Nakao H, Joh T. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas 31: 232-237 (2005).

• Ohira H, Takiguchi J, Rai T, Shishido S, Sato Y. Two cases of primary biliary cirrhosis complicated with syringomyelia. Am. J. Gastroenterol. 98: 224-226 (2003). *

• Ohlemiller KK, Rice ME, Gagnon PM. Strial microvascular pathology and age-associated endocochlear potential decline in NOD congenic mice. Hear. Res. 244: 85-97 (2008). *

• Ohno A, Mitsui T, Endo I, Kunishige M, Sigekiyo T, Matsumoto T. Dermatomyositis associated with Sjogren's syndrome: VEGF involvement in vasculitis. Clin. Neuropathol. 23: 178-182 (2004).

• Ohno K, Hattori T, Kagami H, Ueda M. Effects of preceding sialadenitis on the development of autoimmunity against salivary gland. Oral Dis. 13: 158-162 (2007). *

• Ohyama Y, Carroll VA, Deshmukh U, Gaskin F, Brown MG, Fu SM. Severe focal sialadenitis and dacryoadenitis in NZM2328 mice induced by MCMV: a novel model for human Sjogren's syndrome. J. Immunol. 177: 7391-7397 (2006). *

• Okano Y, Nishikai M, Sato A. Scleroderma, primary biliary cirrhosis, and Sjogren's syndrome after cosmetic breast augmentation with silicone injection: a case report of possible human adjuvant disease. Ann. Rheum. Dis. 43: 520-522 (1984). *

• Okuno T, Seto Y, Okanoue T, Takino T. Chronic active hepatitis with histological features of primary biliary cirrhosis. Dig. Dis. Sci. 32: 775-779 (1987).

• Oliveri C, Hughes GR, D'Cruz DP. MALToma and lupus. Lupus 14: 551-553 (2005).

• Ono M, Takamura E, Shinozaki K, Tsumura T, Hamano T, Yagi Y, Tsubota K. Therapeutic effect of cevimeline on dry eye in patients with Sjogren's syndrome: a randomized, double-blind clinical study. Am. J. Ophthalmol. 138: 6-17 (2004). *

• Onodera M, Okazaki K, Morita M, Nishimori I, Yamamoto Y. Immune complex specific for the pancreatic duct antigen in patients with idiopathic chronic pancreatitis and Sjogren syndrome. Autoimmunity 19: 23-29 (1994).

• Oosterveer MA, Markusse HM, Lennette ET, Zou JZ, Bolhuis RL, Gratama JW. Characterization of Epstein-Barr viral strains in parotid gland saliva and peripheral blood of patients with primary Sjogren's syndrome and healthy EBV carriers. J. Med. Virol. 41: 261-269 (1993).

• Orbach H, Shoenfeld Y. Hyperprolactinemia and autoimmune diseases. Autoimmun. Rev. 6: 537-542 (2007).

• Origuchi T, Kawasaki E, Ide A, Kamachi M, Tanaka F, Ida H, Kawakami A, Migita K, Eguchi K. Correlation between interleukin 10 gene promoter region polymorphisms and clinical manifestations in Japanese patients with Sjogren's syndrome. Ann. Rheum. Dis. 62: 1117-1118 (2003). *

• Ottosson L, Hennig J, Espinosa A, Brauner S, Wahren-Herlenius M, Sunnerhagen M. Structural, functional and immunologic characterization of folded subdomains in the Ro52 protein targeted in Sjogren's syndrome. Mol. Immunol. 43: 588-598 (2006). *

• Ou TT, Lin CH, Lin YC, Li RN, Tsai WC, Liu HW, Yen JH. IkBalpha promoter polymorphisms in patients with primary Sjogren's syndrome. J. Clin. Immunol. 28: 440-444 (2008). *

• Ou Y, Enarson P, Rattner JB, Barr SG, Fritzler MJ. The nuclear pore complex protein Tpr is a common autoantigen in sera that demonstrate nuclear envelope staining by indirect immunofluorescence. Clin. Exp. Immunol. 136: 379-387 (2004). *

• Outschoorn I, Rowley MJ, Cook AD, Mackay IR. Subclasses of immunoglobulins and autoantibodies in autoimmune diseases. Clin. Immunol. Immunopathol. 66: 59-66 (1993).

• Ozaki Y, Ito T, Son Y, Amuro H, Shimamoto K, Sugimoto H, Katashiba Y, Ogata M, Miyamoto R, Murakami N, Amakawa R, Fukuhara S. Decrease of blood dendritic cells and increase of tissue-infiltrating dendritic cells are involved in the induction of Sjogren's syndrome but not in the maintenance. Clin. Exp. Immunol. Dec 14 [Epub ahead of print] (2009). *

• Ozgocmen S, Gur A. Treatment of central nervous system involvement associated with primary Sjogren's syndrome. Curr. Pharm. Des. 14: 1270-1273 (2008).

• Paez MC, Gonzalez MJ, Serrano NC, Shoenfeld Y, Anaya JM. Physiological and pathological implications of laminins: from the gene to the protein. Autoimmunity 40: 83-94 (2007).

• Palacios E, Larusso G, Rojas R, Ramirez G. Lymphoma of the parotid gland in Sjogren's syndrome. Ear Nose Throat J. 83: 156 (2004).

• Palazzi C, D'Amico E, Cacciatore P, Pennese E, Olivieri I. Non-rheumatoid erosive arthritis associated with type I hereditary angioedema. Clin. Rheumatol. 24: 632-633 (2005). *

• Palomba S, Russo T, Sacchinelli A, Oppedisano R, Falbo A, Sena T, Zullo F, Mastrantonio P. Sjogren's syndrome extraglandular expressions. Minerva Ginecol. 60: 183-188 (2008).

• Pals ST, Radaszkiewicz T, Roozendaal L, Gleichmann E. Chronic progressive polyarthritis and other symptoms of collagen vascular disease induced by graft-vs-host reaction. J. Immunol. 134: 1475-1482 (1985).

• Panchovska M, Kolarov R, Firkova E. Health care in patients with primary Sjogren's syndrome. Bratisl. Lek. Listy. 108: 227-228 (2007).

• Panchovska M, Petranova T, Sheitanov Y, Stoilov R, Kolarov R, Bobeva D. Primary Sjogren's syndrome complicated with development of non-Hodgkin's lymphoma - a case report and literature review. J. BUON 7: 277-280 (2002).

• Papadimitraki ED, Kyrmizakis DE, Kritikos I, Boumpas DT. Ear-nose-throat manifestations of autoimmune rheumatic diseases. Clin. Exp. Rheumatol. 22: 485-494 (2004).

• Papadopoulos V, Micheli A, Nikiforidis D, Mimidis K. Primary biliary cirrhosis complicated by transverse myelitis in a patient without Sjogren's syndrome. J. Postgrad. Med. 51: 43-44 (2005). *

• Papiris SA, Tsonis IA, Moutsopoulos HM. Sjogren's syndrome. Semin. Respir. Crit. Care Med. 28: 459-471 (2007).

• Pares A, Grande L, Bruix J, Pera C, Rodes J. Esophageal dysfunction in primary biliary cirrhosis. J. Hepatol. 7: 362-367 (1988).

• Pares A, Martorell J, Caballeria J, Vives J, Bruguera M, Rodes J. Lymphocytotoxic antibodies in primary biliary cirrhosis. Dig. Dis. Sci. 30: 829-833 (1985).

• Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME. Risk factors for primary biliary cirrhosis in a cohort of patients from the United States. Hepatology 33: 16-21 (2001). *

• Parke AL. Pulmonary manifestations of primary Sjogren's syndrome. Rheum. Dis. Clin. North Am. 34: 907-920 (2008).

• Parke AL, Buchanan WW. Sjogren's syndrome: history, clinical and pathological features. Inflammopharmacology 6: 271-287 (1998).

• Parker JC, Burlingame RW, Bunn CC. Prevalence of antibodies to Ro-52 in a serologically defined population of patients with systemic sclerosis. J. Autoimmune Dis. 6: 2 (2009). *

• Patel D, Egner W, Gleeson D, Wild G, Ward A. Detection of serum M2 anti-mitochondrial antibodies by enzyme-linked immunosorbent assay is potentially less specific than by immunofluorescence. Ann. Clin. Biochem. 39: 304-307 (2002).

• Patinen P, Aine L, Collin P, Hietanen J, Korpela M, Enckell G, Kautiainen H, Konttinen Y, Reunala T. Oral findings in coeliac disease and Sjogren's syndrome. Oral Dis. 10: 330-334 (2004). *

• Pena-Sagredo JL, Miro J, Aguayo F, Alvarez C, Berciano J. Primary Sjogren syndrome with involvement of the nervous system. Description of 4 cases. Neurologia 8: 231-234 (1993).

• Perez P, Anaya JM, Aguilera S, Urzua U, Munroe D, Molina C, Hermoso MA, Cherry JM, Alliende C, Olea N, Ruiz-Narvaez E, Gonzalez MJ. Gene expression and chromosomal location for susceptibility to Sjogren's syndrome. J. Autoimmun. 33: 99-108 (2009).

• Perez P, Goicovich E, Alliende C, Aguilera S, Leyton C, Molina C, Pinto R, Romo R, Martinez B, Gonzalez MJ. Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum. 43: 2807-2817 (2000). *

• Perez P, Kwon YJ, Alliende C, Leyton L, Aguilera S, Molina C, Labra C, Julio M, Leyton C, Gonzalez MJ. Increased acinar damage of salivary glands of patients with Sjogren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase/tissue inhibitor of metalloproteinases ratios. Arthritis Rheum. 52: 2751-2760 (2005). *

• Perniola R, Falorni A, Clemente MG, Forini F, Accogli E, Lobreglio G. Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Eur. J. Endocrinol. 143: 497-503 (2000). *

• Perrier S, Coussediere C, Dubost JJ, Albuisson E, Sauvezie B. IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjogren's syndrome and rheumatoid arthritis. Clin. Immunol. Immunopathol. 87: 309-313 (1998). *

• Perron H, Seigneurin JM. Human retroviral sequences associated with extracellular particles in autoimmune diseases: epiphenomenon or possible role in aetiopathogenesis? Microbes Infect. 1: 309-322 (1999). *

• Perrot S, Calvez V, Escande JP, Dupin N, Marcelin AG. Prevalences of herpesviruses DNA sequences in salivary gland biopsies from primary and secondary Sjogren's syndrome using degenerated consensus PCR primers. J. Clin. Virol. 28: 165-168 (2003).

• Pers JO, Daridon C, Devauchelle V, Jousse S, Saraux A, Jamin C, Youinou P. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann. N. Y. Acad. Sci. 1050: 34-39 (2005). *

• Pertovaara M, Antonen J, Hurme M. Endothelial nitric oxide synthase +894 polymorphism is associated with recurrent salivary gland swelling and early onset in patients with primary Sjogren's syndrome. Ann. Rheum. Dis. 66: 1400-1401 (2007). *

• Pertovaara M, Antonen J, Hurme M. Th2 cytokine genotypes are associated with a milder form of primary Sjogren's syndrome. Ann. Rheum. Dis. 65: 666-670 (2006). *

• Pertovaara M, Hulkkonen J, Antonen J, Holopainen P, Laippala P, Pasternack A, Hurme M. Polymorphism of the tumour necrosis factor-alpha gene at position -308 and renal manifestations of primary Sjogren's syndrome. Rheumatology (Oxford) 43: 106-107 (2004). *

• Pertovaara M, Hulkkonen J, Hurme M, Lehtimaki T, Pasternack A. Urinary matrix metalloproteinase-9 and interleukin-6 and renal manifestations of primary Sjogren's syndrome. Rheumatology (Oxford) 43: 807-808 (2004). *

• Pertovaara M, Hurme M, Antonen J, Pasternack A, Pandey JP. Immunoglobulin KM and GM gene polymorphisms modify the clinical presentation of primary Sjogren's syndrome. J. Rheumatol. 31: 2175-2180 (2004).

• Pertovaara M, Jylhava J, Uusitalo H, Pukander J, Helin H, Hurme M. Serum amyloid A and C-reactive protein concentrations are differently associated with markers of autoimmunity in patients with primary Sjogren's syndrome. J. Rheumatol. 36: 2487-2490 (2009).

• Pertovaara M, Korpela M, Saarelainen S, Laitinen J, Jarvenpaa R, Laippala P, Lahdensuo A. Long-term follow-up study of pulmonary findings in patients with primary Sjogren's syndrome. Scand. J. Rheumatol. 33: 343-348 (2004).

• Pertovaara M, Lehtimaki T, Rontu R, Antonen J, Pasternack A, Hurme M. Presence of apolipoprotein E {epsilon}4 allele predisposes to early onset of primary Sjogren's syndrome. Rheumatology (Oxford) 43: 1484-1487 (2004). *

• Petrek M, Cermakova Z, Hutyrova B, Micekova D, Drabek J, Rovensky J, Bosak V. CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjogren's syndrome. Clin. Exp. Rheumatol. 20: 701-703 (2002).

• Pickartz T, Pickartz H, Lochs H, Ockenga J. Overlap syndrome of autoimmune pancreatitis and cholangitis associated with secondary Sjogren's syndrome. Eur. J. Gastroenterol. Hepatol. 16: 1295-1299 (2004).

• Pigg M, Annton-Lamprecht I, Braun-Quentin C, Gustavson KH, Wadelius C. Further evidence of genetic homogeneity in Sjogren-Larsson syndrome. Acta Derm. Venereol. 79: 41-43 (1999).

• Pijpe J, van Imhoff GW, Spijkervet FK, Roodenburg JL, Wolbink GJ, Mansour K, Vissink A, Kallenberg CG, Bootsma H. Rituximab treatment in patients with primary Sjogren's syndrome: an open-label phase II study. Arthritis Rheum. 52: 2740-2750 (2005). *

• Pillemer SR, Brennan MT, Sankar V, Leakan RA, Smith JA, Grisius M, Ligier S, Radfar L, Kok MR, Kingman A, Fox PC. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjogren's syndrome. Arthritis Rheum. 51: 601-604 (2004). *

• Pillemer SR, Casciola-Rosen L, Baum BJ, Rosen A, Gelber AC. Centromere protein C is a target of autoantibodies in Sjogren's syndrome and is uniformly associated with antibodies to Ro and La. J. Rheumatol. 31: 1121-1125 (2004).

• Pillemer SR, Leakan RA, Sankar V, Manny J, Baum BJ, Smith J, Chaudhry U, Fox PC, Radfar L, Ligier S, Brennan MT. Prominent adverse effects of thalidomide in primary Sjogren's syndrome. Arthritis Rheum. 51: 505-506 (2004). *

• Pirildar T, Gumuser G, Ruksen E, Sakar A, Dinc G, Sayit E. Assessment of alveolar epithelial permeability with Tc-99m DTPA aerosol scintigraphy in patients with Sjogren syndrome. Rheumatol. Int. Jul 7 [Epub ahead of print] (2009). *

• Pivetta B, De Vita S, Ferraccioli G, De Re V, Gloghini A, Marzotto A, Caruso G, Dolcetti R, Bartoli E, Carbone A, Boiocchi M. T cell receptor repertoire in B cell lymphoproliferative lesions in primary Sjogren's syndrome. J. Rheumatol. 26: 1101-1109 (1999).

• Plesivcnik Novljan M, Rozman B, Hocevar A, Grmek M, Kveder T, Tomsic M. Incidence of primary Sjogren's syndrome in Slovenia. Ann. Rheum. Dis. 63: 874-876 (2004). *

• Poduval P, Sillat T, Virtanen I, Porola P, Konttinen YT. Abnormal basement membrane type IV collagen alpha-chain composition in labial salivary glands in Sjogren's syndrome. Arthritis Rheum. 60: 938-945 (2009). *

• Popovic K, Brauner S, Ek M, Wahren-Herlenius M, Nyberg F. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun. Lupus 16: 10-17 (2007). *

• Porola P, Laine M, Virkki L, Poduval P, Konttinen YT. The influence of sex steroids on Sjogren's syndrome. Ann. N. Y. Acad. Sci. 1108: 426-432 (2007). *

• Porola P, Virkki L, Przybyla BD, Laine M, Patterson TA, Pihakari A, Konttinen YT. Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in salivary glands in Sjogren's syndrome. J. Rheumatol. 35: 2229-2235 (2008).

• Portincasa P, Vacca M, Moschetta A, Petruzzelli M, Palasciano G, van-Erpecum KJ, van-Berge-Henegouwen GP. Primary sclerosing cholangitis: updates in diagnosis and therapy. World J. Gastroenterol. 11: 7-16 (2005). *

• Potthoff A, Witte T, Rifai K, Hoy L, Deterding K, Feyerabend S, Manns MP, Wedemeyer H. Prevalence of alpha-fodrin antibodies in patients with chronic hepatitis C infection and Sjogren syndrome. Scand. J. Gastroenterol. 44: 994-1003 (2009). *

• Poupon R. Primary biliary cirrhosis. Schweiz. Med. Wochenschr. 121: 727-732 (1991).

• Pournaras JA, Vaudaux JD, Borruat FX. Bilateral sequential optic neuropathy as the initial manifestation of Sjogren syndrome. Klin. Monatsbl. Augenheilkd. 224: 337-339 (2007).

• Prasad D, Khara HS, Gupta M, Sterman P. Celiac disease associated membranous nephropathy - a rare cause or coincidence? A case report. Cases J. 2: 7018 (2009). *

• Prelipcean CC, Mihai C, Gogalniceanu P, Mitrica D, Drug VL, Stanciu C. Extragastric manifestations of Helicobacter pylori infection. Rev. Med. Chir. Soc. Med. Nat. Iasi. 111: 575-583 (2007).

• Priori R, Medda E, Conti F, Cassara EA, Sabbadini MG, Antonioli CM, Gerli R, Danieli MG, Giacomelli R, Pietrogrande M, Valesini G, Stazi MA. Risk factors for Sjogren's syndrome: a case-control study. Clin. Exp. Rheumatol. 25: 378-384 (2007).

• Prochorec-Sobieszek M, Mielnik P, Wagner T, Chwalinska-Sadowska H. Mucosa-associated lymphoid tissue lymphoma (MALT) of salivary glands and scleroderma: a case report. Clin. Rheumatol. 23: 348-350 (2004).

• Prochorec-Sobieszek M, Wagner T. Lymphoproliferative disorders in Sjogren's syndrome. Otolaryngol. Pol. 59: 559-564 (2005).

• Prochorec-Sobieszek M, Wagner T, Loukas M, Chwalinska-Sadowska H, Olesinska M. Histopathological and immunohistochemical analysis of lymphoid follicles in labial salivary glands in primary and secondary Sjogren's syndrome. Med. Sci. Monit. 10: BR115-BR121 (2004). *

• Prunoiu C, Georgescu EF, Georgescu M, Simionescu C. Sjogren's syndrome associated with chronic hepatitis C - the benefit of the antiviral treatment. Rom. J. Morphol. Embryol. 49: 557-562 (2008).

• Punzi L, Betterle C. Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine 71: 275-283 (2004).

• Qian Y, Giltiay N, Xiao J, Wang Y, Tian J, Han S, Scott M, Carter R, Jorgensen TN, Li X. Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjogren's syndrome. Eur. J. Immunol. 38: 2219-2228 (2008). *

• Quartuccio L, De Re V, Fabris M, Marzotto A, Franzolini N, Gasparotto D, Caggiari L, Ferraccioli G, Scott CA, De Vita S. Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. Haematologica 91: 691-694 (2006). *

• Quartuccio L, Fabris M, Ferraccioli G. B Lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis. Reumatismo 56: 143-146 (2004).

• Quartuccio L, Fabris M, Salvin S, Maset M, De Marchi G, De Vita S. Controversies on rituximab therapy in Sjogren syndrome-associated lymphoproliferation. Int. J. Rheumatol. 2009: 424935 (2009). *

• Rabusin M, Andolina M, Maximova N, Lepore L, Parco S, Tuveri G, Jankovic G. Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease. Haematologica 85: S81-S85 (2000).

• Rachapalli SM, Kiely PD, Bourke BE. Prevalence of abnormal ankle brachial index in patients with primary Sjogren's syndrome. Clin. Rheumatol. 28: 587-590 (2009). *

• Ram M, Anaya JM, Barzilai O, Izhaky D, Porat Katz BS, Blank M, Juan-Carlos R, Shoenfeld Y. The putative protective role of hepatitis B virus (HBV) infection against autoimmune disorders. Autoimmun. Rev. 7: 621-625 (2008).

• Ram M, Sherer Y, Shoenfeld Y. Matrix metalloproteinase-9 and autoimmune diseases. J. Clin. Immunol. 26: 299-307 (2006). *

• Ramesh A, Savva CG, Holzenburg A, Sacchettini JC. Crystal structure of Rsr, an ortholog of the antigenic Ro protein, links conformational flexibility to RNA binding activity. J. Biol. Chem. 282: 14960-14967 (2007). *

• Ramirez M, Ramos-Casals M, Graus F. Central nervous system involvement in primary Sjogren syndrome. Med. Clin. (Barc.) 133: 349-359 (2009).

• Ramos HL, Valencia-Pacheco G, Alcocer-Varela J. Constitutive STAT3 activation in peripheral CD3(+) cells from patients with primary Sjogren's syndrome. Scand. J. Rheumatol. 37: 35-39 (2008). *

• Ramos-Casals M, Brito-Zeron P. Emerging biological therapies in primary Sjogren's syndrome. Rheumatology (Oxford) 46: 1389-1396 (2007). *

• Ramos-Casals M, Brito-Zeron P, Font J. The overlap of Sjogren's syndrome with other systemic autoimmune diseases. Semin. Arthritis Rheum. 36: 246-255 (2007). *

• Ramos-Casals M, Brito-Zeron P, Font J. Lessons from diseases mimicking Sjogren's syndrome. Clin. Rev. Allergy Immunol. 32: 275-283 (2007). *

• Ramos-Casals M, Brito-Zeron P, Perez-De-Lis M, Jimenez I, Blanco MJ, Bove A, Soto MJ, Akasbi M, Diaz C, Sentís J, Siso A. Sjogren syndrome or Sjogren disease? The histological and immunological bias caused by the 2002 criteria. Clin. Rev. Allergy Immunol. Jul 4 [Epub ahead of print] (2009). *

• Ramos-Casals M, Brito-Zeron P, Siso A, Vargas A, Ros E, Bove A, Belenguer R, Plaza J, Benavent J, Font J. High prevalence of serum metabolic alterations in primary Sjogren's syndrome: influence on clinical and immunological expression. J. Rheumatol. 34: 754-761 (2007).

• Ramos-Casals M, Brito-Zeron P, Soria N, Nardi N, Vargas A, Munoz S, Bove A, Suarez B, Lozano F. Mannose-binding lectin-low genotypes are associated with milder systemic and immunological disease expression in primary Sjogren's syndrome. Rheumatology (Oxford) 48: 65-69 (2009). *

• Ramos-Casals M, Brito-Zeron P, Yague J, Akasbi M, Bautista R, Ruano M, Claver G, Gil V, Font J. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome. Rheumatology (Oxford) 44: 89-94 (2005). *

• Ramos-Casals M, De Vita S, Tzioufas AG. Hepatitis C virus, Sjogren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun. Rev. 4: 8-15 (2005). *

• Ramos-Casals M, Font J. Primary Sjogren's syndrome: current and emergent aetiopathogenic concepts. Rheumatology (Oxford) 44: 1354-1367 (2005). *

• Ramos-Casals M, Font J. Extrahepatic manifestations in patients with chronic hepatitis C virus infection. Curr. Opin. Rheumatol. 17: 447-455 (2005).

• Ramos-Casals M, Font J, Brito-Zeron P, Trejo O, Garcia-Carrasco M, Lozano F. Interleukin-4 receptor alpha polymorphisms in primary Sjogren's syndrome. Clin. Exp. Rheumatol. 22: 374 (2004).

• Ramos-Casals M, Jara LJ, Medina F, Rosas J, Calvo-Alen J, Mana J, Anaya JM, Font J; THE HISPAMEC STUDY GROUP. Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases. J. Intern. Med. 257: 549-557 (2005). *

• Ramos-Casals M, Khamashta MA. Advances in lupus and Sjogren's syndrome: a tribute to Josep Font. Ann. N. Y. Acad. Sci. 1108: 51-63 (2007).

• Ramos-Casals M, Munoz S, Zeron PB. Hepatitis C virus and Sjogren's syndrome: trigger or mimic? Rheum. Dis. Clin. North Am. 34: 869-884 (2008).

• Ramos-Casals M, Nardi N, Brito-Zeron P, Aguilo S, Gil V, Delgado G, Bove A, Font J. Atypical autoantibodies in patients with primary Sjogren syndrome: clinical characteristics and follow-up of 82 cases. Semin. Arthritis Rheum. 35: 312-321 (2006). *

• Ramos-Casals M, Pares A, Jara LJ, Solans R, Vinas O, Vazquez P, Sanchez-Tapias JM, Rodes J, Font J; the HISPAMEC Study Group. Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature. J. Viral Hepat. 12: 648-654 (2005).

• Ramos-Casals M, Sanchez-Tapias JM, Pares A, Forns X, Brito-Zeron P, Nardi N, Vazquez P, Velez D, Arias I, Bove A, Plaza J, Rodes J, Font J. Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjogren's syndrome. J. Rheumatol. 33: 1593-1599 (2006).

• Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, Calvo-Alen J, Jimenez-Alonso J, Mico ML, Beltran J, Belenguer R, Pallares L; the GEMESS Study Group. Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 87: 210-219 (2008).

• Ramos-Casals M, Trejo O, Garcia-Carrasco M, Cervera R, De La Red G, Gil V, Lopez-Guillermo A, Ingelmo M, Font J. Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma. J. Rheumatol. 31: 495-499 (2004).

• Ramos-Casals M, Tzioufas AG, Font J. Primary Sjogren's syndrome: new clinical and therapeutic concepts. Ann. Rheum. Dis. 64: 347-354 (2005). *

• Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J. Clin. Invest. 116: 3183-3194 (2006). *

• Rascarachi G, Honrado E, Quiroga Prado L. Sarcomatoid carcinoma in a patients with Sjogren's syndrome. Gastroenterol. Hepatol. 32: 150-154 (2009).

• Reed JH, Neufing PJ, Jackson MW, Clancy RM, Macardle PJ, Buyon JP, Gordon TP. Different temporal expression of immunodominant Ro60/60 kDa-SSA and La/SSB apotopes. Clin. Exp. Immunol. 148: 153-160 (2007). *

• Reeves GE. Update on the immunology, diagnosis and management of systemic lupus erythematosus. Intern. Med. J. 34: 338-347 (2004). *

• Rehman HU. Sjogren's syndrome. Yonsei. Med. J. 44: 947-954 (2003). *

• Reksten TR, Jonsson MV, Szyszko EA, Brun JG, Jonsson R, Brokstad KA. Cytokine and autoantibody profiling related to histopathological features in primary Sjogren's syndrome. Rheumatology (Oxford) 48: 1102-1106 (2009). *

• Reske D, Petereit HF. Cerebrospinal fluid and immunological parameters for differentiation of chronic inflammatory central nervous system disease. Nervenarzt 75: 945-952 (2004).

• Reske D, Petereit HF, Heiss WD. Difficulties in the differentiation of chronic inflammatory diseases of the central nervous system - value of cerebrospinal fluid analysis and immunological abnormalities in the diagnosis. Acta Neurol. Scand. 112: 207-213 (2005). *

• Reyes SL, Leon BF, Rozas VM, Gonzalez JP, Naves PR. BAFF: a regulatory cytokine of B lymphocytes involved in autoimmunity and lymphoid cancer. Rev. Med. Chil. 134: 1175-1184 (2006).

• Rhew EY, Ramsey-Goldman R, Buchman AL. Sjogren's syndrome in association with Crohn's disease. J. Clin. Gastroenterol. 37: 312-314 (2003).

• Rhodes DA, Trowsdale J. TRIM21 is a trimeric protein that binds IgG Fc via the B30.2 domain. Mol. Immunol. 44: 2406-2414 (2007). *

• Richards A, Rooney J, Prime S, Scully C. Primary biliary cirrhosis. Sole presentation with rampant dental caries. Oral Surg. Oral Med. Oral Pathol. 77: 16-18 (1994).

• Richards SM, Sullivan DA. Do genetic alterations in sex steroid receptors contribute to lacrimal gland disease in Sjogren's syndrome? Open Endocrinol. J. 3: 5-11 (2009). *

• Ring T, Kallenbach M, Praetorius J, Nielsen S, Melgaard B. Successful treatment of a patient with primary Sjogren's syndrome with Rituximab. Clin. Rheumatol. 25: 891-894 (2006). *

• Rizzi R, Pastore D, Liso A, Liuzzi GM, Dalena AM, Specchia G, Ricco R, Liso V. Autoimmune myelofibrosis: report of three cases and review of the literature. Leuk. Lymphoma 45: 561-566 (2004).

• Rizzo WB. Sjogren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency. Mol. Genet. Metab. 90: 1-9 (2007). *

• Rizzo WB, Carney G. Sjogren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2). Hum. Mutat. 26: 1-10 (2005).

• Rizzo WB, Craft DA, Somer T, Carney G, Trafrova J, Simon M. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjogren-Larsson syndrome. J. Lipid Res. 49: 410-419 (2008). *

• Robert HJ. Aspartame-induced Sjogren syndrome. South. Med. J. 99: 631-632 (2006).

• Robinson CP, Yamachika S, Bounous DI, Brayer J, Jonsson R, Holmdahl R, Peck AB, Humphreys-Beher MG. A novel NOD-derived murine model of primary Sjogren's syndrome. Arthritis Rheum. 41: 150-156 (1998). *

• Rodriguez-Roisin R, Pares A, Bruguera M, Coll J, Picado C, Agusti-Vidal A, Burgos F, Rodes J. Pulmonary involvement in primary biliary cirrhosis. Thorax 36: 208-212 (1981). *

• Roescher N, Tak P, Illei G. Cytokines in Sjogren's syndrome. Oral Dis. 15: 519-526 (2009).

• Roguedas AM, Misery L, Sassolas B, Le Masson G, Pennec YL, Youinou P. Cutaneous manifestations of primary Sjogren's syndrome are underestimated. Clin. Exp. Rheumatol. 22: 632-636 (2004).

• Roguedas AM, Youinou P, Lemasson G, Pennec YL, Misery L. Primary Gougerot-Sjogren syndrome: a dermatological approach. J. Eur. Acad. Dermatol. Venereol. 20: 243-247 (2006).

• Roitberg-Tambur A, Witt CS, Friedmann A, Safirman C, Sherman L, Battat S, Nelken D, Brautbar C. Comparative analysis of HLA polymorphism at the serologic and molecular level in Moroccan and Ashkenazi Jews. Tissue Antigens 46: 104-110 (1995).

• Rolla G, Brussino L, Scappaticci E, Morello M, Innarella R, Rosina F, Bucca C. Source of exhaled nitric oxide in primary biliary cirrhosis. Chest 126: 1546-1551 (2004). *

• Roller C. Sjogren's syndrome. J. Obstet. Gynecol. Neonatal Nurs. 33: 10 (2004).

• Rosen A, Casciola-Rosen L. Altered autoantigen structure in Sjogren's syndrome: implications for the pathogenesis of autoimmune tissue damage. Crit. Rev. Oral Biol. Med. 15: 156-164 (2004).

• Rosignoli F, Roca V, Meiss R, Leceta J, Gomariz RP, Perez Leiros C. Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis. Clin. Exp. Immunol. 142: 411-418 (2005). *

• Rossi R, Valeria Saddi M. Subacute aseptic meningitis as neurological manifestation of primary Sjogren's syndrome. Clin. Neurol. Neurosurg. 108: 688-691 (2006).

• Rousso E, Noel E, Brogard JM, Blickle JF, Andres E. Recurrent facial palsy, primary Sjogren's syndrome and vitamin B12 deficiency. Presse. Med. 34: 107-108 (2005).

• Routsias JG, Kosmopoulou A, Makri A, Panou-Pomonis E, Sakarellos C, Sakarellos-Daitsiotis M, Moutsopoulos HM, Tzioufas AG. Zinc ion dependent B-cell epitope, associated with primary Sjogren's syndrome, resides within the putative zinc finger domain of Ro60kD autoantigen: physical and immunologic properties. J. Med. Chem. 47: 4327-4334 (2004). *

• Routsias JG, Kyriakidis N, Latreille M, Tzioufas AG. RNA recognition motif (RRM) of La/SSB: the bridge for inter-particle spreading of autoimmune response to RNP. Mol. Med. 16: 19-26 (2010). *

• Routsias JG, Tzioufas AG. Sjogren's syndrome - study of autoantigens and autoantibodies. Clin. Rev. Allergy Immunol. 32: 238-251 (2007). *

• Rozman B, Novljan MP, Hocevar A, Ambrozic A, Zigon P, Kveder T, Tomsic M. Epidemiology and diagnostics of primary Sjogren's syndrome. Reumatizam 51: 9-12 (2004).

• Rueda JC, Duarte-Rey C, Casas N. Successful treatment of relapsing autoimmune pancreatitis in primary Sjogren's syndrome with rituximab: report of a case and review of the literature. Rheumatol. Int. 29: 1481-1485 (2009). *

• Ruffatti A, Ostuni P, Grypiotis P, Botsios C, Tonello M, Grava C, Favaro M, Todesco S. Sensitivity and specificity for primary Sjogren's syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA. J. Rheumatol. 31: 504-507 (2004).

• Russell PJ, Doolan TJ, Webb J, Carr GA. Studies of autologous mixed lymphocyte reactions in patients with systemic lupus erythematosus. Pathology 15: 37-43 (1983).

• Rutan G, Martinez AJ, Fieshko JT, Van Thiel DH. Primary biliary cirrhosis, Sjogren's syndrome, and transverse myelitis. Gastroenterology 90: 206-210 (1986).

• Saccodossi N, Cabrera RB, Oliver F, Gelmi L, Magglio DG, Fernandez-Lahore HM, Leoni J, Stumpo RR. Chemical extraction and direct adsorptive purification of recombinant human antigen Ro52. J. Sep. Sci. 27: 589-594 (2004).

• Safrany E, Pazar B, Csongei V, Jaromi L, Polgar N, Sipeky C, Horvath IF, Zeher M, Poor G, Melegh B. Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjogren syndrome in Hungarian population samples. Scand. J. Immunol. 70: 68-74 (2009). *

• Sahin M, Aydintug O, Tunc SE, Tutkak H, Naziroglu M. Serum soluble Fas levels in patients with autoimmune rheumatic diseases. Clin. Biochem. 40: 6-10 (2007). *

• Saito M, Ota Y, Ohashi H, Dei Y, Shimoyama K, Suzuki D, Hayashi H, Ogawa N. CD40-CD40 ligand signal induces the intercellular adhesion molecule-1 expression through nuclear factor-kappa B p50 in cultured salivary gland epithelial cells from patients with Sjogren's syndrome. Mod. Rheumatol. 17: 45-53 (2007). *

• Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J. Immunol. 181: 2898-2906 (2008). *

• Sakai K, Akiyama M, Watanabe T, Sanayama K, Sugita K, Takahashi M, Suehiro K, Yorifuji K, Shibaki A, Shimizu H. Novel ALDH3A2 heterozygous mutations in a Japanese family with Sjogren-Larsson syndrome. J. Invest. Dermatol. 126: 2545-2547 (2006). *

• Sakai K, Ohtsuki Y, Hirasawa Y, Hashimoto A, Nakamura K. Sjogren's syndrome with solitary nodular pulmonary amyloidosis. Nihon Kokyuki Gakkai Zasshi 42: 330-335 (2004).

• Sakakibara R, Hirano S, Asahina M, Sawai S, Nemoto Y, Hiraga A, Uchiyama T, Hattori T. Primary Sjogren's syndrome presenting with generalized autonomic failure. Eur. J. Neurol. 11: 635-638 (2004).

• Sakamoto T, Yamashita K, Mizumoto C, Ueda M, Takeoka T, Hishita T, Hada S, Ohno T. MALT lymphoma of the thymus with Sjogren's syndrome: biphasic changes in serological abnormalities over a 4-year period following thymectomy. Int. J. Hematol. 89: 709-713 (2009).

• Sakarellos-Daitsiotis M, Cung MT, Sakarellos C, El Hilali Z, Kosmopoulou A, Voitharou C. Complementary peptide epitopes and anti-idiotypic antibodies in autoimmunity. Protein Pept. Lett. 11: 367-375 (2004).

• Sakauchi F, Mori M, Zeniya M, Toda G. A cross-sectional study of primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. J. Epidemiol. 15: 24-28 (2005). *

• Sakauchi F, Mori M, Zeniya M, Toda G. Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. J. Epidemiol. 16: 30-34 (2006). *

• Salaffi F, Carotti M, Argalia G, Salera D, Giuseppetti GM, Grassi W. Usefulness of ultrasonography and color Doppler sonography in the diagnosis of major salivary gland diseases. Reumatismo 58: 138-156 (2006).

• Salam MA, Matin K, Matsumoto N, Tsuha Y, Hanada N, Senpuku H. E2f1 mutation induces early onset of diabetes and Sjogren's syndrome in nonobese diabetic mice. J. Immunol. 173: 4908-4918 (2004). *

• Salam MA, Matsumoto N, Matin K, Tsuha Y, Nakao R, Hanada N, Senpuku H. Establishment of an animal model using recombinant NOD.B10.D2 mice to study initial adhesion of oral Streptococci. Clin. Diagn. Lab. Immunol. 11: 379-386 (2004). *

• Salliot C, Gottenberg JE, Bengoufa D, Desmoulins F, Miceli-Richard C, Mariette X. Anticentromere antibodies identify patients with Sjogren's syndrome and autoimmune overlap syndrome. J. Rheumatol. 34: 2253-2258 (2007).

• Salliot C, Mouthon L, Ardizzone M, Sibilia J, Guillevin L, Gottenberg JE, Mariette X. Sjogren's syndrome is associated with and not secondary to systemic sclerosis. Rheumatology (Oxford) 46: 321-326 (2007). *

• Salonen EM, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases. Ann. Rheum. Dis. 63: 1250-1254 (2004). *

• Sanchez-Guerrero J, Perez-Dosal MR, Cardenas-Velazquez F, Perez-Reguera A, Celis-Aguilar E, Soto-Rojas AE, Avila-Casado C. Prevalence of Sjogren's syndrome in ambulatory patients according to the American-European Consensus Group criteria. Rheumatology (Oxford) 44: 235-240 (2005). *

• Sander DM, Szabo S, Gallaher WR, Deas JE, Thompson JJ, Cao Y, Luo-Zhang H, Liu LG, Colmegna I, Koehler J, Espinoza LR, Alexander SS, Hart DJ, Tom DM, Fermin CD, Jaspan JJ, Kulakosky PC, Tenenbaum SA, Wilson RB, Garry RF. Involvement of human intracisternal A-type retroviral particles in autoimmunity. Microsc. Res. Tech. 68: 222-234 (2005).

• Sanders PA, Grennan DM, Dyer PA, Thomson W, deLange GG. A comparison of clinical and immunogenetic features in familial and sporadic rheumatoid arthritis. J. Rheumatol. 14: 718-722 (1987).

• Sangle SR, Davies RJ, Mora M, Baron MA, Hughes GR, D'Cruz DP. Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis. Rheumatology (Oxford) 47: 1058-1060 (2008). *

• Sankar V, Brennan MT, Kok MR, Leakan RA, Smith JA, Manny J, Baum BJ, Pillemer SR. Etanercept in Sjogren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum. 50: 2240-2245 (2004). *

• Santoro P, De Andrea M, Migliaretti G, Trapani C, Landolfo S, Gariglio M. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases. J. Rheumatol. 29: 90-93 (2002). *

• Saqui-Salces M, Martinez-Benitez B, Gamboa-Dominguez A. EBV+ lymphoepithelial carcinoma of the parotid gland in Mexican Mestizo patients with chronic autoimmune diseases. Pathol. Oncol. Res. 12: 41-45 (2006). *

• Sarkar PK, Patel N, Furie RA, Talwar A. Pulmonary manifestations of primary Sjogren's syndrome. Indian J. Chest Dis. Allied Sci. 51: 93-101 (2009).

• Sartor RB. Importance of intestinal mucosal immunity and luminal bacterial cell wall polymers in the aetiology of inflammatory joint diseases. Baillieres Clin. Rheumatol. 3: 223-245 (1989).

• Sasaki M, Nakamura S, Ohyama Y, Shinohara M, Ezaki I, Hara H, Kadena T, Kishihara K, Yamamoto K, Nomoto K, Shirasuna K. Accumulation of common T cell clonotypes in the salivary glands of patients with human T lymphotropic virus type I-associated and idiopathic Sjogren's syndrome. J. Immunol. 164: 2823-2831 (2000). *

• Sato S, Masuda T, Oikawa H, Satoh T, Suzuki Y, Takikawa Y, Yamazaki K, Suzuki K, Sato S. Primary hepatic lymphoma associated with primary biliary cirrhosis. Am. J. Gastroenterol. 94: 1669-1673 (1999). *

• Sawada S. Comment to: regulation of various genes in human leukocytes acutely exposed to morphine: expression microarray analysis. Med. Sci. Monit. 11: LE19-LE20 (2005). *

• Sawalha AH, Potts R, Schmid WR, Scofield RH, Harley JB. The genetics of primary Sjogren's syndrome. Curr. Rheumatol. Rep. 5: 324-332 (2003).

• Sawyer S. Primary Sjogren's syndrome. Nurs. Stand. 18: 33-36 (2004).

• Saxena R, Gianniny L, Burtt NP, Lyssenko V, Giuducci C, Sjogren M, Florez JC, Almgren P, Isomaa B, Orho-Melander M, Lindblad U, Daly MJ, Tuomi T, Hirschhorn JN, Ardlie KG, Groop LC, Altshuler D. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55: 2890-2895 (2006). *

• Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, Hughes TE, Groop L, Altshuler D, Almgren P, Florez JC, Meyer J, Ardlie K, Bengtsson K, Isomaa B, Lettre G, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316: 1331-1336 (2007). *

• Scagliusi P, De Serio S, De Lucia M, D'Amore M, Pipitone V. Immuno-histological findings on Sjogren's syndrome. Minerva Med. 74: 131-141 (1983).

• Scardina GA, Ruggieri A, Messina P. Periodontal disease and Sjogren syndrome: a possible correlation? Angiology Sep 2 [Epub ahead of print] (2009).

• Scardina GA, Ruggieri A, Messina P. Evaluation of labial microvessels in Sjogren syndrome: a videocapillaroscopic study. Ann. Anat. 191: 273-279 (2009).

• Schachter I, Antignani PL. Dysthyroidism and connective pathology. Minerva Cardioangiol. 54: 811-814 (2006).

• Schedel J, Godde A, Schutz E, Bongartz TA, Lang B, Scholmerich J, Muller-Ladner U. Impact of thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations in patients with chronic inflammatory diseases. Ann. N. Y. Acad. Sci. 1069: 477-491 (2006). *

• Scheinfeld N. Sjogren syndrome and systemic lupus erythematosus are distinct conditions. Dermatol. Online J. 12: 4 (2006). *

• Schenke-Layland K, Xie J, Angelis E, Starcher B, Wu K, Riemann I, Maclellan WR, Hamm-Alvarez SF. Increased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjogren's syndrome. Matrix Biol. 27: 53-66 (2008). *

• Schenke-Layland K, Xie J, Magnusson M, Angelis E, Li X, Wu K, Reinhardt DP, Maclellan WR, Hamm-Alvarez SF. Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjogren's syndrome-like exocrinopathy. Exp. Eye Res. Oct 22 [Epub ahead of print] (2009).

• Schofield P. Dementia associated with toxic causes and autoimmune disease. Int. Psychogeriatr. 17 Suppl. 1: S129-S147 (2005).

• Schrader AM, Camden JM, Weisman GA. P2Y(2) nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjogren's syndrome. Arch. Oral Biol. 50: 533-540 (2005).

• Schumann C, Faust M, Gerharz M, Ortmann M, Schubert M, Krone W. Autoimmune polyglandular syndrome associated with idiopathic giant cell myocarditis. Exp. Clin. Endocrinol. Diabetes 113: 302-307 (2005).

• Schwarz C, Barisani T, Bauer E, Druml W. A woman with red eyes and hypokalemia: a case of acquired Gitelman syndrome. Wien. Klin. Wochenschr. 118: 239-242 (2006). *

• Scofield RH, Bruner GR, Harley JB, Namjou B. Autoimmune thyroid disease is associated with a diagnosis of secondary Sjogren's syndrome in familial systemic lupus. Ann. Rheum. Dis. 66: 410-413 (2007). *

• Segal B, Carpenter A, Walk D. Involvement of nervous system pathways in primary Sjogren's syndrome. Rheum. Dis. Clin. North Am. 34: 885-906 (2008).

• Seidel MF, Herguijuela M, Forkert R, Otten U. Nerve growth factor in rheumatic diseases. Semin. Arthritis Rheum. May 27 [Epub ahead of print] (2009). *

• Seitz M. Sjogren's syndrome. Ther. Umsch. 65: 279-282 (2008).

• Seki S, Tanaka K, Fujisawa M, Shiomi S, Saitoh S, Sakagami Y, Matsui T, Mizoguchi Y, Kuroki T, Harihara S, et al. A patient with asymptomatic primary biliary cirrhosis in association with Sjogren syndrome developing features of systemic lupus erythematosus. Nippon Shokakibyo Gakkai Zasshi 83: 2445-2449 (1986).

• Sekiguchi M, Iwasaki T, Kitano M, Kuno H, Hashimoto N, Kawahito Y, Azuma M, Hla T, Sano H. Role of sphingosine 1-phosphate in the pathogenesis of Sjogren's syndrome. J. Immunol. 180: 1921-1928 (2008). *

• Seldin MF, Amos CI. Shared susceptibility variations in autoimmune diseases: a brief perspective on common issues. Genes Immun. 10: 1-4 (2009). *

• Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjogren's syndrome and systemic lupus erythematosus. Ann. Rheum. Dis. 66: 790-797 (2007). *

• Sellam J, Proulle V, Jungel A, Ittah M, Miceli-Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM, Mariette X. Increased levels of circulating microparticles in primary Sjogren's syndrome, systemic lupus erythematosus and rheumatoid arthritis, and relation with disease activity. Arthritis Res. Ther. 11: R156 (2009). *

• Sene D, Ghillani-Dalbin P, Limal N, Thibault V, van Boekel T, Piette JC, Cacoub P. Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome. Ann. Rheum. Dis. 65: 394-397 (2006). *

• Seve P, Gachon E, Petiot P, Stankovic K, Charhon A, Broussolle C. Successful treatment with rituximab in a patient with mental nerve neuropathy in primary Sjogren's syndrome. Rheumatol. Int. 28: 175-177 (2007). *

• Seve P, Poupart M, Bui-Xuan C, Charhon A, Broussolle C. Cricoarytenoid arthritis in Sjogren's syndrome. Rheumatol. Int. 25: 301-302 (2005). *

• Sfriso P, Oliviero F, Calabrese F, Miorin M, Facco M, Contri A, Cabrelle A, Baesso I, Cozzi F, Andretta M, Cassatella MA, Fiocco U, Todesco S, Konttinen YT, Punzi L, Agostini C. Epithelial CXCR3-B regulates chemokines bioavailability in normal, but not in Sjogren's syndrome, salivary glands. J. Immunol. 176: 2581-2589 (2006). *

• Sharma R, Zheng L, Guo X, Fu SM, Ju ST, Jarjour WN. Novel animal models for Sjogren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice. J. Autoimmun. 27: 289-296 (2006).

• Shaw C, Banik S, Islam MN, Biswas MC, Biswas G, Biswas S. Rheumatoid arthritis and ocular involvement. J. Indian Med. Assoc. 101: 537-538 (2003).

• Sheikh SH, Shaw-Stiffel TA. The gastrointestinal manifestations of Sjogren's syndrome. Am. J. Gastroenterol. 90: 9-14 (1995).

• Shen GQ, Ojo-Amaize EA, Agopian MS, Peter JB. Silicate antibodies in women with silicone breast implants: development of an assay for detection of humoral immunity. Clin. Diagn. Lab. Immunol. 3: 162-166 (1996). *

• Shen L, Zhang C, Wang T, Brooks S, Ford RJ, Lin-Lee YC, Kasianowicz A, Kumar V, Martin L, Liang P, Cowell J, Ambrus JL Jr. Development of autoimmunity in IL-14alpha-transgenic mice. J. Immunol. 177: 5676-5686 (2006). *

• Shen M, Zhang F, Zhang X. Pulmonary hypertension in primary biliary cirrhosis: a prospective study in 178 patients. Scand. J. Gastroenterol. 44: 219-223 (2009). *

• Shiari R, Kobayashi I, Toita N, Hatano N, Kawamura N, Okano M, Hayashi Y, Kobayashi K, Ariga T. Epitope mapping of anti-alpha-fodrin autoantibody in juvenile Sjogren's syndrome: difference in major epitopes between primary and secondary cases. J. Rheumatol. 33: 1395-1400 (2006).

• Shibata S, Ubara Y, Sawa N, Tagami T, Hosino J, Yokota M, Katori H, Takemoto F, Hara S, Takaichi K, Fujii A, Murata H, Nishi T. Severe interstitial cystitis associated with Sjogren's syndrome. Intern. Med. 43: 248-252 (2004). *

• Shim GJ, Gherman D, Kim HJ, Omoto Y, Iwase H, Bouton D, Kis LL, Andersson CT, Warner M, Gustafsson JA. Differential expression of oestrogen receptors in human secondary lymphoid tissues. J. Pathol. 208: 408-414 (2006). *

• Shim GJ, Warner M, Kim HJ, Andersson S, Liu L, Ekman J, Imamov O, Jones ME, Simpson ER, Gustafsson JA. Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome. Proc. Natl. Acad. Sci. U.S.A. 101: 12628-12633 (2004). *

• Shimizu S, Yoshinouchi T, Naniwa T, Nakamura M, Sato S, Ohtsuki Y, Fujita J, Yamadori I, Eimoto T, Ueda R. Distribution of CXCR3- or CCR4-positive cells in interstitial pneumonia associated with primary Sjogren's syndrome. Virchows Arch. 445: 477-484 (2004). *

• Shiozawa S, Cummins JM, Fox PC. Opening the flood gates: interferon-alpha treatment for Sjogren's syndrome. BioDrugs 13: 305-311 (2000).

• Shiraiwa H, Takei M, Yoshikawa T, Azuma T, Kato M, Mitamura K, Ueki T, Kida A, Horie T, Seki N, Sawada S. Detection of Grb-2-related adaptor protein gene (GRAP) and peptide molecule in salivary glands of MRL/lpr mice and patients with Sjogren's syndrome. J. Int. Med. Res. 32: 284-291 (2004).

• Shizukuishi K, Nagaoka S, Kinno Y, Saito M, Takahashi N, Kawamoto M, Abe A, Jin L, Inoue T. Scoring analysis of salivary gland scintigraphy in patients with Sjogren's syndrome. Ann. Nucl. Med. 17: 627-631 (2003).

• Shovman O, Sherer Y, Gilbourd B, Gerli R, Bocci EB, delle Monache F, Luccioli F, Shoenfeld Y. Low levels of heat shock proteins-60 and -65 autoantibodies in Sjogren's syndrome. Isr. Med. Assoc. J. 7: 778-780 (2005). *

• Shuckett R, Russell ML, Gladman DD. Atypical erosive osteoarthritis and Sjogren's syndrome. Ann. Rheum. Dis. 45: 281-288 (1986). *

• Sibbitt WL Jr. Oncogenes, growth factors, and autoimmune diseases (review). Anticancer Res. 11: 97-113 (1991).

• Sierra Santos L, Sendino Revuelta A, Pacheco Cuadros R, Aparicio Jabalquinto G, Barbado Hernandez FJ. Hashimoto's thyroiditis and Sjogren syndrome. Association or autoimmune multiple syndrome? An. Med. Interna 18: 86-87 (2001).

• Sisto M, Lisi S, Lofrumento D, D'Amore M, Scagliusi P, Mitolo V. Autoantibodies from Sjogren's syndrome trigger apoptosis in salivary gland cell line. Ann. N. Y. Acad. Sci. 1108: 418-425 (2007). *

• Sjogren F, Anderson C. Sterile trauma to normal human dermis invariably induces IL1beta, IL6 and IL8 in an innate response to "danger". Acta Derm. Venereol. 89: 459-465 (2009).

• Sjogren I, Wengle B, Korsgren M. Primary sclerosing cholangitis associated with fibrosis of the submandibular glands and the pancreas. Acta Med. Scand. 205: 139-141 (1979).

• Sjogren K, Leung KC, Kaplan W, Gardiner-Garden M, Gibney J, Ho KK. Growth hormone regulation of metabolic gene expression in muscle: a microarray study in hypopituitary men. Am. J. Physiol. Endocrinol. Metab. 293: E364-E371 (2007). *

• Sjogren M, Lyssenko V, Jonsson A, Berglund G, Nilsson P, Groop L, Orho-Melander M. The search for putative unifying genetic factors for components of the metabolic syndrome. Diabetologia 51: 2242-2251 (2008). *

• Sjogren YM, Tomicic S, Lundberg A, Bottcher MF, Bjorksten B, Sverremark-Ekstrom E, Jenmalm MC. Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin. Exp. Allergy Sep 3 [Epub ahead of print] (2009). *

• Skalova S, Minxova L, Slezak R. Hypokalaemic paralysis revealing Sjogren's syndrome in a 16-year old girl. Ghana Med. J. 42: 124-128 (2008). *

• Skarstein K, Wahren M, Zaura E, Hattori M, Jonsson R. Characterization of T cell receptor repertoire and anti-Ro/SSA autoantibodies in relation to sialadenitis of NOD mice. Autoimmunity 22: 9-16 (1995).

• Skogh T, Peen E. Lactoferrin, anti-lactoferrin antibodies and inflammatory disease. Adv. Exp. Med. Biol. 336: 533-538 (1993).

• Skopouli FN, Barbatis C, Moutsopoulos HM. Liver involvement in primary Sjogren's syndrome. Br. J. Rheumatol. 33: 745-748 (1994).

• Skopouli FN, Moutsopoulos HM. Autoimmune epitheliitis: Sjogren's syndrome. Clin. Exp. Rheumatol. 12 Suppl. 11: S9-S11 (1994).

• Skoumal M, Haberhauer G, Feyertag J, Kittl EM, Bauer K, Dunky A. Serum levels of cartilage oligomeric matrix protein are elevated in rheumatoid arthritis, but not in inflammatory rheumatic diseases such as psoriatic arthritis, reactive arthritis, Raynaud's syndrome, scleroderma, systemic lupus erythematosus… Arthritis Res. Ther. 6: 73-74 (2004). *

• Smedby KE, Baecklund E, Askling J. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol. Biomarkers Prev. 15: 2069-2077 (2006). *

• Smedby KE, Hjalgrim H, Askling J, Chang ET, Gregersen H, Porwit-MacDonald A, Sundstrom C, Akerman M, Melbye M, Glimelius B, Adami HO. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J. Natl. Cancer Inst. 98: 51-60 (2006). *

• Smith AJ, Gordon TP, Macardle PJ. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjogren's syndrome. Tissue Antigens 63: 255-259 (2004). *

• Smith AJ, Jackson MW, Wang F, Cavill D, Rischmueller M, Gordon TP. Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjogren syndrome. Hum. Immunol. 66: 411-416 (2005).

• So A. Treatment of connective tissue diseases with biological agents. Rev. Med. Suisse. 4: 707-708, 710 (2008).

• Soderberg KC, Jonsson F, Winqvist O, Hagmar L, Feychting M. Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden. Eur. J. Cancer 42: 3028-3033 (2006). *

• Solans R, Bosch JA, Selva A, Simeon CP, Fonollosa V, Vilardell M. Usefulness of oral pilocarpin therapy in the treatment of xerostomia and xerophtalmia in patients with primary Sjogren's syndrome. Med. Clin. (Barc.) 122: 253-255 (2004).

• Soliotis FC, Mavragani CP, Moutsopoulos HM. Central nervous system involvement in Sjogren's syndrome. Ann. Rheum. Dis. 63: 616-620 (2004). *

• Soliotis FC, Moutsopoulos HM. Sjogren's syndrome. Autoimmunity 37: 305-307 (2004).

• Song MK, Seol YM, Park YE, Kim YS, Lee MK, Lee CH, Jeong YJ. Pulmonary nodular lymphoid hyperplasia associated with Sjogren's syndrome. Korean J. Intern. Med. 22: 192-196 (2007).

• Song Q, Liu G, Hu S, Zhang Y, Tao Y, Han Y, Zeng H, Huang W, Li F, Chen P, Zhu J, Hu C, Zhang S, Li Y, Zhu H, Wu L. Novel autoimmune hepatitis-specific autoantigens identified using protein microarray technology. J. Proteome Res. Jun 22 [Epub ahead of print] (2009). *

• Sontheimer RD. Photoimmunology of lupus erythematosus and dermatomyositis: a speculative review. Photochem. Photobiol. 63: 583-594 (1996).

• Sood M, Trehan A, Dinakaran J, Marwaha RK. Sjogren-Larsson syndrome. Indian J. Pediatr. 69: 193-194 (2002).

• Sorrentino D, Faller G, DeVita S, Avellini C, Labombarda A, Ferraccioli G, Kahlow-Toussaint S. Helicobacter pylori associated antigastric autoantibodies: role in Sjogren's syndrome gastritis. Helicobacter 9: 46-53 (2004).

• Soy M, Guldiken S, Arikan E, Altun BU, Tugrul A. Frequency of rheumatic diseases in patients with autoimmune thyroid disease. Rheumatol. Int. 27: 575-577 (2007). *

• Soy M, Pamuk ON, Gerenli M, Celik Y. A primary Sjogren's syndrome patient with distal renal tubular acidosis, who presented with symptoms of hypokalemic periodic paralysis. Report of a case study and review of the literature. Rheumatol. Int. 26: 86-89 (2005). *

• Soy M, Piskin S. Cutaneous findings in patients with primary Sjogren's syndrome. Clin. Rheumatol. 26: 1350-1352 (2007). *

• Soyfoo MS, Steinfeld S, Delporte C. Usefulness of mouse models to study the pathogenesis of Sjogren's syndrome. Oral Dis. 13: 366-375 (2007). *

• Spachidou MP, Bourazopoulou E, Maratheftis CI, Kapsogeorgou EK, Moutsopoulos HM, Tzioufas AG, Manoussakis MN. Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjogren's syndrome. Clin. Exp. Immunol. 147: 497-503 (2007). *

• Sperandeo M, Varriale A, Sperandeo G, Filabozzi P, Piattelli ML, Carnevale V, Decuzzi M, Vendemiale G. Transthoracic ultrasound in the evaluation of pulmonary fibrosis: our experience. Ultrasound Med. Biol. 35: 723-729 (2009).

• Spiewak R, Stojek NM, Chmielewska-Badora J. Antinuclear antibodies are not increased in the early phase of Borrelia infection. Ann. Agric. Environ. Med. 11: 145-148 (2004). *

• Srinivasan S, Slomovic AR. Sjogren syndrome. Compr. Ophthalmol. Update 8: 205-212 (2007).

• Stathopoulou EA, Routsias JG, Stea EA, Moutsopoulos HM, Tzioufas AG. Cross-reaction between antibodies to the major epitope of Ro60 kD autoantigen and a homologous peptide of Coxsackie virus 2B protein. Clin. Exp. Immunol. 141: 148-154 (2005). *

• Statkute L, Oyama Y, Barr WG, Sufit R, Ho S, Verda L, Loh Y, Yaung K, Quigley K, Burt RK. Autologous non-myeloablative hematopoietic stem cell transplantation for refractory systemic vasculitis. Ann. Rheum. Dis. 67: 991-997 (2008).

• Stea EA, Routsias JG, Samiotaki M, Panayotou G, Papalambros E, Moutsopoulos HM, Tzioufas AG. Analysis of parotid glands of primary Sjogren's syndrome patients using proteomic technology reveals altered autoantigen composition and novel antigenic targets. Clin. Exp. Immunol. 147: 81-89 (2007). *

• Steiman-Shimony A, Edelman H, Barak M, Shahaf G, Dunn-Walters D, Stott DI, Abraham RS, Mehr R. Immunoglobulin variable-region gene mutational lineage tree analysis: application to autoimmune diseases. Autoimmun. Rev. 5: 242-251 (2006).

• Steiman-Shimony A, Edelman H, Hutzler A, Barak M, Zuckerman NS, Shahaf G, Dunn-Walters D, Stott DI, Abraham RS, Mehr R. Lineage tree analysis of immunoglobulin variable-region gene mutations in autoimmune diseases: chronic activation, normal selection. Cell. Immunol. 244: 130-136 (2006). *

• Steinfeld SD, Youinou P. Epratuzumab (humanised anti-CD22 antibody) in autoimmune diseases. Expert Opin. Biol. Ther. 6: 943-949 (2006).

• Steuer A, McCrea DJ, Colaco CB. Primary Sjogren's syndrome, ulcerative colitis and selective IgA deficiency. Postgrad. Med. J. 72: 499-500 (1996). *

• Stevenson HA, Jones ME, Rostron JL, Longman LP, Field EA. UK patients with primary Sjogren's syndrome are at increased risk from clinical depression. Gerodontology 21: 141-145 (2004).

• Stewart C, Cha S, Caudle RM, Berg K, Katz J. Decreased levels of soluble receptor for advanced glycation end products in patients with primary Sjogren's syndrome. Rheumatol. Int. 28: 771-776 (2008). *

• Stewart CM, Berg KM, Cha S, Reeves WH. Salivary dysfunction and quality of life in Sjogren syndrome: a critical oral-systemic connection. J. Am. Dent. Assoc. 139: 291-299 (2008).

• Stewart CM, Bhattacharyya I, Berg K, Cohen DM, Orlando C, Drew P, Islam NM, Ojha J, Reeves W. Labial salivary gland biopsies in Sjogren's syndrome: still the gold standard? Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 106: 392-402 (2008).

• Stohl W. Therapeutic targeting of B lymphocyte stimulator (BLyS) in the rheumatic diseases. Endocr. Metab. Immune Disord. Drug Targets 6: 351-358 (2006).

• Stohl W. Targeting B lymphocyte stimulator in systemic lupus erythematosus and other autoimmune rheumatic disorders. Expert Opin. Ther. Targets 8: 177-189 (2004).

• Stojanovich L, Milovanovich B, de Luka SR, Popovich-Kuzmanovich D, Bisenich V, Djukanovich B, Randjelovich T, Krotin M. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjogren syndrome and other autoimmune diseases. Lupus 16: 181-185 (2007). *

• Storstein A, Monstad SE, Nakkestad HL, Husebye ES, Vedeler CA. Paraneoplastic antibodies against HuD detected by a sensitive radiobinding assay. J. Neurol. 251: 197-203 (2004). *

• Streubel B, Huber D, Wohrer S, Chott A, Raderer M. Frequency of chromosomal aberrations involving MALT1 in mucosa-associated lymphoid tissue lymphoma in patients with Sjogren's syndrome. Clin. Cancer Res. 10: 476-480 (2004). *

• Stroehmann A, Dorner T, Lukowsky A, Feist E, Hiepe F, Burmester GR. Cutaneous T cell lymphoma in a patient with primary biliary cirrhosis and secondary Sjogren's syndrome. J. Rheumatol. 29: 1326-1329 (2002).

• Strom SS, Baldwin BJ, Sigurdson AJ, Schusterman MA. Cosmetic saline breast implants: a survey of satisfaction, breast-feeding experience, cancer screening, and health. Plast. Reconstr. Surg. 100: 1553-1557 (1997).

• Suer W, Dahnrich C, Schlumberger W, Stocker W. Autoantibodies in SLE but not in scleroderma react with protein-stripped nucleosomes. J. Autoimmun. 22: 325-334 (2004).

• Sugai S. Interstitial cystitis and Sjogren's syndrome. Intern. Med. 43: 174-176 (2004). *

• Sughimoto K, Nakano K, Gomi A, Nakatani H, Nakamura Y, Sato A. Infective endocarditis associated with Sjogren's syndrome. Asian Cardiovasc. Thorac. Ann. 14: e115-e117 (2006).

• Sumida T, Matsumoto I, Maeda T. TCR repertoire of autoreactive T cells in autoimmune disorders. Nippon Rinsho 55: 1410-1418 (1997).

• Sumida T, Matsumoto I, Murata H, Namekawa T, Matsumura R, Tomioka H, Iwamoto I, Saito Y, Mizushima Y, Hasunuma T, Maeda T, Nishioka K. TCR in Fas-sensitive T cells from labial salivary glands of patients with Sjogren's syndrome. J. Immunol. 158: 1020-1025 (1997).

• Sun J, Feng J, Li Y, Shen B. A novel BLyS antagonist peptide designed based on the 3-D complex structure of BCMA and BLyS. Biochem. Biophys. Res. Commun. 346: 1158-1162 (2006). *

• Surrenti C, Pozzi M, Biagini MR, Franco C, Lombardo R, Avanzi G. Effects of plasma exchange (PE) in primary biliary cirrhosis (PBC). A pilot study. Hepatogastroenterology 37: 128-130 (1990).

• Svensson J, Tivesten A, Sjogren K, Isaksson O, Bergstrom G, Mohan S, Molne J, Isgaard J, Ohlsson C. Liver-derived IGF-I regulates kidney size, sodium reabsorption, and renal IGF-II expression. J. Endocrinol. 193: 359-366 (2007). *

• Szabo N, Csiki Z, Szanto A, Danko K, Szodoray P, Zeher M. Functional and morphological evaluation of hand microcirculation with nailfold capillaroscopy and laser Doppler imaging in Raynaud's and Sjogren's syndrome and poly/dermatomyositis. Scand. J. Rheumatol. 37: 23-29 (2008). *

• Szanto A, Csipo I, Horvath I, Biro E, Szodoray P, Zeher M. Autoantibodies to alfa-fodrin in patients with Hashimoto thyroiditis and Sjogren's syndrome: possible markers for a common secretory disorder. Rheumatol. Int. 28: 1169-1172 (2008). *

• Szanto A, Csipo I, Zeher M. Sensitivity and specificity of anti-a-fodrin antibodies in primary Sjogren's syndrome. J. Rheumatol. 32: 197 (2005).

• Szanto A, Kiss E, Sas A, Szegedi G, Zeher M. Association of systemic lupus erythematosus and Sjogren's syndrome. Orv. Hetil. 146: 2533-2538 (2005).

• Szanto A, Szodoray P, Kiss E, Kapitany A, Szegedi G, Zeher M. Clinical, serologic, and genetic profiles of patients with associated Sjogren's syndrome and systemic lupus erythematosus. Hum. Immunol. 67: 924-930 (2006).

• Szekanecz Z, Szucs G, Szanto S, Koch AE. Chemokines in rheumatic diseases. Curr. Drug Targets 6: 91-102 (2005).

• Szigeti N, Fabian G, Czirjak L. Fatal scleroderma renal crisis caused by gastrointestinal bleeding in a patient with scleroderma, Sjogren's syndrome and primary biliary cirrhosis overlap. J. Eur. Acad. Dermatol. Venereol. 16: 276-279 (2002). *

• Szodoray P, Alex P, Brun JG, Centola M, Jonsson R. Circulating cytokines in primary Sjogren's syndrome determined by a multiplex cytokine array system. Scand. J. Immunol. 59: 592-599 (2004). *

• Szodoray P, Gal I, Barath S, Aleksza M, Horvath IF, Gergely P Jr, Szegedi G, Nakken B, Zeher M. Immunological alterations in newly diagnosed primary Sjogren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines. Scand. J. Rheumatol. 37: 205-212 (2008).

• Szodoray P, Horvath IF, Papp G, Barath S, Gyimesi E, Csathy L, Kappelmayer J, Sipka S, Duttaroy AK, Nakken B, Zeher M. The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren's syndrome. Rheumatology (Oxford) 49: 211-217 (2010).

• Szodoray P, Jonsson R. The BAFF/APRIL system in systemic autoimmunediseases with a special emphasis on Sjogren's syndrome. Scand. J. Immunol. 62: 421-428 (2005). *

• Szodoray P, Koczok K, Szanto A, Horvath IF, Nakken B, Molnar I, Zeher M. Autoantibodies to novel membrane and cytosolic antigens of the lachrymal gland in primary Sjogren's syndrome. Clin. Rheumatol. 27: 195-199 (2008). *

• Szodoray P, Papp G, Horvath IF, Barath S, Sipka S, Nakken B, Zeher M. Cells with regulatory function of the innate and adaptive immune system in primary Sjogren's syndrome. Clin. Exp. Immunol. 157: 343-349 (2009). *

• Szostecki C, Krippner H, Penner E, Bautz FA. Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). Clin. Exp. Immunol. 68: 108-116 (1987). *

• Tabbara KF, Sharara N. Dry eye syndrome. Drugs Today (Barc.) 34: 447-453 (1998).

• Taeda Y, Ariga N, Okamura K, Takei N, Komeno T, Ueki H, Ohtani H. Primary breast mucosa-associated lymphoid tissue (MALT) lymphoma with high-grade transformation evidenced by prominent lymphoepithelial lesions. Breast Cancer 13: 322-327 (2006). *

• Taga M, Abe T, Nishimura S, Kimura H, Oki M, Nojima M, Tanaka H, Matsumoto S, Imai K. A case of Sjogren's syndrome associated with chronic hepatitis C and sarcoidosis. Nihon Rinsho Meneki Gakkai Kaishi 26: 336-340 (2003).

• Taguchi Y, Takashima S, Takata M, Dougu N, Asaoka E, Inoue H. High-dose intravenous immunoglobulin in the treatment of sensory ataxic neuropathy with Sjogren's syndrome: a case report. No To Shinkei 56: 421-424 (2004).

• Taiym S, Haghighat N, Al-Hashimi I. A comparison of the hormone levels in patients with Sjogren's syndrome and healthy controls. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 97: 579-583 (2004).

• Takabayashi K. Age and gender difference in rheumatology. Nippon Ronen Igakkai Zasshi 42: 639-641 (2005).

• Takada K, Takiguchi M, Inaba M. Different effects on the inflammatory lesions in the lacrimal and salivary glands after neonatal thymectomy in IQI/Jic mice, a model for Sjogren's syndrome. J. Vet. Med. Sci. 67: 955-957 (2005). *

• Takada K, Takiguchi M, Konno A, Inaba M. Autoimmunity against a tissue kallikrein in IQI/Jic mice, a model for Sjogren's syndrome. J. Biol. Chem. 280: 3982-3988 (2005). *

• Takada K, Takiguchi M, Konno A, Inaba M. Spontaneous development of multiple glandular and extraglandular lesions in aged IQI/Jic mice: a model for primary Sjogren's syndrome. Rheumatology (Oxford) 43: 858-862 (2004). *

• Takagi T, Kasukawa R. Association of autoimmune disease in primary biliary cirrhosis. Nippon Rinsho 52: 251-255 (1994).

• Takagi Y, Kimura Y, Nakamura T. Cevimeline gargle for the treatment of xerostomia in patients with Sjogren's syndrome. Ann. Rheum. Dis. 63: 749 (2004). *

• Takahashi M, Mimura Y, Hamano H, Haneji N, Yanagi K, Hayashi Y. Mechanism of the development of autoimmune dacryodenitis in the mouse model for primary Sjogren's syndrome. Cell. Immunol. 170: 54-62 (1996).

• Takahashi M, Nagata R, Ozaki A, Kaneko S, Saiki H, Matsumoto S. A case of anti-AQP4 antibody-positive recurrent myelitis overlapped with autoimmune disorders including incomplete CREST syndrome revealed multiple discontinuous cord lesions. Rinsho Shinkeigaku 49: 115-118 (2009).

• Takasaki Y, Yamanaka K, Takasaki C, Matsushita M, Yamada H, Nawata M, Matsudaira R, Ikeda K, Kaneda K, Hashimoto H. Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease. Mod. Rheumatol. 14: 367-375 (2004).

• Takei M, Shiraiwa H, Azuma T, Hayashi Y, Seki N, Sawada S. The possible etiopathogenic genes of Sjogren's syndrome. Autoimmun. Rev. 4: 479-484 (2005).

• Takemoto F, Katori H, Sawa N, Hoshino J, Suwabe T, Sogawa Y, Nomura K, Nakanishi S, Higa Y, Kanbayashi H, Kosuga M, Sasaki M, Tomioka S, Yamashita M, Ubara Y, Yamada A, Takaichi K, Uchida S. Induction of anti-carbonic-anhydrase-II antibody causes renal tubular acidosis in a mouse model of Sjogren's syndrome. Nephron Physiol. 106: p63-p68 (2007).

• Talal N, Dauphinee MJ, Dang H, Alexander SS, Hart DJ, Garry RF. Detection of serum antibodies to retroviral proteins in patients with primary Sjogren's syndrome (autoimmune exocrinopathy). Arthritis Rheum. 33: 774-781 (1990).

• Talal N, Flescher E, Dang H. Are endogenous retroviruses involved in human autoimmune disease? J. Autoimmun. 5 Suppl. A: 61-66 (1992).

• Tamasi L, Szekanecz Z. Biological therapy of arthritis and systemic autoimmune diseases. Orv. Hetil. 148: S63-S70 (2007).

• Tan HH, Tan A, Theng C, Ng SK. Cutaneous Mycobacterium haemophilum infections in immunocompromised patients in a dermatology clinic in Singapore. Ann. Acad. Med. Singapore 33: 532-536 (2004). *

• Tanaka A, Igarashi M, Kakinuma M, Oh-i T, Koga M, Okuda T. The occurrence of various collagen diseases in one family: a sister with ISSc, PBC, APS, and SS and a brother with systemic lupus erythematosus. J. Dermatol. 28: 547-653 (2001).

• Tanaka H, Abe T, Nishimura S, Sakai H, Kimura H, Oki M, Nojima M, Taga M, Matsumoto S, Takahashi H, Imai K. A case of rheumatoid arthritis/Sjogren's syndrome with acute renal failure due to hyperuricemia associated with mizoribine therapy. Nihon Rinsho Meneki Gakkai Kaishi 27: 171-176 (2004).

• Taneichi K, Nagashima M, Shibaki H. A patient with rheumatoid arthritis complicated by Sjogren's syndrome that was possibly caused by reactivation of Epstein-Barr virus. Intern. Med. 32: 77-79 (1993). *

• Tanioka M, Yamamoto Y, Katoh M, Takahashi K, Miyachi Y. Vitiligo vulgaris and autoimmune diseases in Japan: a report from vitiligo clinic in Kyoto University Hospital. Dermatoendocrinol. 1: 43-5 (2009). *

• Tansey D, Wells AU, Colby TV, Ip S, Nikolakoupolou A, Du Bois RM, Hansell DM, Nicholson AG. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 44: 585-596 (2004). *

• Taube B, Billeaud C, Labreze C, Entressangles B, Fontan D, Taieb A. Sjogren-Larsson syndrome: early diagnosis, dietary management and biochemical studies in two cases. Dermatology 198: 340-345 (1999).

• Taura S, Murata Y, Aung W, Ishida R, Zhang L, Hossain M, Takahashi Y, Okada N, Shibuya H. Decreased thyroid uptake of Tc-99m pertechnetate in patients with advanced-stage Sjogren syndrome: evaluation using salivary gland scintigraphy. Clin. Nucl. Med. 27: 265-269 (2002).

• Taylor I, Parsons M. Hypokalemic paralysis revealing Sjogren's syndrome. J. Clin. Neurosci. 11: 319-321 (2004).

• Tektonidou MG, Anapliotou M, Vlachoyiannopoulos P, Moutsopoulos HM. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann. Rheum. Dis. 63: 1159-1161 (2004). *

• Tensing EK, Tornwall J, Hukkanen M, Nordstrom DC, Konttinen YT. The protein kinase C system in focal adenitis of the lacrimal gland in the non-obese diabetic mouse model for Sjogren's syndrome. Acta Ophthalmol. Scand. 82: 569-573 (2004). *

• Terzoglou AG, Routsias JG, Avrameas S, Moutsopoulos HM, Tzioufas AG. Preferential recognition of the phosphorylated major linear B-cell epitope of La/SSB 349-368 aa by anti-La/SSB autoantibodies from patients with systemic autoimmune diseases. Clin. Exp. Immunol. 144: 432-439 (2006). *

• Terzoglou AG, Routsias JG, Moutsopoulos HM, Tzioufas AG. Post-translational modifications of the major linear epitope 169-190aa of Ro60 kDa autoantigen alter the autoantibody binding. Clin. Exp. Immunol. 146: 60-65 (2006). *

• Teubner A, Tillmann HL, Schuppan D, Gericke G, Manns MP, Stolzel U. Prevalence of circulating autoantibodies in healthy individuals. Med. Klin. (Munich) 97: 645-649 (2002).

• Teufel A, Weinmann A, Kahaly GJ, Centner C, Piendl A, Worns M, Lohse AW, Galle PR, Kanzler S. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J. Clin. Gastroenterol. Jan 15 [Epub ahead of print] (2010).

• Thanou-Stavraki A, James JA. Primary Sjogren's syndrome: current and prospective therapies. Semin. Arthritis Rheum. 37: 273-292 (2008). *

• Thaunat O, Nicoletti A. Comment on "Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjogren's syndrome" J. Immunol. 180: 2007-2008 (2008).

• Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT. Lymphoma and other malignancies in primary Sjogren's syndrome. A cohort study on cancer incidence and lymphoma predictors. Ann. Rheum. Dis. 65: 796-803 (2006). *

• Theander E, Jacobsson LT. Relationship of Sjogren's syndrome to other connective tissue and autoimmune disorders. Rheum. Dis. Clin. North Am. 34: 935-947 (2008).

• Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary Sjogren's syndrome: a prospective cohort study. Arthritis Rheum. 50: 1262-1269 (2004). *

• Thomas PB, Samant DM, Zhu Z, Selvam S, Stevenson D, Wang Y, Song SW, Mircheff AK, Schechter JE, Yiu SC, Trousdale MD. Long-term topical cyclosporine treatment improves tear production and reduces keratoconjunctivitis in rabbits with induced autoimmune dacryoadenitis. J. Ocul. Pharmacol. Ther. 25: 285-292 (2009).

• Thompson C, Jacobsen H, Pomeranz Krummel D, Nagai K, Cooke A. Non-depleting anti-CD4 antibody not only prevents onset but resolves sialadenitis in NOD mice. Autoimmunity 37: 549-554 (2004).

• Tinsa F, Brini I, El May A, Bousnina D, Boussetta K, Bousnina S. Nodular regenerative hyperplasia of the liver, coeliac disease and Sjogren's syndrome in a child. Gastroenterol. Clin. Biol. Sep 16 [Epub ahead of print] (2009).

• Tishler M, Alosachie I, Barka N, Lin HC, Gershwin ME, Peter JB, Shoenfeld Y. Primary Sjogren's syndrome and primary biliary cirrhosis: differences and similarities in the autoantibody profile. Clin. Exp. Rheumatol. 13: 497-500 (1995).

• To CH, Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum. 52: 4003-4010 (2005). *

• Tobon GJ, Correa PA, Gomez LM, Anaya JM. Lack of association between TNF-308 polymorphism and the clinical and immunological characteristics of systemic lupus erythematosus and primary Sjogren's syndrome. Clin. Exp. Rheumatol. 23: 339-344 (2005).

• Tobon GJ, Pers JO, Youinou P, Saraux A. B cell-targeted therapies in Sjogren's syndrome. Autoimmun. Rev. Aug 8 [Epub ahead of print] (2009).

• Toda I, Asano-Kato N, Hori-Komai Y, Tsubota K. Ocular surface treatment before laser in situ keratomileusis in patients with severe dry eye. J. Refract. Surg. 20: 270-275 (2004).

• Toda I, Sullivan BD, Rocha EM, Da Silveira LA, Wickham LA, Sullivan DA. Impact of gender on exocrine gland inflammation in mouse models of Sjogren's syndrome. Exp. Eye Res. 69: 355-366 (1999).

• Toda Y, Aoki R, Ikeda Y, Azuma Y, Kioka N, Matsuo M, Sakamoto M, Mori S, Fukumoto M, Ueda K. Detection of ABCA7-positive cells in salivary glands from patients with Sjogren's syndrome. Pathol. Int. 55: 639-643 (2005). *

• Togawa Y, Shinkai H, Utani A. Prurigo pigmentosa in a patient with primary biliary cirrhosis and Sjogren syndrome. J. Dermatol. 31: 815-819 (2004).

• Toker E, Yavuz S, Direskeneli H. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjogren's syndrome. Br. J. Ophthalmol. 88: 384-387 (2004).

• Tokuno T, Takahashi H, Suzuki C, Yamamoto M, Naishiro Y, Sugaya A, Sakamoto H, Imai K. Analysis of B-cell clonality in the hepatic tissue of patients with Sjogren's syndrome. Scand. J. Rheumatol. 32: 268-272 (2003).

• Tomiak C, Dorner T. Sjogren's syndrome: current aspects from a rheumatological point of view. Z. Rheumatol. 65: 505-519 (2006).

• Tosun M, Karkucak M, Capkin E, Cakirbay H, Guler M, Topbas M. Coexisting ankylosing spondylitis and Sjogren's syndrome: a case report. Rheumatol. Int. 25: 478-480 (2005). *

• Toubi E, Shoenfeld Y. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 37: 457-464 (2004).

• Toussirot E, Lohse A, Wendling D, Mougin C. Sjogren's syndrome occurring after hepatitis B vaccination. Arthritis Rheum. 43: 2139-2140 (2000). *

• Triantafyllopoulou A, Moutsopoulos HM. Autoimmunity and coxsackievirus infection in primary Sjogren's syndrome. Ann. N. Y. Acad. Sci. 1050: 389-396 (2005). *

• Triantafyllopoulou A, Tapinos N, Moutsopoulos HM. Evidence for coxsackievirus infection in primary Sjogren's syndrome. Arthritis Rheum. 50: 2897-2902 (2004). *

• Trousdale MD, Zhu Z, Stevenson D, Schechter JE, Ritter T, Mircheff AK. Expression of TNF inhibitor gene in the lacrimal gland promotes recovery of tear production and tear stability and reduced immunopathology in rabbits with induced autoimmune dacryoadenitis. J. Autoimmune Dis. 2: 6 (2005). *

• Tsai TC, Chen CY, Lin WT, Lee WJ, Chen HC. Sjogren's syndrome complicated with IgA nephropathy and leukocytoclastic vasculitis. Ren. Fail. 30: 755-758 (2008).

• Tsianos EV, Hoofnagle JH, Fox PC, Alspaugh M, Jones EA, Schafer DF, Moutsopoulos HM. Sjogren's syndrome in patients with primary biliary cirrhosis. Hepatology 11: 730-734 (1990).

• Tsuboi H, Katsuoka K. Ulcerative lichen planus associated with Sjogren's syndrome. J. Dermatol. 34: 131-134 (2007).

• Tsuji K, Suzuki D, Naito Y, Sato Y, Yoshino T, Iwatsuki K. Primary cutaneous marginal zone B-cell lymphoma. Eur. J. Dermatol. 15: 480-483 (2005).

• Tsunemi Y, Tada Y, Saeki H, Ihn H, Tamaki K. Multiple dermatofibromas in a patient with systemic lupus erythematosus and Sjogren's syndrome. Clin. Exp. Dermatol. 29: 483-485 (2004). *

• Tsuneyama K, Nose M, Nisihara M, Katayanagi K, Harada K, Nakanuma Y. Spontaneous occurrence of chronic non-suppurative destructive cholangitis and antimitochondrial autoantibodies in MRL/lpr mice: possible animal model for primary biliary cirrhosis. Pathol. Int. 51: 418-424 (2001). *

• Tsuneyama K, Van de Water J, Nakanuma Y, Cha S, Ansari A, Coppel R, Gershwin ME. Human combinatorial autoantibodies and mouse monoclonal antibodies to PDC-E2 produce abnormal apical staining of salivary glands in patients with coexistent primary biliary cirrhosis and Sjogren's syndrome. Hepatology 20: 893-898 (1994).

• Tsuneyama K, Van De Water J, Van Thiel D, Coppel R, Ruebner B, Nakanuma Y, Dickson ER, Gershwin ME. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis. Hepatology 22: 1440-1446 (1995).

• Tsuneyama K, Van De Water J, Yamazaki K, Suzuki K, Sato S, Takeda Y, Ruebner B, Yost BA, Nakanuma Y, Coppel RL, Gershwin ME. Primary biliary cirrhosis an epithelitis: evidence of abnormal salivary gland immunohistochemistry. Autoimmunity 26: 23-31 (1997).

• Tsurumaru M, Kawasaki E, Ida H, Migita K, Moriuchi A, Fukushima K, Fukushima T, Abiru N, Yamasaki H, Noso S, Ikegami H, Awata T, Sasaki H, Eguchi K. Evidence for the role of small ubiquitin-like modifier 4 (SUMO4) as a general autoimmunity locus in Japanese population. J. Clin. Endocrinol. Metab. 91: 3138-3143 (2006). *

• Tsutsumi A, Sasaki K, Wakamiya N, Ichikawa K, Atsumi T, Ohtani K, Suzuki Y, Koike T, Sumida T. Mannose-binding lectin gene: polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome. Genes Immun. 2: 99-104 (2001). *

• Tubach F, Hayem G, Elias A, Nicaise P, Haim T, Kahn MF, Meyer O. Anticentromere antibodies in rheumatologic practice are not consistently associated with scleroderma. Rev. Rhum. Engl. Ed. 64: 362-367 (1997).

• Tuisku IS, Konttinen YT, Soinila S, Karma A, Tervo TM. Neurosarcoidosis mimicking Sjogren's syndrome. Acta Ophthalmol. Scand. 82: 599-602 (2004). *

• Tuli SS, Schultz GS, Downer DM. Science and strategy for preventing and managing corneal ulceration. Ocul. Surf. 5: 23-39 (2007).

• Tumiati B, Casoli P, Parmeggiani A. Hearing loss in the Sjogren syndrome. Ann. Intern. Med. 126: 450-453 (1997).

• Tunc R, Gonen MS, Acbay O, Hamuryudan V, Yazici H. Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren's syndrome: a case-control study. Ann. Rheum. Dis. 63: 575-577 (2004). *

• Turkcapar N, Kinikli G, Sak SD, Duman M. Specific immunotherapy-induced Sjogren's syndrome. Rheumatol. Int. 26: 182-184 (2005). *

• Turkcapar N, Olmez U, Ozer D, Duzgun N, Duman M. A case of overlap syndrome with rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis and secondary Sjogren's syndrome. Rheumatol. Int. 26: 841-845 (2006). *

• Turkcapar N, Olmez U, Tutkak H, Duman M. The importance of alpha-fodrin antibodies in the diagnosis of Sjogren's syndrome. Rheumatol. Int. 26: 354-359 (2006). *

• Turpie B, Yoshimura T, Gulati A, Rios JD, Dartt DA, Masli S. Sjogren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice. Am. J. Pathol. 175: 1136-1147 (2009). *

• Tutuncu Z, Morgan GJ Jr, Kavanaugh A. Anti-TNF therapy for other inflammatory conditions. Clin. Exp. Rheumatol. 20 (6 Suppl. 28): S146-S151 (2002).

• Tyndall A. Hematopoietic stem cell transplantation in rheumatic diseases other than systemic sclerosis and systemic lupus erythematosus. J. Rheumatol. Suppl. 48: 94-97 (1997).

• Tzioufas AG, Moutsopoulos HM. Ultrasonography of salivary glands: an evolving approach for the diagnosis of Sjogren's syndrome. Nat. Clin. Pract. Rheumatol. 4: 454-455 (2008).

• Tzioufas AG, Tsonis J, Moutsopoulos HM. Neuroendocrine dysfunction in Sjogren's syndrome. Neuroimmunomodulation 15: 37-45 (2008).

• Tzioufas AG, Voulgarelis M. Update on Sjogren's syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract. Res. Clin. Rheumatol. 21: 989-1010 (2007).

• Uchiyama-Tanaka Y, Mori Y, Kimura T, Sonomura K, Umemura S, Kishimoto N, Nose A, Tokoro T, Kijima Y, Yamahara H, Nagata T, Masaki H, Umeda Y, Okazaki K, Iwasaka T. Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am. J. Kidney Dis. 43: e18-e25 (2004).

• Uddenfeldt P, Danielsson A, Forssell A, Holm M, Ostberg Y. Features of Sjogren's syndrome in patients with primary biliary cirrhosis. J. Intern. Med. 230: 443-448 (1991).

• Uehara T, Hamano H, Kawa S, Sano K, Honda T, Ota H. Distinct clinicopathological entity 'autoimmune pancreatitis-associated sclerosing cholangitis'. Pathol. Int. 55: 405-411 (2005). *

• Ueno Y, Ishii M, Igarashi T, Mano Y, Yahagi K, Kisara N, Kobayashi Y, Niitsuma H, Kobayashi K, Shimosegawa T. Primary biliary cirrhosis with antibody against carbonic anhydrase II associates with distinct immunological backgrounds. Hepatol. Res. 20: 18-27 (2001).

• Ueno Y, Shibata M, Onozuka Y. Association of extrahepatic autoimmune diseases in primary biliary cirrhosis - clinical statistics and analyses of Japanese and non-Japanese cases. Nippon Rinsho 56: 2687-2698 (1998).

• Uesugi H, Ozaki S, Sobajima J, Osakada F, Shirakawa H, Yoshida M, Nakao K. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases. J. Rheumatol. 25: 703-709 (1998).

• Ulcova-Gallova Z, Brabcova H, Kokes V, Hradecky L, Novotny Z, Rokyta Z. History of incidence of autoimmune and oncological diseases in identical female twins. Am. J. Reprod. Immunol. 62: 349-351 (2009).

• Ulvestad E. Modelling autoimmune rheumatic disease: a likelihood rationale. Scand. J. Immunol. 58: 106-111 (2003). *

• Umehara H, Sawaki T, Kawanami T, Masaki Y, Fukushima T. Sjogren's syndrome. Nippon Rinsho 67: 511-516 (2009).

• Valera MJM, Smok SG, Poniachik TJ, Oksenberg RD, Silva PG, Ferrario BM, Buckel GE, Brahm BJ. Primary biliary cirrhosis: a thirteen years experience. Rev. Med. Chil. 134: 469-474 (2006).

• Valtysdottir ST, Wide L, Hallgren R. Mental wellbeing and quality of sexual life in women with primary Sjogren's syndrome are related to circulating dehydroepiandrosterone sulphate. Ann. Rheum. Dis. 62: 875-879 (2003). *

• van Blokland SC, van Helden-Meeuwsen CG, Wierenga-Wolf AF, Drexhage HA, Hooijkaas H, van de Merwe JP, Versnel MA. Two different types of sialoadenitis in the NOD- and MRL/lpr mouse models for Sjogren's syndrome: a differential role for dendritic cells in the initiation of sialoadenitis? Lab. Invest. 80: 575-585 (2000).

• Van Buuren HR, Vleggaar FP, Willemien Erkelens G, Zondervan PE, Lesterhuis W, Van Eijck CH, Puylaert JB, Van Der Werf SD. Autoimmune pancreatocholangitis: a series of ten patients. Scand. J. Gastroenterol. Suppl. 243: 70-78 (2006). *

• Van De Merwe JP, Yamada T, Sakamoto Y. Systemic aspects of interstitial cystitis, immunology and linkage with autoimmune disorders. Int. J. Urol. 10 Suppl. 1: S35-S38 (2003).

• van den Brink DM, van Miert JM, Wanders RJ. A novel assay for the prenatal diagnosis of Sjogren-Larsson syndrome. J. Inherit. Metab. Dis. 28: 965-969 (2005). *

• van den Brink DM, van Miert JN, Dacremont G, Rontani JF, Jansen GA, Wanders RJ. Identification of fatty aldehyde dehydrogenase in the breakdown of phytol to phytanic acid. Mol. Genet. Metab. 82: 33-37 (2004). *

• Van Mello NM, Pillemer SR, Tak PP, Sankar V. B cell MALT lymphoma diagnosed by labial minor salivary gland biopsy in patients screened for Sjogren's syndrome. Ann. Rheum. Dis. 64: 471-473 (2005). *

• Van Rappard-Van Der Veen FM, Radaszkiewicz T, Terraneo L, Gleichmann E. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice. J. Immunol. 130: 2693-2701 (1983).

• van Woerkom JM, Geertzema JG, Nikkels PG, Kruize AA, Smeenk RJ, Vroom TM. Expression of Ro/SS-A and La/SS-B determined by immunohistochemistry in healthy, inflamed and autoimmune diseased human tissues: a generalized phenomenon. Clin. Exp. Rheumatol. 22: 285-292 (2004).

• Vander Cruyssen B, Peene I, Cantaert T, Hoffman IE, De Rycke L, Veys EM, De Keyser F. Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor. Autoimmun. Rev. 4: 468-474 (2005).

• Vandergheynst F, Ocmant A, Sordet C, Humbel RL, Goetz J, Roufosse F, Cogan E, Sibilia J. Anti-PM/Scl antibodies in connective tissue disease: clinical and biological assessment of 14 patients. Clin. Exp. Rheumatol. 24: 129-133 (2006).

• Vassiliou VA, Moyssakis I, Boki KA, Moutsopoulos HM. Is the heart affected in primary Sjogren's syndrome? An echocardiographic study. Clin. Exp. Rheumatol. 26: 109-112 (2008).

• Vazquez JJ, Vazquez M, Idoate MA, Montuenga L, Martinez-Anso E, Castillo JE, Garcia N, Medina JF, Prieto J. Anion exchanger immunoreactivity in human salivary glands in health and Sjogren's syndrome. Am. J. Pathol. 146: 1422-1432 (1995). *

• Venables PJ. Sjogren's syndrome. Best Pract. Res. Clin. Rheumatol. 18: 313-329 (2004).

• Versapuech JM, Labayle D, Grange D, Fischer D, Kemeny F, D'Hubert E. Sclerosing cholangitis, chronic pancreatitis and Sjogren's syndrome. Ann. Med. Interne. (Paris) 137: 147-151 (1986).

• Versnel MA. Id3 knockout mice as a new model for Sjogren's syndrome; only a T cell defect or more? Immunity 21: 457-458 (2004). *

• Versura P, Frigato M, Bernabini B, Mule R, Malavolta N, Campos EC. Ocular surface analysis in patients affected with rheumatic diseases. Reumatismo 56: 262-271 (2004).

• Versura P, Frigato M, Cellini M, Mule R, Malavolta N, Campos EC. Diagnostic performance of tear function tests in Sjogren's syndrome patients. Eye 21: 229-237 (2007).

• Versura P, Frigato M, Mule R, Malavolta N, Campos EC. A proposal of new ocular items in Sjogren's syndrome classification criteria. Clin. Exp. Rheumatol. 24: 567-572 (2006).

• Vianello M, Vitaliani R, Pezzani R, Nicolao P, Betterle C, Keir G, Thompson EJ, Tavolato B, Scaravilli F, Giometto B. The spectrum of antineuronal autoantibodies in a series of neurological patients. J. Neurol. Sci. 220: 29-36 (2004). *

• Villalta D, Tonutti E, Tampoia M, Bizzaro N, Papisch W, Tozzoli R, Stella S. Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection. Clin. Chem. Lab. Med. 42: 1161-1167 (2004).

• Vitale S, Goodman LA, Reed GF, Smith JA. Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjogren's syndrome-related dry eye. Health Qual. Life Outcomes 2: 44 (2004). *

• Vitali C. Measurement of disease activity and damage in Sjogren's syndrome. Rheum. Dis. Clin. North Am. 34: 963-971 (2008).

• Vogelsang P, Jonsson MV, Dalvin ST, Appel S. Role of dendritic cells in Sjogren's syndrome. Scand. J. Immunol. 64: 219-226 (2006). *

• Voitharou C, Krikorian D, Sakarellos C, Sakarellos-Daitsiotis M, Panou-Pomonis E. A complementary La/SSB epitope anchored to sequential oligopeptide carrier regulates the anti-La/SSB response in immunized animals. J. Pept. Sci. 14: 1069-1076 (2008). *

• Volter F, Fain O, Mathieu E, Thomas M. Esophageal function and Sjogren's syndrome. Dig. Dis. Sci. 49: 248-253 (2004). *

• Vosters JL, Landek-Salgado MA, Yin H, Swaim WD, Kimura H, Tak PP, Caturegli P, Chiorini JA. Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjogren's syndrome. Arthritis Rheum. 60: 3633-3641 (2009). *

• Vosters JL, Yin H, Roescher N, Kok MR, Tak PP, Chiorini JA. Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjogren's syndrome. Arthritis Res. Ther. 11: R189 (2009). *

• Voulgarelis M, Skopouli FN. Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients. Clin. Rev. Allergy Immunol. 32: 265-274 (2007). *

• Voulgarelis M, Tzioufas AG, Moutsopoulos HM. Mortality in Sjogren's syndrome. Clin. Exp. Rheumatol. 26: S66-S71 (2008).

• Wada K, Kamitani T. Autoantigen Ro52 is an E3 ubiquitin ligase. Biochem. Biophys. Res. Commun. 339: 415-421 (2006). *

• Wakatsuki T, Miyata M, Shishido S, Suzuki T, Ohira H, Kokubun M, Sato Y, Yamamoto T, Kasukawa R. Sjogren's syndrome with primary biliary cirrhosis, complicated by transverse myelitis and malignant lymphoma. Intern. Med. 39: 260-265 (2000). *

• Wallace JG Jr, Tong MJ, Ueki BH, Quismorio FP. Pulmonary involvement in primary biliary cirrhosis. J. Clin. Gastroenterol. 9: 431-435 (1987).

• Wallaert B, Prin L, Hatron PY, Ramon P, Tonnel AB, Voisin C. Lymphocyte subpopulations in bronchoalveolar lavage in Sjogren's syndrome. Evidence for an expansion of cytotoxic/suppressor subset in patients with alveolar neutrophilia. Chest 92: 1025-1031 (1987). *

• Wanchu A, Chawla Y, Dhiman RK, Sud A, Bambery P. Paucity of anti-hepatitis C virus antibodies in the serum of Indian patients with Sjogren's syndrome and inflammatory myositis. Indian J. Pathol. Microbiol. 46: 191-193 (2003).

• Wang PZ, Lu Q, Chen SL, Jiang YH. The pathological changes of lip biopsies and dental caries on Sjogren's syndrome. Shanghai Kou Qiang Yi Xue 2: 77-79 (1993).

• Wang XF, Yuan SL, Jiang L, Zhang XL, Li SF, Guo Y, Wu CL, Chen JJ. Changes of serum BAFF and IL-21 levels in patients with systemic lupus erythematosus and their clinical significance. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 23: 1041-1042 (2007).

• Wang Y, Shnyra A, Africa C, Warholic C, McArthur C. Activation of the extrinsic apoptotic pathway by TNF-alpha in human salivary gland (HSG) cells in vitro, suggests a role for the TNF receptor (TNF-R) and intercellular adhesion molecule-1 (ICAM-1) in Sjogren's syndrome-associated autoimmune sialadenitis. Arch. Oral Biol. 54: 986-996 (2009).

• Wang Y, Virji AS, Howard P, Sayani Y, Zhang J, Achu P, McArthur C. Detection of cleaved alpha-fodrin autoantigen in Sjogren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands. Arch. Oral Biol. 51: 558-566 (2006).

• Wang Y, Wang SL, Zou YZ, Luan GM. Psychiatric and central nervous system involvement in Sjogren's syndrome. Zhonghua Kou Qiang Yi Xue Za Zhi 39: 158-160 (2004).

• Wang ZY, Morinobu A, Kanagawa S, Kumagai S. Polymorphisms of the mannose binding lectin gene in patients with Sjogren's syndrome. Ann. Rheum. Dis. 60: 483-486 (2001). *

• Waterhouse JC, Perez TH, Albert PJ. Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease. Ann. N. Y. Acad. Sci. 1173: 757-765 (2009). *

• Whelan BR, Isenberg DA. mAbs in nonlupus autoimmune rheumatic disease. Curr. Opin. Hematol. 16: 280-284 (2009).

• Whitehead EM, Daly JG, Hayes JR. Renal tubular acidosis in association with Sjogren's syndrome, primary biliary cirrhosis and coeliac disease. Ir. J. Med. Sci. 156: 124-125 (1987).

• Whittingham S, Mackay IR, Tait BD. Autoantibodies to small nuclear ribonucleoproteins. A strong association between anti-SS-B(La), HLA-B8, and Sjogren's syndrome. Aust. N. Z. J. Med. 13: 565-570 (1983).

• Whittingham S, McNeilage J, Mackay IR. Primary Sjogren's syndrome after infectious mononucleosis. Ann. Intern. Med. 102: 490-493 (1985).

• Wielosz E, Majdan M, Zychowska I, Jeleniewicz R. Coexistence of five autoimmune diseases: diagnostic and therapeutic difficulties. Rheumatol. Int. 28: 919-923 (2008). *

• Wildenberg ME, van Helden-Meeuwsen CG, van de Merwe JP, Moreno C, Drexhage HA, Versnel MA. Lack of CCR5 on dendritic cells promotes a proinflammatory environment in submandibular glands of the NOD mouse. J. Leukoc. Biol. 83: 1194-1200 (2008). *

• Williams BO, St Onge RA, Young A, Nuki G, Dick WC, Whaley K. Penicillin allergy in rheumatoid arthritis. With special reference to Sjogren's syndrome. Ann. Rheum. Dis. 28: 607-611 (1969).

• Williams PH, Cobb BL, Namjou B, Scofield RH, Sawalha AH, Harley JB. Horizons in Sjogren's syndrome genetics. Clin. Rev. Allergy Immunol. 32: 201-209 (2007). *

• Witte T. Pathogenesis and diagnosis of Sjogren's syndrome. Z. Rheumatol. 69: 50-56 (2010).

• Witte T, Matthias T, Bierwirth J, Schmidt RE. Antibodies against alpha-fodrin are associated with sicca syndrome in the general population. Ann. N. Y. Acad. Sci. 1108: 414-417 (2007). *

• Wolke AM, Schaffner F, Kapelman B, Sacks HS. Malignancy in primary biliary cirrhosis. High incidence of breast cancer in affected women. Am. J. Med. 76: 1075-1078 (1984).

• Wu HJ, Bondada S. CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function. J. Clin. Immunol. 29: 12-21 (2009). *

• Wu R, Shovman O, Zhang Y, Gilburd B, Zandman-Goddard G, Shoenfeld Y. Increased prevalence of anti-third generation cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and CREST syndrome. Clin. Rev. Allergy Immunol. 32: 47-56 (2007).

• Yamamoto M, Harada S, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, Takahashi H, Imai K. Clinical and pathological differences between Mikulicz's disease and Sjogren's syndrome. Rheumatology (Oxford) 44: 227-234 (2005). *

• Yamamoto M, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, Takahashi H, Imai K. Elevated IgG4 concentrations in serum of patients with Mikulicz's disease. Scand. J. Rheumatol. 33: 432-433 (2004).

• Yamamoto M, Takahashi H, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, Shinomura Y, Imai K. A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease. Mod. Rheumatol. 16: 335-340 (2006). *

• Yamamoto S, Imoto T, Ohashi Y, Inoue S, Yamada E, Kaneko S, Morimoto S, Kubota S, Ichida T, Inoue K. Case of primary biliary cirrhosis complicated with Sjogren's syndrome: a diagnostic difficulty with hepatic biopsy lacking the sign of chronic non-suppurative destructive cholangitis and a negative anti-glomerular antibody reaction. Nippon Naika Gakkai Zasshi 83: 632-634 (1994).

• Yamasaki Y, Narain S, Hernandez L, Barker T, Ikeda K, Segal MS, Richards HB, Chan EK, Reeves WH, Satoh M. Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases. Arthritis Res. Ther. 8: R111 (2006). *

• Yamasaki Y, Narain S, Yoshida H, Hernandez L, Barker T, Hahn PC, Sobel ES, Segal MS, Richards HB, Chan EK, Reeves WH, Satoh M. Autoantibodies to RNA helicase A: a new serologic marker of early lupus. Arthritis Rheum. 56: 596-604 (2007). *

• Yamazaki M, Kitamura R, Kusano S, Eda H, Sato S, Okawa-Takatsuji M, Aotsuka S, Yanagi K. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjogren's syndrome patients… Clin. Exp. Immunol. 139: 558-568 (2005). *

• Yamout B, El-Hajj T, Barada W, Uthman I. Successful treatment of refractory neuroSjogren with rituximab. Lupus 16: 521-523 (2007).

• Yan HP, Zhuang H, Liu YM, Feng X, Tan YF, Liu Y, Zhang X, Zhao CH. Immunological characteristics of primary biliary cirrhosis patients. Zhonghua Gan Zang Bing Za Zhi 13: 12-16 (2005).

• Yang CH, Chen JY, Lee SC, Luo SF. Successful preventive treatment of congenital heart block during pregnancy in a woman with systemic lupus erythematosus and anti-Sjogren's syndrome A/Ro antibody. J. Microbiol. Immunol. Infect. 38: 365-369 (2005). *

• Yasuda S, Ogura N, Horita T, Yasuda I, Hioka T, Kondo N, Fujisaku A. Abacterial prostatitis and primary biliary cirrhosis with Sjogren's syndrome. Mod. Rheumatol. 14: 70-72 (2004).

• Yavuz S, Toker E, Bicakcigil M, Mumcu G, Cakir S. Comparative analysis of autoantibodies against a-fodrin in serum, tear fluid, and saliva from patients with Sjogren's syndrome. J. Rheumatol. 33: 1289-1292 (2006).

• Ye MQ, Suriawinata A, Black C, Min AD, Strauchen J, Thung SN. Primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type in a patient with primary biliary cirrhosis. Arch. Pathol. Lab. Med. 124: 604-608 (2000). *

• Yen JH, Chen CJ, Tsai WC, Lin CH, Ou TT, Hu CJ, Liu HW. Manganese superoxide dismutase and cytochrome P450 1A1 genes polymorphisms in rheumatoid arthritis in Taiwan. Hum. Immunol. 64: 366-373 (2003).

• Yen JH, Tsai WC, Chen CJ, Ou TT, Lin CH, Hu CJ, Liu HW. Tumor necrosis factor receptor 2 microsatellite and exon 6 polymorphisms in rheumatoid arthritis in Taiwan. J. Rheumatol. 30: 438-442 (2003).

• Ying M, Ahuja AT, Yuen HY. Grey-scale and power Doppler sonography of unusual cervical lymphadenopathy. Ultrasound Med. Biol. 30: 449-454 (2004). *

• Yoneyama K, Tochigi N, Oikawa A, Shinkai H, Utani A. Primary localized cutaneous nodular amyloidosis in a patient with Sjogren's syndrome: a review of the literature. J. Dermatol. 32: 120-123 (2005).

• Yoon KC, Jeong IY, Park YG, Yang SY. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea 26: 431-437 (2007).

• Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig. Dis. Sci. 40: 1561-1568 (1995).

• Yoshida M, Okabe M, Eimoto T, Shimizu S, Ueda-Otsuka K, Okamoto M, Ishii G, Ueda R, Chan JK, Nakamura S, Inagaki H. Immunoglobulin V(H) genes in thymic MALT lymphoma are biased toward a restricted repertoire and are frequently unmutated. J. Pathol. 208: 415-422 (2006). *

• You X, Liu W, Zhang X, Zhang FC. Patterns of anti-nuclear antibodies in patients with primary biliary cirrhosis and primary Sjogren syndrome. Zhonghua Yi Xue Za Zhi 88: 168-170 (2008).

• Youinou P. Sjogren's syndrome: a quintessential B cell-induced autoimmune disease. Joint Bone Spine 75: 1-2 (2008). *

• Youinou P, Pers JO, Saraux A, Pennec YL. Viruses contribute to the development of Sjogren's syndrome. Clin. Exp. Immunol. 141: 19-20 (2005). *

• Youssef WI, Tavill AS. Connective tissue diseases and the liver. J. Clin. Gastroenterol. 35: 345-349 (2002).

• Yu CQ, Hu BP, Zheng LY, Ding YM. The analysis and discussion of clinical features and treatment of tumor-like Sjogren's syndrome in 46 cases. Shanghai Kou Qiang Yi Xue 10: 302-304 (2001).

• Yu CQ, Liu WL, Hu BP, Lu CY. Current research in the etiology and mechanism of Sjogren's syndrome. Shanghai Kou Qiang Yi Xue 8: 184-186 (1999).

• Yu CQ, Qiu WL. Oral manifestation and diagnosis of Sjogren's syndrome. Shanghai Kou Qiang Yi Xue 7: 117-120 (1998).

• Yu CQ, Qiu WL, Hu BP, Ding YM. Detection of clinical diagnosis and different symptoms of Sjogren's syndrome by traditional Chinese medicine (TCM). Shanghai Kou Qiang Yi Xue 8: 21-23 (1999).

• Yu CQ, Qiu WL, Hu BP, Ding YM. Experimental research on animal model and treatment of Sjogren's syndrome by traditional Chinese medicine (TCM). Shanghai Kou Qiang Yi Xue 8: 24-26 (1999).

• Yukawa S, Tahara K, Yukawa N, Shoji A, Tsuji S, Hayashi H, Tsuboi N. Dramatic regression of mesenteric abnormalities demonstrated on angiography following prednisolone and cyclophosphamide combination therapy in a patient with polyarteritis nodosa associated with Sjogren's syndrome. Mod. Rheumatol. 18: 416-421 (2008). *

• Yurtseven N, Gokalp S. Oral sugar clearance and other caries-related factors of stimulated whole saliva in patients with secondary Sjogren syndrome. Quintessence Int. 38: E151-E157 (2007).

• Zadura AF, Theander E, Blom AM, Trouw LA. Complement Inhibitor C4b-binding protein in primary Sjogren's syndrome and its association with other disease markers. Scand. J. Immunol. 69: 374-380 (2009). *

• Zamboni G, Luttges J, Capelli P, Frulloni L, Cavallini G, Pederzoli P, Leins A, Longnecker D, Kloppel G. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 445: 552-563 (2004). *

• Zandbelt MM, De Wilde P, Van Damme P, Hoyng CB, Van De Putte L, Van Den Hoogen F. Etanercept in the treatment of patients with primary Sjogren's syndrome: a pilot study. J. Rheumatol. 31: 96-101 (2004).

• Zandbelt MM, Vogelzangs J, Van De Putte LB, Van Venrooij WJ, Van Den Hoogen FH. Anti-alpha-fodrin antibodies do not add much to the diagnosis of Sjogren's syndrome. Arthritis Res. Ther. 6: R33-R38 (2004). *

• Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun. Rev. 1: 329-337 (2002).

• Zapata LF, Agudelo LM, Paulo JD, Pineda R. Sjogren keratoconjunctivitis sicca treated with rituximab. Cornea 26: 886-887 (2007).

• Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T, de Bakker PI, Abecasis GR, Almgren P, Andersen G, Ardlie K, Bostrom KB, Bergman RN, Bonnycastle LL, Borch-Johnsen K, Burtt NP, Chen H, Chines PS, Daly MJ, Deodhar P, Ding CJ, et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet. 40: 638-645 (2008). *

• Zeher M, Horvath IF, Szanto A, Szodoray P. Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjogren's syndrome. Thyroid 19: 39-45 (2009).

• Zelissen PM, Bast EJ, Croughs RJ. Associated autoimmunity in Addison's disease. J. Autoimmun. 8: 121-130 (1995).

• Zeng QY, Chen R, Darmarwan J, Xiao ZY, Chen SB, Wigley R, Chen SL, Zhang NZ. Rheumatic diseases in China. Arthritis Res. Ther. 10: R17 (2008). *

• Zervou MI, Goulielmos GN, Castro-Giner F, Tosca AD, Krueger-Krasagakis S. STAT4 gene polymorphism is associated with psoriasis in the genetically homogeneous population of Crete, Greece. Hum. Immunol. 70: 738-741 (2009).

• Zhang F, Jia J, Cui R, Wang B, Wang H. Clinical features of forty patients with primary biliary cirrhosis. Chin. Med. J. (Engl.) 115: 904-908 (2002).

• Zhang F, Jia J, Wang B, Qian L, Yin S, Wang Y, Cui Y, You H, Ma H, Wang H, Zhang C. Clinical characteristics of primary biliary cirrhosis: a report of 45 cases. Zhonghua Nei Ke Za Zhi 41: 163-167 (2002).

• Zhang XW, Liu X, Li ZG. Clinical features of undifferentiated connective tissue diseases: analysis of 145 patients. Zhonghua Yi Xue Za Zhi 86: 2458-2461 (2006).

• Zhang Y, Holford TR, Leaderer B, Zahm SH, Boyle P, Morton LM, Zhang B, Zou K, Flynn S, Tallini G, Owens PH, Zheng T. Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women. Cancer Causes Control 15: 419-428 (2004). *

• Zheng LY, Yu CQ, Hu BP, Ha Q. Preliminary study on diagnosis of tumor-like Sjogren's syndrome. Shanghai Kou Qiang Yi Xue 9: 138-140 (2000).

• Zhou JG, Qing YF, Jiang L, Yang QB, Luo WF. Clinical analysis of primary Sjogren's syndrome complicating anemia. Clin. Rheumatol. Feb 20 [Epub ahead of print] (2010). *

• Zhou JG, Zheng M. Role of HMGB1 in rheumatic diseases. Zhejiang Da Xue Xue Bao Yi Xue Ban 36: 412-416 (2007).

• Ziakas PD, Routsias JG, Giannouli S, Tasidou A, Tzioufas AG, Voulgarelis M. Suspects in the tale of lupus-associated thrombocytopenia. Clin. Exp. Immunol. 145: 71-80 (2006). *

• Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch. Intern. Med. 165: 2337-2344 (2005). *

• Zoukhri D. Effect of inflammation on lacrimal gland function. Exp. Eye Res. 82: 885-898 (2006). *

• Zucker-Franklin D. Non-HIV retroviral associations with rheumatic disease. Curr. Rheumatol. Rep. 2: 156-162 (2000).

• Zurgil N, Bakimer R, Moutsopoulos HM, Tzioufas AG, Youinou P, Isenberg DA, Scheinberg M, Kveder T, Rozman B, Luderschmidt C, et al. Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases. J. Clin. Immunol. 12: 201-209 (1992).

• Zylberait D, Krulik M, Audebert AA, Debray J, Darnis F. Association of scleroderma with primary biliary cirrhosis. Sem. Hop. 55: 1473-1478 (1979).

Number of references = 1342

www psc-literature.org